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Alveolar ridge is a tooth dependent structure. Following tooth extraction, volume reduction 
and dimensional changes take place. These changes often make it difficult to replace the 
missing teeth due to a lack of bony support and compromised aesthetics.  
To minimise and overcome these issues various alveolar ridge preservation techniques (ARP) 
have been developed. One of the more commonly used techniques is treatment with bone 
replacement graft material (BRG) covered by a barrier membrane. One of the more frequently 
used BRG materials in Australasia is Bio-Oss® (Geislich, Switzerland) in combination with 
Bio-Gide® (Geistlich, Switzerland) membrane. This project sought to compare established 
membrane Bio-Gide® to Ovine Forestomach Matrix (OFM, Aroa Biosurgery Limited, New 
Zealand). 
Objectives 
To conduct a systematic review and assess the existing evidence for outcomes of bone 
xenograft in combination with resorbable collagen membranes for alveolar ridge preservation 
in randomised clinical trials in non-human and human experimental models. To analyse healing 
outcomes and compare OFM to Bio-Gide® in a pre-clinical and histological equivalency trial; 
and to test non-inferiority between these two membranes. 
Materials and methods 
Thirty sheep underwent the extraction of three left mandibular premolars. Using Latin-square 
allocation three treatment groups were assigned. Treatment A (OFM + Bio-Oss®), treatment B 
(Bio-Gide® + Bio-Oss®, positive control) and treatment C (naturally healed socket, negative 
control). Ten animals were allocated to each of three healing time points of 4-, 8- and 16-weeks. 
After the allocated healing time the animals were euthanised, mandibles dissected, and 
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At four weeks, all sockets mostly comprised connective tissue. The sites grafted with BRG, 
regardless of membrane used, showed small projections of woven bone that extended towards 
the lumen of the socket and surrounded the Bio-Oss® particles. At eight weeks, the control 
sockets were still predominantly filled with connective tissue, while sockets with BRG formed 
a hard tissue bridge composed of woven bone between the buccal and lingual cortical plates. 
At 16-weeks of healing, complete bridging between socket margins was evident in all three 
groups. Histomorphometric analysis demonstrated significant new bone increase over time in 
OFM group (p<0.009). At 4-weeks the Bio-Gide® group had more residual bone graft 
compared to the OFM group, 13.92±10.64% and 5.45±6.59% respectively (p=0.005). 
However, this difference was not observed at 8- or 16-weeks. Both grafted groups have 
significantly less connective tissue compared to the ungrafted control group at 4-weeks 
(p<0.045). 
Radiographic and histology images of the same sites were matched well. 
Conclusion 
This study found that OFM demonstrated equivalent outcomes to Bio-Gide® membrane in 
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It is generally accepted that alveolar ridge is a tooth dependent structure and following tooth 
loss, it undergoes structural and dimensional changes (Lam, 1960; Pietrokovski and Massler 
1967; Schropp et al., 2003; Wang and Lang 2012). With tooth extractions frequently performed 
in dental offices around the world, edentulism, partial or complete, represents a potential 
clinical issue, especially when considering fixed tooth replacement options.  
One of the options for replacing extracted teeth is dental implants and their clinical use has 
been steadily rising over the past few years (Aghaloo et al., 2019; Berglundh et al., 2019; 
Blanco et al., 2019). Dental implant treatment is not a cheap exercise and needs to be planned 
and executed carefully. For the treatment to be successful, implants must be optimally 
positioned and surrounded by good quality bone (Darby et al., 2008). 
Unfortunately, following tooth extraction, alveolar ridge undergoes atrophy with significant 
dimensional and volumetric changes (Schropp et al., 2003; Vittorini et al., 2013). These 
changes result in reduced dimensions and quality of bone as well as a shift of the long axis of 
the ridge in a lingual direction, which may compromise outcomes of prosthodontic 
rehabilitation (Vittorini et al., 2013; Walker et al., 2017). 
To limit or overcome these changes, various alveolar ridge preservation techniques (ARP) have 
been developed over the years. These include, but are not limited to, the use of bone 
replacement graft (BRG) material on its own, the use of a barrier membrane on its own, or the 
combination of BRG and a barrier membrane (Darby et al., 2008; Llanos et al 2019; Nart et al 
2017). Significant reduction in ridge atrophy has been reported for sites treated with ARP 
compared to naturally healed sites, indicating that ARP shows promise (Barone et al., 2013; 
Cardaropoli et al., 2014; Fickl et al., 2008). However, not one material or technique to date has 
managed to completely eliminate post-extraction alveolar ridge loss (Atieh et al., 2015). 
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According to Darby, in Australia, one of the more commonly used barrier membranes for ARP 
is Bio-Gide® (Geistlich, Switzerland) (Darby et al., 2008). It is an animal-derived resorbable 
collagen membrane and is often used in combination with the BRG material Bio-Oss® 
(Geistlich, Switzerland). Currently, no “gold standard” material for ARP, that completely 
prevents ridge atrophy has been reported and the search for new and better materials continues. 
In New Zealand, Aroa Biosurgeries Ltd have developed a collagen membrane from ovine 
forestomach matrix (OFM) with a potential application in ARP. This study was designed to 
compare this biomaterial in combination with Bio-Oss® BRG material against a well-accepted 
oral regenerative membrane (Bio-Gide®) in an established ovine (sheep) tooth extraction 
model. The first, introductory, chapter will review the available literature on socket healing, 
ARP techniques and materials as well as the place of animal models in dental research. 
 
1.1 Alveolar ridge 
The shape and form of the alveolar ridge largely depends on the presence and position of the 
tooth within the bony envelope. It is the part of the jawbone that surrounds the roots of the teeth 
and whose development is intricately linked to their presence (Marks, 1995; Schroeder, 1986; 
Van der Weijden et al., 2009). Following tooth extraction, the alveolar ridge atrophies and 
decreases in size both vertically and horizontally, resulting in unsightly defects and 
compromised prosthodontic treatment (Chappuis et al., 2017). 
 
1.1.1 Alveolar ridge anatomy 
The anatomical configuration of the alveolar ridge can be considered in three main parts: 
cortical plates, central cancellous bone, and alveolar bone proper (Lang and Lindhe 2015; 
Nanci and Bosshardt 2006). Alveolar bone proper immediately surrounds the tooth and is also 
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known as the bundle bone or cribriform plate, as it provides the matrix for periodontal fibre 
attachment (Lang and Lindhe 2015). Encasing the bundle bone is the central cancellous bone 
with trabeculae and bone marrow organised in Haversian canals. The outermost layer of the 
alveolar ridge is the cortical plate, one on the buccal aspect of the jaw and one on the lingual. 
The cortical plates meet the bundle bone at the alveolar crest, and in that location the middle 
trabecular layer is absent (Nanci and Bosshardt 2006). 
 
1.1.2 Alveolar ridge alterations following tooth extraction 
It is well established that alveolar ridge atrophy takes place following extraction of a tooth. 
Extensive research has been carried out in this area in both animal and human studies (Amler, 
1960; Araujo and Lindhe 2005; Cardaropoli et al., 2003; Chappuis et al., 2017; Claflin, 1936). 
The healing of an extraction socket can generally be divided into three phases – the 
inflammatory phase, the proliferative phase and the modelling/remodelling phase, with all three 
phases taking place on the internal and external surfaces of the extraction socket (Amler, 1960; 
Araujo et al., 2015; Darby et al., 2008). The internal changes result in formation of bone within 
the socket, while the external changes lead to alveolar ridge atrophy and volume reduction 
(Schropp et al., 2003). Healing begins within minutes of extraction with the formation of a 
blood clot. Following clot formation, in the first 24 hours, inflammatory cells such as 
neutrophils and monocytes are recruited (through cytokine mediation) and begin to debride the 
wound. Neutrophils themselves serve as a source of pro-inflammatory cytokines and provide 
signals that activate keratinocytes and fibroblasts. Seventy-two hours after extraction the area 
is dominated by macrophages and fibroblasts, the blood clot gradually dissipates and is 
replaced by granulation tissue (Aukhil, 2000). Macrophages play an important role in 
formation of granulation tissue by secreting growth factors and cytokines that are involved in 
the proliferation and migration of fibroblasts and endothelial cells into the wound. One week 
23 
 
following tooth extraction, the blood clot is completely replaced by granulation tissue and 
osteoid is present at the base of the socket as uncalcified bone spindles (Darby et al., 2008). 
Over the next 2-3 weeks osteoid begins to mineralise and remodel, starting from the base of 
the socket and extending coronally. As these changes occur internally within the socket, 
externally the epithelium proliferates along the periphery of the socket, starting as early as four 
days after extraction and by six weeks after extraction re-epithelialisation is complete (Darby 
et al., 2008). Although the socket appears fully healed by five weeks post-extraction, the final 
bone density is not reached for a further nine to ten weeks. 
Simultaneous with internal changes, marked osteoclastic activity takes place on the external 
surfaces of buccal and lingual cortical plates in the first eight weeks following extraction 
(Araujo and Lindhe 2005; Schropp et al., 2003). Several animal studies conducted by Araujo 
and colleagues specifically investigated the external changes of the post-extraction socket. 
These studies reported that two weeks following extraction, the buccal crest was positioned 
more apically compared to the lingual crest and the distance between the two only increased at 
two and eight weeks, with the buccal crest resorbing more and moving further apically by 
almost 2 mm (Araujo and Lindhe 2005; Araujo et al., 2005). The explanation for this 
phenomenon, offered by the authors, was the fact that the crestal region of the buccal bone was 
mainly made up of bundle bone. Since the function of bundle bone is to anchor the tooth, 
through the periodontal ligament, to the alveolar bone; as soon as the tooth is extracted, bundle 
bone loses its function and resorbs (Araujo et al., 2005). Several studies reported similar 
observations - the reduction of height of the alveolar ridge was more pronounced at the buccal 
aspect than on the lingual. Also, the most significant changes took place in the first three 
months following extraction, although alveolar ridge shape continued to change, but at a slower 
rate, for up to 24 months (Araujo and Lindhe 2005; Cardaropoli et al., 2003; Johnson, 1969 




1.1.2.1 Intraosseous critical size defect and tooth extraction models 
The classical definition of a critical size defect (CSD), as described by Schmitz and Hollinger 
(1986), is the smallest intrabony defect in a specific bone and animal species that fails to heal 
spontaneously in the lifetime of the animal (Schmitz and Hollinger, 1986). This definition was 
later modified by Hollinger and Kleinschmidt (1990) to describe the CSD as a defect that has 
less than 10 percent of bone regeneration over the lifetime of the animal (Hollinger and 
Kleinschmidt, 1990). 
Strictly speaking, tooth extraction models in any animal species commonly used in dental 
research, do not fit the above definitions of CSD, as extraction sites generally heal 
spontaneously within weeks (Duncan, 2005). 
However, if we think of a CSD as an intraosseous defect that takes longer to heal and achieve 
complete bone density or heals to reduced dimensions through bone loss, then the extraction 
socket models could fit this alternative definition. 
Duncan (2005), comprehensively described the healing of mandibular bone in sheep and 
reported that ovine CSD is 4-5 mm for a square defect (Duncan, 2005). The size of the 
intraosseous defect is not the only factor that affects its healing. The age and health status of 
the animal, the functional role of the bone as well as the anatomical location of the defect are 
some of the other factors that can influence the intrabony healing (Duncan, 2005). 
Various CSD tooth socket animal models have been used to investigate alveolar bone 
regeneration materials (Dau et al., 2015; Decker et al., 2010; Ma et al., 2009; Trombelli et al., 
1999; Wikesjo et al., 2006). The limitations of bone regeneration have been documented in 
CSD animal models when fast-proliferating tissues were allowed to fill the intraosseous defect 
(Schenk et al., 1994). On the contrary, when CSD were covered with a barrier membrane and 
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fast-growing connective tissues were excluded from the intraosseous sites, a complete and 
faster bone regeneration took place (Sculean et al., 2019). 
1.1.3 Significance of alveolar ridge atrophy 
The significance of alveolar ridge atrophy lays in its potential for compromising and severely 
limiting the prosthodontic rehabilitation of the edentulous space. Regardless of the type of 
prosthesis planned for replacement of the missing tooth, the absence of intact alveolar ridge 
and the consequent soft tissue collapse results in compromised function and aesthetic 
outcomes. The shift of the long axis of the ridge in a lingual direction may also contribute to 
less than ideal restoration position and aesthetics (Botticelli et al., 2004). Reduction in ridge 
height may then necessitate the use of extra material to simulate the gingival tissues or create 
longer teeth, both of which could compromise the aesthetics. Finally, implants must be ideally 
positioned and have bone surrounding them from all aspects, to ensure stability and successful 
function. In cases with ridge resorption, to achieve this ideal position, one might have to place 
implants more lingually, thus compromising aesthetics and potentially function, which is no 
longer acceptable (Tan et al., 2012; Van der Waijden et al., 2009). 
 
1.1.4 Summary 
The shape and form of the alveolar process is closely related to the presence and position of 
the teeth. Following a dental extraction, the alveolar ridge undergoes atrophy which results in 
significant width and height reduction. This could compromise and limit rehabilitation of the 





1.2 Alveolar ridge preservation (ARP) 
Atieh and colleagues defined alveolar ridge preservation as “the procedure of arresting or 
minimising the alveolar ridge resorption following tooth extraction for future prosthodontic 
treatment including placement of dental implants” (Atieh et al., 2015). Various other terms 
have been used in the literature to describe ARP such as “socket preservation”, ridge 
preservation”, “socket grafting”, “bone grafting” and “ridge augmentation” (Ackerman, 2009; 
Atieh et al., 2015). This terminology appears to be interchangeable in the published literature, 
which can lead to some confusion. For example, “ridge augmentation” could involve 
procedures performed on completely healed alveolar ridge bone, many months or even years 
following extraction, and could mean changing the shape of the jawbone. The term “socket 
preservation” also lacks clarity, as we do not wish to preserve a defect (socket) in the jaw, but 
rather prevent the walls of that defect from atrophy. Techniques and materials for ARP will be 
discussed in further detail in the following sections, however, one of the techniques used for 
ARP follows the principles of guided bone regeneration (GBR) and for that reason some 
consider ARP as a form of GBR that is performed immediately after tooth extraction (Darby, 
2008; Lee et al., 2018). Others argue that GBR is a corrective procedure that is indicated in 
cases with existing ridge deficiencies, whilst ARP is performed on an intact alveolar socket 
(Brendam et al., 2015). For the purpose of this manuscript the term ‘alveolar ridge preservation’ 
will be used to describe procedures performed to preserve the ridge immediately after tooth 
extraction, with the aim of retaining the original shape of the existing bone. 
 
1.2.1 History of ARP 
ARP is not a new concept. It started to emerge in the late 1960s when Lam and Poon 
investigated placement of cold-cure acrylic resin roots into extraction sockets for the purpose 
of preserving the residual alveolar bone (Lam and Poon 1968, 1969). In the early 1970s, Osburn 
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investigated the effects of submerging vital roots on ridge preservation (Osburn, 1974). Other 
research groups also investigated vital root retention for ARP, used under a removable 
prosthesis, but later discarded the idea due to complications (Garver and Fenster 1980). 
Decoronation and submergence of endodontically treated teeth for ARP was also investigated 
and demonstrated adequate ridge preservation after a 10-year observation period without 
complications (Howell, 1970). Submerged root procedures were extensively investigated 
during the 1970s and were found to have an acceptable place in ARP alongside conventional 
overdenture techniques (Casey et al., 1980).  
As dental implants and osseointegration concepts began to emerge, new ARP therapies were 
required to keep up with implant supported restorations, and techniques for filling extraction 
sockets with various biomaterials began to develop (Araujo et al., 2009; Artzi and Nemcovsky 
1998; Gumaer et al., 1985; Stanley et al., 1976). Over the years multiple biomaterials have 
been used for ARP techniques and they will be discussed below. 
 
1.2.2 Rational and indications for ARP 
In certain clinical situations dental extractions are difficult to avoid and following tooth 
removal, replacement is required. It is not always possible to provide an immediate replacement 
option (for example, immediate placement of a dental implant), and in some cases, edentulous 
spaces remain unrestored for years. As a consequence of tooth loss and healing, the alveolar 
bone that previously supported the tooth loses its function, atrophies and results in ridge defect 
and soft tissue collapse (Araujo and Lindhe, 2005; Trombelli et al., 2008; Chappuis et al., 
2017). These deficiencies in bone and soft tissue compromise tooth replacement therapy and 
have a negative impact on aesthetics and function especially when implant supported 
rehabilitation is proposed (Avila-Ortiz et al., 2014; Chappuis et al., 2017). 
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Removable dentures, fixed bridges and implants are widely used prosthodontic tooth 
replacement options, although demand for implant-supported tooth replacement is on the rise. 
All these options require good bone support for optimal comfort, function, and aesthetics. ARP 
should thus be considered in situations where the buccal plate is less than 1.5-2 mm thick, in 
sockets with damaged or missing walls and in strategically important sites, to retain the 
possibility of future edentulous space rehabilitation. It should also be considered for patients 
with high aesthetic demands as well as for patients with multiple extractions. ARP therapy is 
also indicated in the posterior maxillary and mandibular sites where maintaining bone volume 
is crucial to avoid negative impacts on important anatomical structures such as the maxillary 
sinus and inferior alveolar nerve (Darby, 2008). 
 
1.2.3 Clinical procedures for ARP 
Current procedures for ARP include minimally traumatic extractions, immediate implant 
placement and socket grafting. Several variations of grafting techniques have been described 
in the literature, such as the use of hard tissue BRG only; the use of barrier membrane only; or 
the use of a combination of membrane and hard tissue biomaterials (Darby, 2008; Jung et al., 
2018). These methods are effective in minimising post-extraction alveolar ridge atrophy, but 
none completely eliminate it (Atieh et al., 2015; Avila-Ortiz et al., 2019; Bassir et al., 2018; 
Ten Heggeler et al., 2011; Vignoletti et al., 2012). 
 
1.2.3.1 Minimally traumatic extractions and the ARP technique 
Minimally traumatic extractions should be the standard of treatment for all dental extraction 
regardless of the need for future tooth replacement. This involves the use of fine instruments 
inserted into the periodontal ligament space to severe the coronal fibres and loosen the tooth 
29 
 
until it can be gently delivered with forceps without cortical plate damage. Multi-rooted 
posterior teeth should be decoronated and sectioned prior to the use of fine periotomes and 
luxators (Darby, 2008). These techniques are designed to minimise lateral pressure on the 
buccal and lingual cortical plates and to limit damage to soft and hard tissues during extractions 
(Kubilius et al., 2012). 
According to several animal studies, whenever possible, raising a full thickness flap for 
extraction should be avoided, as it has been associated with increased ridge resorption (Blanco 
et al., 2008; Fickl et al., 2008; Melcher, 1976). Fickl and co-workers demonstrated a 14% 
increase in alveolar crest reduction following tooth extraction in the first 3 months of healing 
in a group who had extractions with flap elevation, which was in agreement with a similar 
study in beagle dogs by Blanco and colleagues (Blanco et al., 2008; Fickl et al., 2008). Contrary 
to this, Araujo and Lindhe found no differences in ridge resorption between flap-elevated and 
flapless extraction groups after six months of healing in mongrel dogs (Araujo and Lindhe, 
2009a). 
Following an extraction, debridement of a socket is recommended to remove any chronic 
inflammatory tissues and to encourage bleeding. Socket walls should also be inspected to 
ascertain whether any fractures or defects exist prior to ARP. In the presence of severe 
infection, it is recommended that ridge preservation and grafting should be delayed (Darby, 
2008). 
 
1.2.3.2 Immediate implant placement as ARP technique 
Immediate placement of a dental implant into a fresh extraction socket was previously thought 
to preserve alveolar bone, prevent ridge resorption and minimise surgical procedures. Several 
pre-clinical and clinical trials have investigated this concept and found that remodelling of 
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alveolar crest takes place regardless of implant placement and that alveolar ridge dimensions 
were altered with some sites losing on average up to 56% of buccal bone plate and up to 1 mm 
of vertical ridge dimension (Araujo et al., 2005; Botticelli et al., 2004; Vignoletti et al., 2012). 
Other investigators have examined immediately-placed and loaded implants for alveolar ridge 
preservation. One such study by Blanco and co-workers, investigated immediate implant 
placement with simultaneous loading in dog mandibles (Blanco et al., 2011). The 
histomorphometric results showed no difference between immediately-loaded and unloaded 
implants and the authors concluded that “immediate implant placement with or without loading 
does not prevent bone resorption that occurs following tooth extraction” (Blanco et al., 2011). 
Some pre-clinical studies extended this approach and combined the implants immediately 
placed into an extraction socket with BRG (Caneva et al., 2011). Results suggested that the use 
of BRG around immediately placed implants in extraction sockets did not prevent buccal bone 
atrophy. 
Interestingly, when BRG was combined with a barrier membrane over implants immediately 
placed into the extraction socket, the results were more positive. In another study by Caneva 
and co-workers, BRG material (in this case, deproteinised bovine bone mineral) was combined 
with a collagen membrane. After four months healing, the location of the buccal soft tissue was 
more coronal in the test group, prompting the authors to conclude that the placement of a 
collagen membrane at immediately-placed implant sites positively contributes to the 




1.2.3.3 Socket grafting as ARP technique 
ARP grafting techniques include the use of BRG material on its own or in combination with a 
barrier membrane. Alternatively, the use of membrane or a soft tissue graft on its own, without 
BRG material, has also been reported (Darby et al., 2008).  
Currently, one of the widely used techniques for ARP is the combination of BRG and a barrier 
membrane, as it is reported to be associated with less alveolar ridge resorption (Avila-Ortiz et 
al., 2014; Darby et al., 2009; Tomlin et al., 2014; Vittorini et al., 2013). 
 
1.2.4 Materials used for ARP 
The materials that are used for ARP can be divided into bone replacement graft materials and 
barrier membranes and will discussed in more detail in this section. 
 
1.2.4.1 Bone replacement graft (BRG) materials 
BRG materials are placed inside the thoroughly debrided socket immediately following tooth 
extraction. Depending on the type of BRG material used it can act as a scaffold for osteogenesis 
or might have osteoinductive or osteoconductive properties that contribute to formation of new 
bone during healing. Generally, BRG materials are divided into four categories according to 
their origin - autografts, allografts, xenografts, and alloplastic grafts (Tomlin et al., 2014). 
 
1.2.4.1.1 Autograft BRG material 
Autografts or autogenous bone grafts are derived from the same person as they are implanted 
into; the donor and the recipient are the same person. These grafts can be obtained from intra-
oral or extra-oral sites and are the only graft materials shown to demonstrate osteogenic 
properties (Alpiste-Illueca et al., 2006). Autologous bone was regarded for many years as the 
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“gold standard” of BRG (Alpiste-Illuece et al., 2006; Wang and Lang, 2012). However, this 
technique comes with several disadvantages. One such disadvantage is a secondary surgical 
site from which the graft is harvested with associated morbidity. The other drawbacks include 
rapid graft resorption and limited availability of high-quality bone (Wang et al., 2004). 
 
1.2.4.1.2 Allograft BRG material 
Allografts or allogenic grafts are materials derived from the same species but a different 
individual and are usually harvested from cadavers. The main advantages of this type of graft 
is the lack of a secondary surgical site, unlimited supply of bone and minimal risk of infection 
(Nasr et al., 1999). Allografts have been shown to induce bone formation through bone 
morphogenic proteins (BMPs) that are exposed during demineralisation of the donor bone. 
However, the concentration of BMPs within the graft, and therefore the osteoinductive 
properties, depends largely on the quality of the donor bone, the donor age and general health 
(Jergesen et al., 1991; Schwartz et al., 1998).  
 
1.2.4.1.3 Xenograft BRG material 
Xenografts are tissue grafts that are derived from other species, such as bovine (cow), porcine 
(pig), equine (horse) or from marine organisms such as coral. These are usually extensively 
processed particulate grafts, with all organic component removed to eliminate antigenicity 
(Tischler and Misch, 2004). One widely used BRG, regarded by some as the “gold standard” 
of xenograft materials is Bio-Oss® (Geislich, Switzerland), a demineralised bovine bone 
mineral (DBBM) that serves as a scaffold or osteoconductive material for new bone formation 
(Schneider et al., 2009; Tomlin et al., 2014). The advantages of xenografts are their unlimited 
supply, biocompatibility, extremely low risk of infection and the lack of a second surgical site 
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(Nasr et al., 1999). Some studies investigating the use of DBBM for ARP reported delayed 
healing with a slower rate of bone formation when compared to ungrafted sockets, which could 
be considered as a disadvantage of this material (Artzi et al., 2000; Schneider et al., 2009). A 
six-month pre-clinical study in beagle dogs investigated the effects of xenograft material on 
tissue formation and ridge augmentation. The study found that although bone formation was 
not enhanced compared to non-grafted sockets, the alveolar ridge was better preserved in the 
xenograft group (Araujo and Lindhe, 2009).  
The origin of these xenografts, particularly bovine and porcine derived BRG, could be a 
potential limiting factor for the use of these materials in some patients due to their religious or 
cultural beliefs. 
 
1.2.4.1.4 Alloplastic BRG material 
Alloplastic grafts are inert synthetic filler materials, that act as a scaffold for new bone 
formation, therefore they only have osteoconductive properties (Allegrini et al., 2008). The 
common examples include hydroxyapatite, tricalcium phosphate, calcium sulphate and 
bioactive glass polymers (Froum and Orlowski 2000; Tomlin et al., 2014). 
 
1.2.4.2 Barrier membranes 
The use of barrier membranes for guided tissue regeneration (GTR) arose from the principle of 
cellular exclusion (Dahlin et al., 1988; Melcher, 1976; Nyman et al., 1982). A physical barrier 
is used to exclude the fast proliferating cells of gingival epithelium from the surgical site and 
to allow migration of slower fibroblasts and osteoblasts into the surgical wound, leading to 
regeneration of the periodontal ligament (PDL) and alveolar bone. Many different materials 
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have been used as barrier membranes; generally, they can be divided into two groups: 
resorbable and non-resorbable (Alpiste-Illueca et al., 2006; Tomlin et al., 2014). 
 
1.2.4.2.1 Non-resorbable membranes 
Non-resorbable membranes were the first generation of barrier membranes to be used for GTR. 
They include methylcellulose membranes (Millipore filters), polytetrafluoroethylene (Teflon-
PTFE), expanded polytetrafluoroethylene (ePTFE), high density PTFE (dPTFE), titanium 
reinforced PTFE and titanium mesh. The expanded PTFE membrane, at one point, was the 
most studied membrane for periodontal regeneration and was considered as the “gold standard” 
to which all new barrier membranes were compared (Alpiste- Illuece et al., 2006; Scantlebury, 
1993). 
These membranes were extensively studied in both histological and clinical trials and were 
found to be biocompatible, easy to handle, good at excluding the epithelial cells and at 
preserving space for bone regeneration (Dahlin et al., 1988; Dahlin et al., 1990; Omar et al., 
2019). The main disadvantage of non-resorbable membranes is the necessity for a second 
surgery to remove them (Elgali et al., 2017). Furthermore, they are associated with the 
significant complication of exposure and wound dehiscence, which can result in serious 
infection and compromise the treatment outcome (Carbonell et al., 2014; Liu and Kerns, 2014). 
Due to a high rate of exposure, the use of non-resorbable membranes decreased and preference 
was given to resorbable membranes (Darby, 2008). 
 
1.2.4.2.2 Resorbable membranes 
The second generation of barrier membranes were naturally derived or synthetic resorbable 
materials. They became widely used, as they did not require a second surgery for removal and 
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did not become exposed (Darby, 2008). These membranes include natural polymers such as 
collagen and extracellular matrix. They were derived from many sources, both natural and 
synthetic including: bovine, porcine, equine or human tissues; polyglycoside synthetic 
copolymers such as polylactic acid (PLA), polyglycolic acid (PGA) poly(e-caprolactone) 
(PCL), poly (hydroxyl valeric acid), poly(hydroxyl butyric acid); and calcium sulphate based 
membranes. Unfortunately, these membranes do not uphold the principle of space preservation 
and therefore need structural support in the form of BRG material (Elgali et al., 2017).  
Currently the combination of a natural collagen membrane and BRG material is one of the most 
commonly used technique for ARP (Tomlin et al., 2014). These membranes demonstrated 
similar results in terms of bone regeneration to non-resorbable membrane but with an added 
benefit of simpler management, fewer surgical visits, and a lower risk of membrane exposure 
(Alpiste-Illuece et al., 2006; Zitzmann et al., 1997). 
 
1.2.4.3 Summary 
There are multiple materials and techniques used for ARP. There is no single material or 
technique that has been proven to completely eliminate changes in alveolar ridge following 
tooth extraction. Currently there is no consensus on the ideal clinical protocol, although, the 
combination of BRG and a naturally derived collagen membrane is the most widely used 
technique for ARP. 
 
1.2.5 ARP outcomes 
Currently, ARP seems to be a popular topic in periodontal literature. There are multiple peer-
reviewed articles and over 20 systematic reviews published since 2013. In addition, there are 
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three systematic reviews evaluating the quality of the published systematic reviews (De 
Buitrago et al., 2013; Moraschini et al., 2016; Ting et al., 2017).  
Many have reported on implant-placement related outcomes. Several studies found no 
differences in terms of implant placement into naturally healed sockets versus sites that were 
treated with various ARP techniques (Aimetti et al., 2009; Froum et al., 2002; Iasella et al., 
2003; Serino et al., 2003; Serino et al., 2008). Despite reporting no differences in implant 
placement between the treatment groups, Serino et al. (2003) and Iasella et al. (2003) discussed 
changes in alveolar ridge shape and size. They concluded that the quality of bone in the grafted 
sockets was optimal for implant placement and that grafting materials reduced bone resorption 
following tooth extraction (Iasella et al., 2003; Serino et al., 2003). 
Several studies found differences between ARP-treated sockets and ungrafted controls when 
evaluating feasibility of implant placement and necessity for simultaneous ridge augmentation; 
GBR was required in the control group due to the presence of buccal bone dehiscences (Barone 
et al., 2008; Pelegrine et al., 2010). 
Adequate alveolar ridge width and height have also been considered as important prerequisites 
for successful implant surgery and several research groups reported this as their primary 
outcome measure. Five systematic reviews, which include 55 articles, reported that ARP limits 
and reduces post-extraction alveolar ridge resorption and concluded that ridge preservation 
procedures are effective in limiting horizontal and vertical ridge alterations (Horvath et al., 






The maintenance of adequate alveolar ridge volume to allow implant placement without 
additional ridge augmentation is one of the principal goals of ARP. Multiple techniques and 
materials have been investigated for ARP and found to be successful in preserving alveolar 
ridge width and height when compared to extraction alone. In addition, sockets that have 
undergone ARP required less augmentation during implant placement when compared to non-
grafted sites. However, currently no single technique or materials have demonstrated complete 
prevention of post-extraction ridge resorption. There is no long-term data available on implant 
related outcomes such as implant survival/success rates following ARP therapy versus 
naturally healed sockets. 
 
1.3 Animal models 
Animal trials are considered a prerequisite to human clinical trials for testing the safety and 
efficacy of novel dental devices and techniques; both the FDA and the European equivalent 
(European Medicines Agency, EMA) require pre-clinical data before permitting phase 1 
clinical trials (Umscheil et al., 2011). The analysis of the effectiveness and safety of dental and 
biomedical products, particularly the ones concerned with hard and soft tissue healing requires 
histological and histomorphometric examinations which are not possible in vitro. Furthermore, 
animal models allow researchers to test biocompatibility and potential toxic effects of novel 
biomedical devices, which is impossible to achieve in vitro. 
Various animals have historically been used in periodontal research (Kantarci et al., 2015). The 
species used, range from rodents such as rats and mice to larger animals such as dogs, non-
human primates, and sheep. The animal model selection largely depends on the research 
question being asked, the disease model being studied, as well as the availability of the animals 
(Kantarci et al., 2015; Pearce et al., 2007). Larger animals tend to be used in studies 
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investigating hard and soft tissue healing, as their dento-alveolar anatomy more closely 
resembles the human (Kantarci et al., 2015). 
 
1.3.1 Similarities and differences between animal and human bone 
While larger animals closely resemble human dento-alveolar anatomy, there are some 
significant differences that should be taken into the account. Animal models are an 
approximation rather than an exact replica of the events taking place inside the human body; 
with different alveolar microstructure and varying healing times (Pearce et al., 2007). With that 
in mind, all species have advantages and disadvantages with regards to their use in dental 
research. When investigating hard tissue healing and bone regeneration, researchers should 
select a species which closely resembles the structure of human bone. Pearce and colleagues 
compared the composition of human bone to some of the more commonly used animal species 
in dental research and the findings are summarised in table 1.1 (Pearce et al., 2007). 
 
Table 0-1 Similarities between human and animal bone (adapted from Pearce et al., 2007) 
 Dog Sheep/Goat Pig Rabbit 
Macrostructure ++ +++ ++ + 
Microstructure ++ + ++ + 
Bone composition +++ ++ +++ ++ 
Bone remodelling ++ ++ +++ + 
Similarity to human bone: +least similar; ++moderately similar; +++most similar 
 
1.3.2 Non-human primate animal model 
Non-human primates of various sizes have been extensively used in dental research due to their 
physiological and genetic similarity to humans. They have naturally occurring dental plaque, 
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calculus, and gingivitis, with similar deciduous and permanent dentition as humans. The studies 
investigating periodontal disease progression, surgical procedures and osseointegration of 
dental implants are well documented in the literature. However, the cost of non-human 
primates, the difficulty of acquisition, handling and housing, ethical concerns, as well as the 
risk of infection transmission, from these animals to the research team, limits this animal model 
mainly to osteoporosis research (Kantarci et al., 2015; Thompson et al., 1995; Vlaminck et al., 
2008; Weinberg et al., 1999) 
 
1.3.3 Canine animal model 
The canine (dog) animal model became one of the more frequently used and well-established 
models in dental research. This species’ natural susceptibility to periodontal disease made them 
a useful model in investigating periodontal disease progression, hard and soft tissue wound 
healing, guided tissue regeneration, ARP and dental implants (Araujo et al., 2005, 2005b, 2009, 
2009b; Indovina et al., 2002; Kantarci et al., 2015).  
Canine animal models have been extensively used to test new materials and techniques for 
periodontal regeneration. Bone replacement graft materials and barrier membranes were used 
in dogs to demonstrate the biocompatibility and efficacy of these materials prior to their use in 
humans (Caffesse et al., 1990; Fleisher et al., 1991; Haney et al., 1993; Magnusson et al., 1988; 
Pitaru et al., 1988). 
Despite being a frequently used and well-established model, differences exist between dog and 
man. One of the major differences that has an influence on regenerative studies is the faster 
bone turnover rate in dogs compared to humans. Dogs also differ from humans in the 
composition and microstructure of their bone, having higher mineral density (Giannobile et al., 
1994; Pearce et al., 2007; Wang et al., 1998).  
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The canine animal model is an excellent experimental model in dental and specifically 
periodontal research, however its use is declining, as it is becoming less acceptable to use 
companion animals for dental and biomedical research. Moreover, alternative large animal 
models such as sheep, mini-pigs and goats are available and are better accepted by 
contemporary society (Kantarci et al., 2015; Pearce et al., 2007). 
 
1.3.4 Ovine animal model 
Ovine models are becoming widely used and accepted as a large animal model in dentistry and 
biomedical research, ranking 7th among the most commonly used animal models worldwide 
and increasing in use from just 5% in the 1980s to 12% in the late 1990s (An and Friedman, 
1998; Pearce et al., 2007). In New Zealand, the use of sheep as a research animal is second 
only to human studies 26.5% and 35.8% respectively (Duncan, 2005). 
In New Zealand, domestic sheep (Ovis aries) are commercially farmed and are available in 
large numbers. These animals are easy to acquire, reasonably easy to handle and house; they 
are robust and well accepted by the general public for dental and biomedical research (Duncan, 
2005). The additional advantages of this animal model include similarities in size, weight, 
metabolic rate, and general physiology to humans (Newman et al., 1995).  
However, significant differences exist between human and ovine bone structure. 
Histologically, sheep have a bone structure, containing predominantly primary osteons and the 
bone structure also changes with age; with younger animals of 3-4 years of age having a 
combination of woven and lamella bone, while older animals 7-9 years of age exhibit 
secondary, Haversian remodelling (Newman et al., 1995; Pearce et al., 2007). Differences in 
bone density and therefore strength have also been demonstrated, with sheep having 
significantly higher bone density and greater strength compared to humans (Nafei et al., 2000). 
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Despite these differences, the ovine animal model is widely accepted and results of the 
investigations using these animals can be extrapolated to human patients (Lippuner et al., 1992; 
Martini et al., 2001). Dental and medical research in New Zealand have made significant use 
of sheep to develop model systems. 
 
1.3.4.1 Ovine dental anatomy 
Ovine dental anatomy is unique. Sheep do not have upper incisors or canines. Instead they have 
a “dental pad” that functions against three bilateral mandibular incisors and one canine tooth. 
A wide edentulous space (diastema) is located immediately posterior to the lower canine teeth 
and the upper “dental pad” on both sides of the jaw and separates the anterior segment from 
premolars and molars. Unlike humans, sheep have three premolar teeth and like humans three 
molar teeth. In the upper arch edentulous space posterior to the “dental pad” extends to the first 




Figure 0-1 Sheep jaw and dental anatomy; (a) maxilla; (b) mandible. Images from Colorado 






Ovine anterior teeth have very short roots and shallow alveolar housing and are frequently 
mobile; therefore, the anterior segment is not used in dental regeneration research. The 
mandibular premolar region has been extensively investigated and well published with studies 
examining various dental materials and techniques (Baharuddin et al., 2014; Danesh-Meyer et 
al., 1997; Duncan, 2005; Liu et al., 2016). Ovine premolar teeth closely resemble human 
premolars, although unlike human teeth they have contact surfaces instead of contact points. 
The first premolar (P1) is a very small tooth with short roots and in some animals might be 
absent or exfoliated. The size of these teeth increases from P1 to P3 (third premolar). All 
premolar teeth have two roots, with the second and third premolars having long slender, often 
similar sized roots (Figure 1.2). 
 
 




1.3.4.2 Healing times in sheep 
The extraction protocol and ovine dental defect model was developed by Professor Duncan at 
the University of Otago for the evaluation of new dental devices (Duncan, 2005). As part of 
that investigation the differences in bone healing times between humans and ruminants were 
established (Table 1.2). 
Table 0-2 Comparison of human and ovine bone healing times (adapted from Duncan, 2005) 
Human healing times Sheep healing times 
1 week 5 days 
3 weeks 2 weeks 
5 weeks 4 weeks 
8 weeks 6 weeks 
11 weeks 8 weeks 
16 weeks 12 weeks 
21 weeks 16 weeks 
 
The sheep extraction model was also described by Liu and colleagues (Liu et al., 2016). Their 
study was the first to use the sheep extraction socket model for BRG research. In that study 
only second and third mandibular premolars were used. Following completion of the study, 
Liu and colleagues recommended using all three mandibular premolars to allow comparison of 
six test sites to maximise the statistical significance of the results (Liu et al., 2016). 
 
1.3.5 Summary 
Animal models are an essential prerequisite for testing new materials and techniques prior to 
their use in human clinical trials. All animal models have advantages and disadvantages and 
not a single animal model completely replicates human biology. The selection of the 
appropriate model depends on many factors. One of the main considerations should be the 
research question and the disease process under investigation. Several species have been used, 
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with canine model still being the most frequently used model around the world. In New 
Zealand, the ovine animal model is widely used and better accepted by the general public as it 
utilises non-companion, commercially farmed animals. Considering the cost of animals, ease 
of handling, housing and ethics we chose the ovine animal model for our study. 
 
1.4 Development of a new barrier membrane 
1.4.1 Properties of an ideal barrier membrane 
The use of barrier membranes is the main principle of guided tissue regeneration (GTR) and 
depends on the exclusion of fast proliferating epithelial/connective tissue cells while allowing 
slower growing bone and periodontal ligament to regenerate (Dahlin et al., 1988; Melcher, 
1976). Various barrier membranes have been extensively used in ARP both on their own and 
in combination with bone replacement grafting material (Darby et al., 2008). 
The ideal properties of a barrier membrane for both GTR and ARP include safety, 
biocompatibility, cell exclusion, space maintenance, tissue integration, effectiveness, and ease 
of use (Omar et al., 2019). 
 
1.4.2 Disadvantages of commercially available barrier membranes 
Different types of barrier membranes have been discussed previously. Currently not one type 
of membrane meets all criteria of an ideal barrier. Non-resorbable membranes are excellent for 
space maintenance and do not require bone graft substitute materials, however they need to be 
removed following a healing period, which necessitates a second surgical procedure. On the 
other hand, resorbable membranes do not require a second surgery for their removal but they 
are unable to support and maintain space especially in ARP procedures without a bone graft 
substitute. Non-resorbable membranes are also prone to exposure that leads to infection and 
45 
 
compromises the outcome of ARP therapy with some authors concluding that “resorbable 
membranes should be preferred over non-resorbable” (Darby et al., 2008). 
Unfortunately, there is no published data on the handling, and difficulty of placement, of 
various types of barrier membranes. Anecdotal evidence and the authors personal experience 
with the use of Bio-Gide® membrane suggests that it can be time consuming and difficult to 
keep that membrane in place during wound closure. Contamination of Bio-Gide® with 
moisture, usually blood, causes it to become soft and friable and difficult to stop it from 
moving. 
 
1.4.3 Ovine forestomach matrix (OFM) membrane 
The OFM technology has been developed by Aroa Biosurgery (Auckland, New Zealand) and 
has potential applications in dental surgery. OFM is a resorbable extracellular matrix (ECM) 
scaffold widely used for the repair of missing or damaged soft tissues. OFM acts as a temporary 
scaffold for the patient’s own cells to promote the formation of a healthy functional tissue at 
the surgical site. 
OFM is manufactured from the rumen of the ovine forestomach, as that tissue offers a potential 
to generate relatively large quantity of biomaterial. An additional reason for this particular 
tissue selection is to increase clinical acceptance due to cultural and religious reasons, as well 
as minimise the risk of infection transmission from prions and viral pathogens (Lun et al., 
2010). 
A proprietary method of decellularization called “sealed transmural osmotic flow” (STOF) is 
used to manufacture OFM dental membrane. During this process, a detergent solution is drawn 
by osmosis through the intact ovine forestomach tissue, resulting in delamination, 
decellularisation and removal of epithelial and muscle layers (Lun et al., 2010). Following 
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decellularisation and delamination processes, the remaining submucosa tissue is lyophilised 
and sterilised using ethylene oxide. The resultant membrane retains the biochemistry and 
structural properties of the native extracellular matrix, and contains collagens type I, III and 
IV, as well as elastin, laminin, glycosaminoglycans, fibronectin and hyaluronic acid (Dempsey 
et al., 2019;  Floden et al., 2011; Lun et al., 2010). The composition of OFM was confirmed by 
Lun and colleagues in an in vitro study investigating the extracellular matrix components. They 
compared unprocessed ovine forestomach tissue with the OFM and reported decellularised 
connective tissue under fluorescence, with the presence of collagens type I and III, as well as 
proteoglycans as constituting the bulk of the membrane. Using scanning electron microscopy, 
the authors observed an intact collagen framework and measured individual collagen fibres, 
which they found to be on average 4.1±0.1 μm and consistent with other reports (Baer et al., 
1991; Lun et al., 2010). 
An in vivo study to test the angiogenic properties of OFM was conducted using a pig model. 
Wound sites were created extra-orally in the dorsal region posterior to the shoulder blades. Five 
female pigs were used, twenty wounds 20 mm in diameter were created using a sterile biopsy 
punch, OFM was inserted in the allocated sites and the wounds were dressed. The study 
reported increase blood vessel density in the OFM sites compared to the naturally healing 
wounds, as well as better performance compared to similar commercially available ECM 
technologies (Irvine et al., 2011). 
Another in vivo study utilising a rat animal model tested OFM for rotator cuff tendon repair. 
Thirty-four animals were used in this study with repairs examined at 6- and 12-week time 
points. All animals survived until the experimental endpoints and the study reported improved 
histological healing, as well as no hypersensitivity reactions, no infections and no inflammatory 
changes (Street et al., 2015). 
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The current study is the first study to test OFM as a dental matrix in an animal model.  
 
1.4.4 Summary 
The properties of an ideal barrier membrane for ARP should include biocompatibility and 
safety. These membranes should also exclude unwanted tissue while at the same time allowing 
tissue integration and penetration of the cells responsible for angiogenesis and osteogenesis. 
They must also maintain space and prevent the collapse of soft tissue into the socket and be 
easy to use and secure in place. Unfortunately, not one barrier membrane available currently 
meets all these principles. With that in mind, either a new resorbable collagen membrane or 
modifications to already existing membranes are needed to meet the criteria of an ideal barrier 
as described by Omar and colleagues (Omar et al., 2019).   
 
1.5 Techniques for analysing healing following ridge preservation in animal 
studies 
ARP therapy is carried out to minimise and limit dimensional changes of the residual ridge 
following tooth extraction and to allow implant placement without further bone augmentation. 
It is also essential to have good quality bone within the extraction socket into which an implant 
can be placed. For these reasons, ARP studies are usually divided into the investigations 
evaluating the changes in the ridge dimensions and investigations measuring the ratios of 
tissues within the extraction socket. 
 
1.5.1 Evaluation of alveolar ridge dimensions 
1.5.1.1 Study models 
One of the early methods of investigating alveolar ridge changes following tooth extraction 
was the use of study casts. These were taken prior to or immediately following tooth extraction 
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with additional casts taken after a specified healing period, the casts were measured, and the 
measurements compared (Pietrokovski and Masslet, 1967; Schropp et al., 2003). This is a 
simple and easy to use method and does not require any special equipment. However, it is not 
without disadvantages. The casts record the jaw in its entirety, combining both the hard and 
soft tissues, thus providing only limited information about hard tissue changes. Any 
discrepancies during the taking of the impressions would also add to the error and affect the 
measurements. 
 
1.5.1.2 Digital 3D analysis 
Several studies, rather than measuring the study casts directly, scanned the models with laser 
scanners and created three-dimensional virtual models which they analysed using a specially 
designed software (Fickl et al., 2009; Thalmair et al., 2013; Tomasi et al., 2018). Similar to the 
manual method, impressions of the mouth were taken prior to extractions and again following 
an allocated healing period. Measurements were carried out using specialised computer 
software and results compared. The authors mentioned that it was not possible to evaluate 
separately the changes in hard and soft tissues and that accuracy of the measurements could be 
influenced by the dimensional changes of the impression and cast materials. Performing direct 
intra-oral scans to overcome the source of error was suggested. 
 
1.5.1.3 Bone sounding and ridge mapping 
Bone sounding is a technique by which the level of bone is identified through firm pressure on 
the gingiva. This technique does not require any special equipment and can be easily performed 
under local anaesthesia using a periodontal probe. Ridge mapping was developed based on 
bone sounding to measure the width of alveolar ridge with dental callipers ( Bruggenkate et al., 
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1994). This is a simple and easy to use technique that can precisely measure the width of 
alveolar ridge and produced reliable diagnostic data (Chen et al., 2008). However, Bruggenkate 
and colleagues reported some disadvantages with this method (Bruggenkate et al., 1994). One 
of these disadvantages was that the direction of the needle was not always consistent when 
inserted into the soft tissue. The authors did not suggest how to overcome this limitation, but 
the use of a rigid stent or a template could ensure that the callipers are inserted in the same 
location and in the same direction thus potentially minimising the positional error. 
 
1.5.1.4 Radiographic analysis 
The use of plain intra-oral films to measure changes in alveolar ridge height and bone density 
was reported by Oltramari and colleagues. The study used six minipigs, who had maxillary and 
mandibular teeth extracted, and radiographs taken of extraction sites immediately and three 
months after surgery. Standard radiographic films were used and digitised prior to radiographic 
evaluation (Oltramari et al., 2007). The bone height was measured using software by counting 
the number of pixels, while bone density was evaluated though densitometric variations in 
grayscale. The authors commented on the low accuracy of the radiographic analysis when 
measuring bone density. This is one of the limitations of radiographic analysis when 
investigating bone density. The radiographs produce a two-dimensional image of a three-
dimensional structure, which inevitably could lead to errors and inaccuracies in measurements. 
 
1.5.1.5 Cone beam computer tomography (CBCT) 
CBCT overcomes the limitations of plain radiographic films by producing three-dimensional 
images. The use of this method of imaging has been slowly increasing over the past few years 
and becoming widely accepted as the “gold standard” of pre-operative implant planning. The 
main disadvantage of this mode of analysis is the higher dose of radiation associated with it, 
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however with the latest technologies and limiting the field of view, radiation dose can be 
minimised (Monsous and Dudhia, 2008). More recently, many clinical studies have used CBCT 
as the method for the analysis of alveolar ridge dimensional changes (Jung et al., 2018; Llanos 
et al., 2019; Nart et al., 2017; Tomasi et al., 2018). The study by Jung and colleagues reported 
some disadvantages of this mode of analysis. The presence of artefacts in the CBCT images 
and not being able to set the reference lines, as well as difficulty in identifying the bone graft 
material were all considered as limitations of this method (Jung et al., 2018). The difficulty in 
identifying the bone grafting material on CBCT images was due to the system’s inability to 
accurately measure bone density (Benavides et al., 2012). With these limitations in mind 
Benavides and colleagues have recommended the use of CBCT in dental implant treatment 
planning particularly with regards to three-dimensional evaluation of alveolar ridge dimensions 
and linear measurements. 
 
1.5.1.6 Micro-computed tomography (μCT) 
The main advantage of μCT is that it provides a non-destructive three-dimensional method of 
evaluating mineralised structures with a high level of resolution. It allows the study of bone 
dimensions as well as its density (Vanderoost and van Lenthe, 2014). The disadvantage of μCT 
is a high level of radiation and the size of the equipment, which limits its application to small 
size samples and in vitro studies (Postnov et al., 2003).  
A study by Kim and colleagues investigated ARP therapy in extraction sockets in a canine 
animal model. Six beagle dogs had distal roots of 3rd and 4th mandibular premolars extracted, 
and chronic periodontal lesions induced around the mesial roots with black silk, collagen 
sponges and endodontic files. Following four months of “healing” the mesial roots were 
removed and sockets grafted using bone replacement grafts and collagen membranes. 
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Following three months of healing, the animals were sacrificed, and extraction sockets 
dissected. μCT analysis was used to analyse the differences in height between buccal and 
lingual crests as well as bone morphometric parameters in the sockets (Kim et al., 2017). 
Histomorphometric analysis was also carried out in this study, but unfortunately the authors 
did not compare the results of μCT and histomorphometry to assess their agreement. No 
limitations or issues with μCT were reported by the authors.  
A similar study by Bashara et al., in six beagle dogs, investigated changes in socket wall height 
following tooth extraction and grafting. μCT and histology were used for analysis. Yet again, 
no difficulties with microtomography analysis were reported by the authors, and no comparison 
of results between histomorphometric and μCT data was presented (Bashara et al., 2012). 
One study was found which investigated the correlation between the sets of data obtained from 
histomorphometric analysis and μCT (Thomsen et al., 2005). That study was conducted using 
human tibia biopsies and reported a strong correlation (r=0.95) between the two methods of 
analysis with regards to bone volume and tissue volume as well as connectivity denticity. The 
authors concluded that for morphometric analysis of bone, μCT can replace histomorphometry. 
 
1.5.1.7 Histometric analysis 
Histological analysis, including histometric and histomorphometric methods, is still considered 
as the “gold standard” for obtaining quantitative information on bone structure and volume 
(Thomsen et al., 2005). This method of analysis has been extensively published by the Araujo 
group (Araujo and Lindhe, 2005; Araujo et al., 2008; Araujo and Lindhe, 2009). These 
researchers used a dog model to evaluate changes in height and width of alveolar ridge 
following extractions of the mandibular premolar teeth and grafting. The assumption was made 
that mesial and distal roots of premolar teeth were the same width and thus the bone over these 
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structures would have the same dimensions. Therefore, changes in the shape of the alveolar 
bone were estimated by subtracting the values of the measurements taken from the extracted 
distal roots from values of the remaining mesial roots. The main disadvantage of histological 
analysis is the destruction of samples during the preparation of conventional histological 
sections. 
 
1.5.2 Evaluation of bone and connective tissue formation within extraction socket 
Ridge preservation for the purpose of future implant treatment requires not only optimal width 
and height of bone but also good quality bone inside the socket to house the implant. Evaluation 
of tissues within the socket are usually performed using histomorphometric analysis on either 
demineralised or un-demineralised specimens. 
 
1.5.2.1 Histomorphometric analysis 
In ARP, histomorphometric analysis is used to measure the quantity of different tissue volumes 
within the extraction socket. The studies investigating bone replacement graft materials are 
usually interested in the amount of newly formed bone, residual bone graft and connective 
tissue within the extraction socket (Liu et al., 2016). Two different techniques may be used to 
prepare the specimens: resin embedding or paraffin embedding. Non-demineralised samples 
may be resin-embedded which is permits differentiation between mineralised tissues such as 
newly formed bone and residual bone graft, and soft tissues such as connective tissue. 
Conversely, demineralised specimens may be paraffin-embedded, which is useful for studying 






Many techniques to evaluate healing following ARP are available, although histology is still 
considered to be the “gold standard”. Histomorphometric analysis and descriptive histology 
result in quantitative and qualitative data and are often employed in conjunction with other 
techniques.   
 
1.6 Outcomes of ARP in animal extraction socket 
Most ARP animal studies examine dog extraction sockets as a model, with a small number of 
studies from other animal models such as sheep (Araujo et al., 2005, 2008, 2010, 2010a; Araujo 
and Lindhe, 2005, 2009, 2009a; Bashara et al., 2012; Cioban et al., 2015; Kim et al., 2017; Liu 
et al., 2016).  Many studies report the percentage of new bone formation in the extraction 
socket, with grafted sockets exhibiting less newly formed bone compared to the naturally 
healed sockets (Araujo et al., 2010 and 2010a; Araujo and Lindhe, 2009, 2009a; Kim et al., 
2017; Liu et al., 2016). 
Differences in height and width between grafted test sockets and ungrafted controls have also 
been reported by some studies. Grafted sockets record less dimensional changes compared to 
non-grafted sockets that lose more height and width from the buccal aspect of the ridge (Araujo 
et al., 2008; Bashara et al., 2012; Kim et al., 2017). 
 
1.7 Aim of the study 
The current study had two main aims. First, to review the current literature surrounding the use 
of bone xenograft and resorbable collagen membranes in alveolar ridge preservation in clinical 
and pre-clinical trials. Second, to conduct a preclinical equivalency study, evaluating the 
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efficacy of the OFM when compared with Bio-Gide® (a well characterised and accepted 
collagen membrane). 
 
1.8 Objectives of the study 
To conduct a systematic review and assess the existing evidence for outcomes of bone 
xenograft in combination with resorbable collagen membranes for alveolar ridge preservation 
in randomised clinical trials in non-human and human experimental models.  
In an established sheep tooth extraction model, determine the percentage of new bone 
formation, residual graft, and connective tissue within extraction sockets filled with Bio-Oss® 




OFM will demonstrate equivalent outcomes to Bio-Gide® membrane on all parameters 










Chapter 2  
Systematic Review – submitted for publication. 
“Bone xenograft with resorbable collagen membranes for alveolar 
ridge preservation: a systematic review and meta-analysis”. 




















Tooth extraction is one of the most common procedures in dentistry. Natural healing and socket 
bone remodelling take place following tooth removal and result in considerable alveolar ridge 
loss (Amler, 1960; Pietrokovski and Massler, 1967; Araujo et al., 2015; Schropp et al., 2003). 
That loss can have detrimental effects on future rehabilitation of the edentulous site, limiting 
available restorative options due to a lack of supporting bone (Walker et al., 2017). The greatest 
change occurs horizontally, with a smaller amount of vertical reduction, resulting in a reduced 
volume of bone and shifting the long axis of the ridge in the lingual direction (Vittorini and 
Clementini, 2013). 
With increasing aesthetic demands in dentistry and implant therapy becoming a more common 
treatment option, greater emphasis is being placed on alveolar ridge preservation. Many 
approaches have been described to prevent, limit and reconstruct reduced alveolar ridges. 
These include tooth decoronation (Cohenca and Stabholz, 2007; Filippi et al., 2001), ultrasound 
techniques (Kerr et al., 2008), ostectomies, distraction osteogenesis (Ettl et al., 2010; Bormann 
et al., 2011) immediate implant placement and alveolar ridge preservation (ARP) (Darby et al., 
2008). None of these techniques completely prevent or eliminate bone resorption and volume 
changes. Nevertheless, APR has demonstrated promising results in limiting the amount of bone 
loss compared to a naturally healed socket (NH) (Al Qabbani et al., 2018; Barone et al., 2013; 
Cardaropoli et al., 2014; Fickl et al., 2008; Marconcini et al., 2018). 
ARP has been defined as “the procedure of arresting or minimising the alveolar ridge resorption 
following tooth extraction for future prosthodontic treatment including placement of dental 
implants” (Atieh et al., 2015). Commonly used materials include bone replacement grafts 
(BRG), alone or in combination with barrier membranes. ARP follows the same principles as 
guided bone regeneration (GBR) and therefore some authors have classified ARP as a GBR 
procedure that is performed immediately following tooth extraction (Lee et al., 2018).  Others 
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argue that ARP should not be confused with GBR, as GBR is a corrective procedure indicated 
in cases with existing ridge deficiency or dehiscence, whilst ARP is indicated in situations with 
an intact alveolus (Brandam et al., 2015). Regardless of this argument, the combination of 
barrier membrane and xenograft is one of the commonly used techniques for preserving 
alveolar dimensions following tooth extraction (Llanos et al., 2019; Nart et al, 2017).  
Barrier membranes can be divided into two groups: non-resorbable and resorbable membranes 
(Scantlebury and Ambruster, 2012). Non-resorbable membranes were the first to be used for 
ARP and were initially applied without BRG material. These membranes were able to prevent 
soft tissue ingress, maintain space and limit bone resorption. However, premature membrane 
exposure and the need for a second surgery to remove the membrane were an issue (Lekovic 
et al., 1998). In contrast, resorbable membranes are able to limit alveolar ridge resorption 
without second stage surgery (Darby et al., 2008), but they are often combined with BRG to 
prevent collapse of the membrane and maintain the space for bone regeneration. 
BRG materials used for ARP can be divided into four main categories: autografts, allografts, 
xenografts and alloplastic grafts (Willenbacher et al, 2016). Various barrier membranes and 
BRG materials have been investigated individually or in combination with each other to 
determine which technique offers the best ridge preservation with the least amount of bone 
loss. Several systematic reviews have been published evaluating flap design for ARP (Lee et 
al., 2018), ARP techniques (Moraschini and Barboza, 2015; De Risi et al., 2015; Corbella et 
al., 2017; Atieh et al., 2015; Avila-Ortiz et al., 2019; Barallat et al., 2014) and implant outcomes 
following ARP (Mardas et al., 2015). There is currently no evidence to show that one material 
or ARP technique is superior. Nevertheless, the combination of resorbable collagen membranes 
with xenograft bone substitutes (CMX) appears to be a commonly-used ARP technique (Darby 
et al., 2008; Jung et al., 2018; Araujo et al., 2015). There are no systematic reviews that 
specifically examine the effectiveness of CMX for ARP.  
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The purpose of this systematic review was to assess the published literature regarding the use 
of CMX for ARP in both animal and human studies. 
2.2 Materials and methods 
This systematic review followed the guidelines of the Preferred Reporting of Systematic 
Review and Meta-analysis (PRISMA) statement (Moher et al., 2009) and Cochrane 
Collaboration (Higgins and Green, 2011). 
2.2.1 PICO framework 
A PICO framework was used to establish a focused question and to define inclusion and 
exclusion criteria for this systematic review (Miller and Forrest, 2001): Population: Human 
and animal participants requiring single or multiple tooth extractions. Intervention: ARP 
procedure using CMX. Comparison: Un-assisted NH tooth socket. Outcomes: Dimensional 
changes in alveolar ridge width and height, histologic changes including percentages of 
residual grafting material, connective tissue and new bone formation in extraction sockets, and 
patient-related outcomes. 
2.2.2 Types of studies 
2.2.2.1 Inclusion criteria 
 Publications included in this systematic review were randomized controlled trials (RCTs) that 
compared CMX-treated sockets with NH sockets and reported on one or more of the following 
outcomes: changes in alveolar ridge width and height, amount of new bone formation, and 
percentages of connective tissue and residual graft, as well as patient-related outcomes. Only 
studies published in English were included. 
2.2.2.2 Exclusion criteria 
Studies that were not RCTs, or that were retrospective or case series, were excluded. Studies 
that used grafting materials other than xenografts, that failed to use a resorbable collagen 
membrane, that used CMX in the treatment of periodontal bony defects rather than tooth 
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sockets, that lacked a control group, or which did not provide sufficient information, were also 
excluded.  
2.2.3 Outcome measures 
The amount of new bone formation was the primary outcome measure. Secondary outcome 
measures were changes in clinical and radiographic alveolar bone height and width (mm), and 
patient related outcomes such as pain or swelling following surgery. 
2.2.4 Search strategy 
The search strategy followed the guidelines set out by Faggion and colleagues (Faggion et al., 
2013). Four electronic databases were searched for articles up to January 15, 2019: National 
Library of Medicine (MEDLINE – PubMed), EMBASE via Ovid, Scopus and Web of Science 
(Appendix 1). No limits were imposed regarding publication date or publication status. To 
supplement the electronic database search, a hand-search, cross-referencing cited publications 
in 31 systematic reviews up to January 14, 2019 was carried out independently by two authors 
(T.T. and M.A.). (Atieh et al., 2015; Avila-Ortiz et al., 2019 ; Avila-Ortiz et al., 2014; Barallat 
et al., 2014; Bassir et al., 2018; Castro et al., 2017; Chan et al., 2013; Corbella et al., 2017; De 
Buitrago et al., 2013; De Risi et al., 2015; Del Fabbro et al., 2017; Dewi and Ana, 2018; 
Heggeler et al., 2011; Horváth et al., 2013; Iocca et al., 2017; Jambhekar et al., 2015; Lee et 
al., 2018; MacBeth et al., 2016; Mardas et al., 2015; Moraschini and Barboza, 2016; 
Moraschini et al., 2015; Morjaria et al., 2014; Moslemi et al., 2018; Natto et al., 2017; Orgeas 
et al., 2013; Tan et al., 2012; Troiano et al., 2017; Vignoletti et al., 2012; Vittorini et al., 2013; 
Weng et al., 2011;Willenbacher et al., 2016). 
2.2.5 Selected studies 
Studies identified through the search strategy were independently screened and reviewed by 
two reviewers (T.T. and M.A.). Following removal of duplicate studies, the initial eligibility 
was assessed based on title and abstract. The remaining studies were assessed for inclusion 
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using the eligibility criteria, with two reviewers reading the full text independently. Any 
disagreements on the selection of publications were resolved by discussion and the reason for 
exclusion was recorded. In cases where an agreement could not be reached a third co-author 
(W.D.) acted as arbiter. 
2.2.6 Data extraction 
Data extraction was performed by one author (T.T.) using a specially designed data sheet. The 
accuracy of the extracted data was independently verified by the other two co-authors (M.A. 
and W.D.). The collected data included study details, participant details, extracted tooth 
position, smoking habit, flap design, intervention (test), comparison (control), treatment effects 
and outcomes and the length of observation time. All efforts were made to have a complete 
data set for each study included in this systematic review. If any data was missing, the primary 
author of the study in question was contacted and asked to provide additional information.  
2.2.7 Assessment of quality and risk of bias in selected studies 
Two reviewers (T.T. and M.A.) assessed the risk of bias independently, using the Cochrane 
risk of bias assessment tool as described in the Cochrane Handbook for Systematic Reviews 
for Interventions (Higgins and Green, 2011). There were six main validity parameters: 
selection bias, performance bias, detection bias, attrition bias, reporting bias and other sources 
of bias. The overall risk of bias was determined by completing a “Risk of bias” table for each 
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Table 0-2 Assessment of risk of bias of the included animal studies 
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article 
High risk 
No information in the 
article 
High risk 
No information in the 
article 
High risk 
No information in the 
article 








No mention of 
blinding of outcome 
assessment in the 
article 
No mention of 
blinding of outcome 
assessment in the 
article 
No mention of blinding 
of outcome assessment 
in the article 
No mention of 
blinding of the 
outcome assessment 
in the article 
No mention of blinding 
of the outcome 








All data presented 
Low risk 
All data presented 
Low risk 
All data presented 
Unclear risk 
It is not clear how the 
excluded animals 
influenced the main 
findings 
Low risk 






All outcomes appear 
to be detected 
Low risk 
All outcomes appear 
to be detected 
Low risk 
All outcomes appear to 
be detected 
Low risk 
All outcomes appear 
to be detected 
Low risk 






provided by the 
manufacturer and 
two of the authors 










ownership of the 
company that 
provided the funding 
for the study.  
Unclear risk 
Test materials 




to their category: “Low risk”, all assessed key parameters were at low risk of bias; “High risk”, 
one or more assessed parameters were recorded at high risk of bias, and “Unclear risk”, one or 
more examined parameters were not disclosed or were unclear. 
2.2.8 Data analysis 
Data was analysed using a statistical software program (Review Manager (RevMan) software, 
version 5.3, The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, 
Denmark). Continuous data, such as changes in alveolar bone height and width, were expressed 
in mean difference (MD) and 95% confidence intervals (CIs). Dichotomous data, such as the 
number of postoperative events, were expressed in risk ratio (RR) estimates and 95% CIs. 
A fixed-effects model was used to calculate MDs and RRs except where notable heterogeneity 
was observed, in which case the random-effects model was used. The generic inverse variance 
option in the statistic software program was used to combine split-mouth and parallel group 
studies. Publication bias was not formally assessed because the power to detect publication 
bias is low when less than 10 studies are included (Higgins and Green, 2011). The statistical 
heterogeneity between trials was tested by means of the Cochran’s test for heterogeneity and 
I2 statistic. An I2 values of > 50 indicated a significant heterogeneity. The unit of analysis was 





2.3.1 Characteristics of the included human studies  
A total of 1276 references were identified from the databases and other resources (Figure 2-1). 






























Figure 0-1 PRISMA flowchart of the screening and selection process 
Records identified through database 

































Records after duplicates removed  
(n = 902) 
Records screened  
(n = 904) 
Records excluded  
(n = 861) 
Full-text articles 
assessed for eligibility 
(n =43) 
Full-text articles excluded (n =31) 
• Measurements/population/results not 
relevant for this review (Cardaropoli et al. 2014 
(measured buccal plate thickness effect on 
resorption), Marconcini et al. 2018 (did not 
measure bone volume or dimensional changes), 
Schneider et al. 2014 (evaluated labial soft tissue 
volume), Zhao et al. 2018 (severe bone defect 
due to periodontitis), Zitzmann et al. 2001 (non-
extraction site, already healed ridge 
augmentation)). 
• No control group (Al-Hamoudi et al. 2015, Al 
Qabbani et al. 2018; Hua et al. 2014, Roman et 
al. 2015, Barone et al. 2013, Cook et al. 2013, 
Gholami et al. 2012, Llanos et al., 2019, Mardas 
et al. 2011, Nart et al. 2017, Pang et al. 2014, 
Pellegrini et al. 2014, Perelman – Karmon et al. 
2012, Ramaglia et al. 2018, Schulz et al. 2016, 
Serrano Mendez et al. 2017, Tomasi et al. 2018, 
Vance et al. 2004, Villanueva-Alcojol et al. 2013). 
• No collagen membrane used (Fickl et al. 2008, 
Ho et al. 2016, Indovina et al. 2002, Zhou et al. 
2017). 
• Not RCT (Carmagnola et al. 2003, Kivovics et al. 
2017, Sbordone et al. 2017). 
Additional records identified through 
other sources (n = 2) 
Total studies meeting eligibility 
criteria (n =12) 
Animal 
studies (n=5) 
Bashara et al. 2012 
Cioban et al. 2015 
Kim et al. 2017 
Liu et al. 2016 





Barone et al. 2008 
Cardoropoli et al. 2012 
Festa et al. 2013 
Guarnieri et al. 2017 
Iorio-Siciliano et al. 2017 
Jung et al. 2013 




the present review (Barone et al., 2008; Cardaropoli et al., 2012; Festa et al., 2013; Guarnieri 
et al., 2017; Iorio-Siciliano et al., 2017; Jung et al., 2013; Jung et al., 2018) (Table 2-3); of 
these, five were conducted in Italy (Barone et al., 2008; Cardaropoli et al., 2012; Festa et al., 
2013; Guarnieri et al., 2017; Iorio-Siciliano et al., 2017) one in Switzerland (Jung et al., 2013) 
and one in China (Jung et al., 2018). 
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Table 0-3 Characteristics of the included human studies 
 Barone et al. 
2008 
Cardaropoli et al. 
2012 




Jung et al. 2013† Jung et al. 2018 
        














Study location  Italy Italy  Italy Italy Italy Switzerland China 
Number of 
participants / 
extraction sites  




























26 to 69  24 to 71  28 to 58 20 to 63 28 to 52 33 to 78 NR 
























Premolar / molar 
Socket 
configuration 
Four-wall socket Three intact 
walls with at 
least 80% of the 
fourth wall 
Four-wall socket Socket types I, II 
and III‡  
Four-wall socket Four-wall socket Four-wall socket 
Flap design  Crestal and 
intrasulcular 
incisions  





Flapless  Elevation of 
mucoperiosteal 
flap extending 
one tooth in the 
mesial and distal 
directions 















































































Surgical caliper  
Periodontal 
probe 
Surgical caliper  
Periodontal 
probe 
CBCT analyses  
 









26.34 ± 16.91 
43.82 ± 12.23 
 






29.2 ± 10.1 
 
 
18.46 ± 11.18 
NR NR NR NR NR 
Changes in ridge 





2.5 ± 1.2 
4.5 ± 0.8 
 
 
1.04 ± 1.08 
4.48 ± 0.65 
 
 
1.8 ± 1.3 
3.7 ± 1.2 
 
 
0.91 ± 0.53 
3.96 ± 0.87 
 
 
1.6 ± 1.3 
2.8 ± 1.1 
 
 
1.2 ± 0.8 
3.3 ± 2.0 
 
 
1.18 ± 1.50 
2.17 ± 1.80 








0.7 ± 1.4 




0.46 ± 0.46 




0.6 ± 1.4 




0.37 ± 0.7 




0.3 ± 0.5 




0.0 ± 1.2 




0.32 ± 0.68 
0.84 ± 0.67  


























0.4 ± 1.3 
3.0 ± 1.6 
0.5 ± 1.3 
2.4 ± 1.6 
0.1 ± 0.3 
0.7 ± 0.7 
0.4 ± 1.4 
0.6 ± 0.6 
0.31 ± 0.73  



























than pain and 
swelling 







7 4 6 5 6 6 6 
CMX: collagen membrane with xenograft; NH: natural healing; CHX mw: chlorhexidine mouthwash; CBCT: cone beam computed tomography; NR: not reported 
*Data related to using collagen membrane without xenograft were not included  
†Data related to using alloplast and xenograft without collagen membrane were not included  
‡As suggested by Juodzbalys et al. 2008 
§MP3, OsteoBiol, Coazze, Italy 
‖ Evolution, OsteoBiol, Coazze, Italy 
¶Bio-Oss, Geistlich Pharma AG, Wolhusen, Switzerland 
#Bio-Gide, Geistlich Pharma AG, Wolhusen, Switzerland 
**Gen-Os; Osteobiol, Tecnoss srl, Giaveno, Italy 
††Lamina; Osteobiol, Tecnoss srl, Giaveno, Italy 
‡‡MinerOss XP, BioHorizons, Birmingham, Al, USA 
§§Mem-Lok Pliable, BioHorizons, Birmingham, Al, USA 
‖‖Bio-Oss Collagen, Geistlich Pharma AG, Wolhusen, Switzerland 




Study designs were described as parallel-group in five studies (Barone et al., 2008; Cardaropoli 
et al., 2012; Guarnieri et al., 2017; Iorio-Siciliano et al., 2017; Jung, 2013) and split-mouth in 
two studies (Festa et al., 2013; Jung et al., 2018). Four studies (Cardaropoli et al, 2012; 
Guarnieri et al., 2017; Jung et al., 2013; Jung et al., 2018) received financial support from the 
xenograft manufacturing industry, while three were self-funded (Barone et al., 2008; Festa et 
al., 2013; Iorio-Siciliano et al., 2017). Six studies (Barone et al., 2008; Festa et al., 2013; 
Guarnieri et al., 2017; Iorio-Siciliano et al., 2017; Jung et al., 2013; Jung et al., 2018) were 
conducted in a university setting and one was carried out in a private practice (Cardaropoli et 
al., 2012). 
 
2.3.1.1 Characteristics at baseline 
2.3.1.1.1 Inclusion criteria 
1. Age ≥ 18 years of age (Barone et al., 2008; Festa et al., 2013; Guarnieri et al., 2017; 
Iorio-Siciliano et al., 2017; Jung et al., 2018). 
2. Systemically healthy participants (Guarnieri et al., 2017 #7661; Jung et al., 2013; Jung 
et al., 2018). 
3. Adequate plaque control with full-mouth plaque score and full mouth bleeding score ≤ 
25% (Iorio-Siciliano et al., 2017) or ≤ 20% (Jung et al., 2013; Jung et al., 2018). 
4. Incisor, canine or premolar tooth requiring extraction (Barone et al., 2008; Jung et al., 
2013).  
5. Premolar or premolar/molar tooth requiring extraction (Cardaropoli et al., 2012; Festa 
et al., 2013; Guarnieri et al., 2017; Jung et al., 2018). 
6. Presence of adjacent teeth (Barone et al., 2008; Jung et al., 2018). 
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7. A minimum of 10 mm of alveolar bone height without impingement on the maxillary 
sinus or mandibular canal (Guarnieri et al., 2017). 
8. Presence of at least 2 mm of keratinized tissue (Iorio-Siciliano et al., 2017). 
 
2.3.1.1.2 Exclusion criteria 
1. Uncontrolled medical conditions or systemic contraindications to surgery (Barone et 
al., 2008; Festa et al., 2013; Guarnieri et al., 2017; Iorio-Siciliano et al., 2017).  
2. Long-term use of non-steroidal anti-inflammatory drugs or antibiotic therapy (Barone 
et al., 2008; Cardaropoli et al., 2012; Festa et al., 2013; Guarnieri et al., 2017). 
3. Use of oral bisphosphonate therapy (Guarnieri et al., 2017; Jung et al., 2018). 
4. History of radiotherapy or chemotherapy for malignancy (Cardaropoli et al., 2012). 
5. History of autoimmune disease (Cardaropoli et al., 2012). 
6. Metabolic bone disease (Cardaropoli et al., 2012; Jung et al., 2018). 
7. Smoking (Iorio-Siciliano et al., 2017), smoking > 10 cigarettes per day (Barone et al., 
2008; Cardaropoli et al., 2012; Guarnieri et al., 2017; Jung et al., 2018) or smoking > 
20 cigarettes (Jung et al., 2013). 
8. Current pregnancy or lactation (Cardaropoli et al., 2012; Festa et al., 2013; Guarnieri 
et al., 2017; Iorio-Siciliano et al., 2017; Jung et al., 2018). 
2.3.1.2 Characteristics of interventions 
All the surgical procedures were conducted under local anaesthetic. Four studies (Cardaropoli 
et al., 2012; Guarnieri et al., 2017; Jung et al., 2013; Jung et al., 2018) followed a flapless 
approach while three studies (Barone et al., 2008 ;Festa et al., 2013; Iorio-Siciliano et al, 2017) 
used intrasulcular incisions extending to the neighbouring teeth. Minimally traumatic 
extraction of teeth was performed using an ultrasonic device (Cardaropoli et al., 2012), or 
periotomes and elevators (Guarnieri et al., 2017; Jung et al., 2018). The sockets were then 
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thoroughly debrided to remove all soft tissue. In the ARP group, a xenograft of bovine 
(Cardaropoli et al., 2012; Iorio-Siciliano et al., 2017 ;Jung et al., 2013; Jung et al., 2018) or 
porcine origin (Barone et al., 2008; Festa et al., 2013; Guarnieri et al., 2017) was packed into 
the socket without compression and covered completely with a resorbable collagen membrane. 
Spontaneous healing without any graft materials was allowed in the control group. Primary 
closure over the tooth socket was attempted in two of seven studies (Barone et al., 2008; Festa 
et al., 2013). 
Postoperatively, participants were instructed to rinse with chlorhexidine mouthwash (Barone 
et al., 2008; Cardaropoli et al., 2012; Festa et al., 2013; Iorio-Siciliano et al., 2017; Jung et al., 
2013; Jung et al., 2018) or to apply a gel rich in hyaluronic and amino acids over the wound 
(Cardaropoli et al., 2012). Oral antibiotics and analgesics were prescribed in six studies 
(Barone et al., 2008; Cardaropoli et al., 2012; Festa et al., 2013; Guarnieri et al., 2017; Iorio-
Siciliano et al., 2017; Jung et al., 2013). The sutures were removed after seven (Barone et al., 
2008; Festa et al., 2013; Iorio-Siciliano et al., 2017), seven to ten (Jung et al., 2013; Jung et al., 
2018) or 14 days after extraction (Cardaropoli et al., 2012). 
 
 
2.3.1.3 Characteristics of outcome measures  
Primary outcome measures: Amount of new bone formation (Cardaropoli et al., 2012). 
Secondary outcome measures: Changes in alveolar ridge width and height (Barone et al., 2008; 
Cardaropoli et al., 2012; Festa et al., 2013; Guarnieri et al., 2017; Iorio-Siciliano et al., 2017; 
Jung et al., 2013; Jung et al., 2018). 
Postoperative morbidity (Barone et al, 2008; Cardaropoli et al., 2012; Festa et al., 2013; Jung 
et al., 2013). 
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2.3.1.4 Risk of bias in included studies  
The assessment of risk of bias is summarized in Figure 2-2 and discussed in detail below. 
 
Figure 0-2 Risk of bias summary for the human studies 
 
2.3.1.4.1 Allocation (selection bias)  
The random sequence generation was clearly described in five studies (Barone et al., 2008; 
Festa et al., 2013; Guarnieri et al., 2017; Jung et al., 2013; Jung et al., 2018) and was judged at 
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low risk of bias for this domain. Two trials (Cardaropoli et al., 2012; Iorio-Siciliano et al., 
2017) did not provide sufficient information and were classified as unclear risk of bias. Three 
out of the seven trials (Guarnieri et al., 2017; Jung et al., 2013; Jung et al., 2018) described 
adequate concealment and were assessed at low risk of bias for this domain. 
2.3.1.4.2 Blinding  
Blinding of participants to the selected intervention was not possible due to the nature of 
intervention, which required either the use of grafting material or leaving the socket to heal 
spontaneously. Blinding of outcome assessment may be possible to reduce the risk of detection 
bias. Two studies (Barone et al., 2008; Cardaropoli et al., 2012) reported blinded outcome 
assessment and therefore were assessed at low risk of bias for this domain.  
2.3.1.4.3 Incomplete outcome data and selective reporting  
Withdrawal from the study occurred in one trial (Jung et al., 2018) where six participants were 
excluded due to artefacts in the cone beam computed tomography scans and difficulty in setting 
reference lines. In the remaining studies (Barone et al., 2008; Cardaropoli et al., 2012; Festa et 
al., 2013; Guarnieri et al., 2017; Iorio-Siciliano et al., 2017; Jung et al., 2013), the outcome 
data were reported in full without any withdrawals and the risks of attrition and reporting bias 
were assessed as low.  
2.3.1.4.4 Other potential sources of bias  
Only three of the seven studies (Barone et al., 2008; Festa et al., 2013; Iorio-Siciliano et al., 
2017) were self-funded. The remaining studies (Cardaropoli et al., 2012; Guarnieri et al., 2017; 
Jung et al., 2013; Jung et al., 2018) declared support from the manufacturer of the grafting 
material used in the study, either in the form supply of material or as a research grant and 
therefore were assessed at unclear risk for this domain.  
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2.3.1.5 Effects of intervention  
In total, 215 extractions sites in 174 participants were included in this review. Of these, 108 
extraction sockets were treated using CMX. In two included studies, either alloplastic grafts 
(Jung et al., 2013), or collagen membranes without xenograft (Guarnieri et al., 2017) were also 
used for ARP; only the data related to the use of CMX were included in our analysis.  
2.3.1.5.1 Primary outcome  
Only one study reported the percentage of new bone formation in CMX-grafted versus NH 
sockets in humans (Cardaropoli et al., 2012).   This study reported that sockets treated with 
CMX had significantly lower new bone volume than NH sockets (MD 17.48; 95% CI 9.13 to 
25.83; P < 0.0001) (Figure 2-3).  
 
Figure 0-3 Comparison: collagen membrane with xenograft (CMX) versus natural healing 
(NH) socket 
 
2.3.1.5.2 Secondary outcomes 
Seven studies in human participants reported secondary outcomes. These parameters included 
changes in ridge width (seven studies), ridge height at mid-buccal (seven studies), and ridge 
height at mid-lingual (five studies).  The overall meta-analysis showed that the use of CMX 
was associated with significantly smaller changes in ridge width (MD -2.17; 95% CI -2.88 to -
1.46; P < 0.0001) (Figure 2-4a), mid-buccal height (MD -1.36; 95% CI -1.89 to -0.84; P < 
0.0001) (Figure 2-4b) and mid-lingual height (MD -1.03; 95% CI -1.84 to -0.21; P = 0.01) 
(Figure 2-4c). Substantial heterogeneity was detected for the reported mean changes in alveolar 












Figure 0-4 Comparison: Xenograft with collagen membrane (CMX) versus natural healing 
(NH). Secondary outcomes: (a) changes in the ridge width (mm), (b) changes in the ridge 




2.3.1.5.3 Patient-related outcomes 
Three studies (Barone et al., 2008; Cardaropoli et al., 2012; Festa et al., 2013) reported that 
pain and swelling were the most common recorded complications as patient-related outcomes. 
Quantitative analysis was not possible, as the exact number of events for each group was not 
reported. 
2.3.1.6 Determination of sample size  
Three studies (Cardaropoli et al., 2012; Guarnieri et al., 2017; Jung et al., 2018) reported a 
priori calculation for the sample size. 
2.3.2 Characteristics of the included animal studies 
Five animal studies were included in this systematic review (Bashara et al., 2012; Cioban et 
al., 2015; Kim et al., 2017; Liu et al., 2016; Raveendiran et al., 2019) (Table 2-4). Studies were 
conducted in Ireland (Bashara et al., 2012), in Romania (Cioban et al., 2015), in South Korea 
(Kim et al., 2017),  in New Zealand (Liu, 2016) and in Australia (Raveendiran, 2019). Four out 
of the five studies were performed in dogs (Bashara et al., 2012; Cioban et al., 2015; Kim et 
al., 2017; Raveendiran et al., 2019) and one in sheep (Liu et al., 2016). 
All five studies were described as split-mouth design (Bashara et al., 2012; Cioban et al., 2015; 
Kim et al., 2017; Liu et al., 2016; Raveendiran et al., 2019). Three studies were supported by 
the graft manufacturing industry (Bashara et al., 2012; Liu et al., 2016; Raveendiran et al., 
2019), while the other two were supported by science research and university grants (Cioban 






Table 0-4 Characteristics of the included animal studies 
 Bashara et al. 2012 Cioban et al. 2015 Kim et al. 2017 Liu et al. 2016 Raveendiran et 
al.,2019 
Study design RCT (split-mouth) RCT (split-mouth) RCT (split-mouth) RCT (split-mouth) RCT (split-mouth) 




6/36 2/8 6/18 16/64 9/18 
Age of participants 
 (years) 
1 to 2 1 1 to 2 4 to 5 1+ 












Socket configuration NR NR NR 4 walls 4 walls 
Flap design Full thickness buccal 
and lingual 
Full thickness buccal 
and lingual 
Sulcular incisions, 
full buccal and 
lingual flaps raised 
Intra-sulcular 
incision from the 
mesial of the 1st 
premolar to the 
distal of the 3rd 
premolar with full 



















xenograft with 10% 
collagenII 
Collagen matrix¶¶ 
Postoperative care Antibiotics Antibiotics 
Pain control 
Soft diet 
Plaque control (tooth 























































NR NR  
 
27.04±5.25 
2months      4 months 
 








NR NR NR NR NR 
 
 




































NR Uneventful healing 
Length of observation 
period (months) 
6 1 3 2 and 4 3 
CMX: collagen membrane with xenograft; NH: natural healing; NR: not reported 
*Data related to using collagen membrane without xenograft were not included  
†Data related to using alloplast and xenograft without collagen membrane were not included  
¶Bio-Oss, Geistlich Pharma AG, Wolhusen, Switzerland 
#Bio-Gide, Geistlich Pharma AG, Wolhusen, Switzerland 
‖‖Bio-Oss Collagen, Geistlich Pharma AG, Wolhusen, Switzerland 
¶¶Mucograft, Geistlich Pharma AG, Wolhusen, Switzerland 
ѲOsseoGuard Biomet 3i 






2.3.2.1 Characteristics at baseline 
2.3.2.1.1 Inclusion criteria 
1. Age ≥ 1 year (Bashara et al., 2012; Cioban et al, 2015; Kim et al, 2017; Raveendiran et 
al, 2019), ≥4 years (Liu et al., 2016). 
2. Good health (Cioban et al., 2015). healthy periodontium (Liu et al., 2016). 
3. Mandibular premolar (Bashara et al., 2012; Cioban et al., 2015; Kim et al., 2017; Liu 
et al., 2016) and maxillary incisor (Raveendiran et al., 2019) extractions. 
2.3.2.1.2 Exclusion criteria were not specifically mentioned in any of the studies 
 
2.3.2.2 Characteristics of interventions 
In these animal studies, all the surgical procedures were carried out using both general and 
local anaesthesia. Full thickness flaps were raised in four trials (Bashara et al., 2012; Cioban et 
al., 2015; Kim et al., 2017; Liu et al., 2016) and one trial performed extractions using a flapless 
approach (Raveendiran et al., 2019). One study extracted the premolar teeth in their entirety 
(Liu et al., 2016), one study hemisected the teeth and removed the distal roots only, leaving the 
mesial roots in the sockets but filling it with gutta-percha (Bashara et al., 2012) and one study 
also removed the distal root but it is not clear whether the nerve tissue within the mesial root 
was removed or not (Cioban et al., 2015). In another study, the experimental model was 
designed to create a chronically-inflamed wound mimicking a periodontal-endodontic 
infection in the human situation.  In this study, the distal premolar roots were extracted, the 
mesial roots reamed with endodontic files and the canal space injected with Porphyromonas 
gingivalis. In addition, collagen sponges and silk ligatures soaked in P. gingivalis were placed 
adjacent to the remaining root. After repositioning the flaps and allowing the sockets to heal 
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for four months, the flap was raised again, and the mesial roots were then removed prior to 
grafting (Kim et al., 2017). The last study involved the extraction of maxillary lateral incisors 
(Raveendiran et al., 2019). 
One study described a minimally traumatic technique using a surgical piezotome unit and 
elevators to avoid cortical plate damage, with a focus on retaining a four-wall socket 
configuration (Liu et al., 2016). Another trial reported using elevators for careful removal of 
distal roots (Bashara et al., 2012). While three studies did not report on socket configuration or 
pre-grafting socket debridement (Bashara et al., 2012; Cioban et al., 2015; Kim et al., 2017), 
two studies described both the socket configuration (intact socket) and debridement of the 
sockets after extraction (Liu et al., 2016; Raveendiran et al., 2019). 
Four out of five studies evaluated more than one ARP technique, but for the purpose of this 
systematic review only the data on CMX and NH sockets were extracted. In the ARP group, 
bovine-derived xenograft was placed into the socket and completely covered with a collagen 
membrane (Bashara et al., 2012; Cioban et al., 2015; Kim et al., 2017; Liu et al., 2016; 
Raveendiran et al., 2019). The control group was allowed to heal naturally without any grafting 
material or membrane coverage and primary closure was reported in three out of five studies 
(Liu et al., 2016; Bashara et al., 2012; Cioban et al., 2015). 
Post-operative care included antibiotics (Bashara et al., 2012; Cioban et al., 2015; Liu et al., 
2016), pain control medications and soft diet (Cioban et al., 2015; Kim et al., 2017; 
Raveendiran et al., 2019). Two studies reported performing mechanical plaque control for the 
experimental animals (Cioban et al., 2015; Raveendiran et al., 2019). Sutures were removed 10 
days after surgery in one study (Bashara et al, 2012), no other studies reported on suture 
removal (Cioban et al., 2015; Kim et al., 2017; Liu et al., 2016; Raveendiran et al, 2019). The 
animals were sacrificed after various healing periods: one month (Cioban et al., 2015), two and 
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four months (Liu et al., 2016), three months (Kim et al., 2017; Raveendiran et al., 2019) and  
six months (Bashara, 2012). Grafted and naturally healed sites were dissected and prepared for 
histologic (Bashara et al., 2012; Cioban et al., 2015), histomorphometric (Bashara et al., 2012; 
Kim et al., 2017; Liu et al., 2016) and radiographic analysis (Raveendiran et al., 2019). 
2.3.2.3 Characteristics of outcome measures 
Primary outcome measures: The amount of new bone formation was reported by three studies 
but due to different animal model being used we were unable to pool data for meta-analysis 
(Kim et al., 2017; Liu et al., 2016; Raveendiran et al., 20190. 
Secondary outcome measures: Two studies reported on differences in width and height of 
alveolar ridge but due to heterogeneity of reporting we were unable to pool data for meta-
analysis (Bashara et al., 2012; Kim et al., 2017; Raveendiran et al., 2019). 
Postoperative morbidity was reported in all canine studies (Bashara et al., 2012; Cioban et al., 
2015; Kim et al., 2017; Raveendiran et al., 2019). 
 2.3.2.4 Risk of bias in included studies 




Figure 0-5 Risk of bias summary for the animal studies 
 
2.3.2.4.1 Allocation (selection bias) 
Only two of the included studies clearly described the randomisation process (Liu et al., 2016; 
Raveendiran et al., 2019) and were considered to have a low risk of bias. Two studies provided 
some information about randomisation but due to insufficient reporting were judged to have 
unclear risk of bias (Bashara et al., 2012; Kim et al., 2017). In one study, random sequence 
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generation was not described at all, therefore this study was judged to have a high risk of bias 




Due to the nature of intervention, which dictated either the use of grafting material or leaving 
the extraction site to heal spontaneously, blinding of experimental animals to the selected 
treatment was not possible. To reduce the risk of detection bias, blinding of outcome 
assessment could be difficult but possible, however blinding of outcome assessment was not 
reported in any of the studies (Bashara et al., 2012; Cioban et al., 2015; Kim et al., 2017; Liu 
et al., 2016; Raveendiran et al., 2019). 
2.3.2.4.3 Incomplete data and selective reporting 
One study had to exclude six specimens due to incomplete healing and root retention (Liu et 
al., 2016). That study was given an unclear risk of bias for the domain, as it is not clear if the 
excluded cases would have influenced the outcomes of the study. The remaining four studies 
reported no exclusions or withdrawals and therefore the risk of reporting bias was judged as 
low (Bashara et al., 2012; Cioban et al., 2015; Kim et al., 2017; Raveendiran et al., 2019). 
2.3.2.4.4 Other potential sources of bias 
Two out of five included studies were funded by the manufacturer of the grafting material used 
in the trial (Bashara et al., 2012; Liu et al., 2016). In one of these studies, two of the authors 
were paid as consultants by the company (Bashara et al., 2012). Therefore, these trials were 
rated as being at high risk of bias. Two other studies (Cioban et al., 2015; Kim et al., 2017) 
were funded by university and research grants and therefore were deemed to have a low risk 
for that domain. One study did not report the source of funding but stated that graft material 
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was supplied by the manufacturer and was deemed to have an unclear risk of bias (Raveendiran 
et al., 2019). 
2.3.2.5 Effects of intervention 
Only data pertaining to this systematic review were extracted from the included animal studies 
and were based on a total of 78 extraction sites (mandibular premolar and maxillary lateral 
incisor tooth sockets) in 30 animals (23 dogs and 16 sheep). Due to heterogeneity of reported 
outcomes and differences in animal model, meta-analysis for these studies was not feasible. 
2.3.2.5.1 Primary outcome 
The percentage of new bone formation in the extraction socket was reported in three studies 
(Kim et al., 2017; Liu et al., 2016; Raveendiran et al., 2019). Although different animal models 
were used in these studies, they demonstrated that sockets treated with CMX had a smaller 
percentage of new bone formation compared to the NH sites. In the dog-model studies, after 
three months of healing, the percentages of new bone formation in CMX and NH sites were 
61.38 ± 6.9% and 68.08 ± 6.51% (Kim et al., 2017) and 37.51% (range 25.4-46.6%) and 
46.49% (range37.4-60.0%) (Raveendiran et al., 2019). The ovine study reported the percentage 
of newly formed bone in extractions after two healing time periods, two and four months. At 
CMX sites, the percentages of newly formed bone after two and four months were 38.6 ± 18.1% 
and 41.1 ± 11.1%, respectively. Higher percentages of new bone were reported in NH sockets 
(47.9 ± 5.0 % at two months and 45.7 ± 10.7% at four months) (Liu et al., 2016). The remaining 
dog-model studies did not report on the primary outcome measure of new bone formation 
(Bashara et al., 2012; Cioban et al., 2015). 
2.3.2.5.2 Secondary outcomes 
One of the included studies did not report on differences in height or width between test and 
control groups (Liu et al., 2016). One study provided a descriptive analysis of hard-tissue 
healing without any comment on the changes in ridge width or height (Cioban et al., 2015). A 
88 
 
third study reported on the difference between buccal and lingual alveolar ridge height but not 
the width of the ridge. The data provided in this study showed no statistically significant 
differences between CMX and NH sites (Bashara et al., 2012). The final study did not report 
on the changes in alveolar ridge height and width but reported the difference in vertical distance 
between buccal and lingual crests. A statistically significant difference was shown with greater 
difference in the NH sites compared with the one observed in CMX sites (2.22 ± 0.26 mm vs 
1.80 ± 0.16mm) (Kim et al., 2017). 
Four studies reported no post-operative complications or dehiscences (Bashara et al., 2012; 
Cioban et al., 2015; Kim et al., 2017; Raveendiran et al., 2019). The remaining paper did not 
report on complications but later excluded a number of sites due to incomplete healing and 
fenestrations (Liu et al., 2016). None of the included studies reported sample size calculations 




2.4.1 Summary of evidence 
This systematic review focused on the effects of using CMX for ARP in comparison to NH 
sockets. We included both animal and human studies in order to examine the strength of 
available evidence and to look for any potential differences between CMX-preserved extraction 
sites and NH sockets. We found significant reduction in ridge height and width resorption with 
the use CMX but also reduced new bone formation. Whether the reduced amount of new bone 
has any negative impact on the long-term outcomes of implant treatment is still unclear. 
The main purpose of ARP is to allow restoration of the edentulous space with dental implants 
preferably without additional bone grafting procedures. This requires maintenance of ridge 
89 
 
shape and size as well as formation of new bone in the extraction socket. Hence, the formation 
of new bone was considered the primary outcome measure in the present review while changes 
in horizonal and vertical dimensions of the alveolar ridge were assessed as secondary outcome 
measures.  
Several studies reported on the formation of new bone within grafted and non-grafted sockets 
and all found that CMX treated sockets showed less new bone formation compared to NH sites 
(Cardaropoli et al., 2012; Kim et al., 2017; Liu et al., 2016; Raveendiran et al., 2019). The 
results of these studies are in agreement with other publications reporting on the use of 
xenograft in ARP (Carmagnola et al., 2003; Heberer et al., 2011; Chan et al., 2013). In one 
study, after four months of healing the differences between the amount of new bone in CMX 
site was almost half the amount found in NH socket (Cardaropoli et al., 2012). Conversely, in 
the animal studies, the differences in new bone formation were not as substantial (Liu et al., 
2016; Kim et al., 2017). The ovine (sheep) study had overall less newly-formed bone compared 
to the canine (dog) model and more bone compared to the human studies. The reported 
differences are most likely attributed to different rates of healing between species.  
Differences in the species of origin or in the manufacturing processes for the xenografts may 
have influenced the amount of new bone. Bovine-derived graft material was used in one human 
and one ovine trial (Cardaropoli et al., 2012; Liu et al., 2016), bovine-derived xenograft with 
10% collagen was used in three human and two canine trials (Kim et al., 2017; Raveendiran et 
al., 2019; Iorio-Siciliano et al., 2017; Jung et al., 2013; Jung et al., 2018). In addition, different 
species heal at different rates. Dogs have the fastest rate of bone turnover and healing, followed 
by sheep and lastly by humans (Claflin, 1936; Duncan, 2005). Eight weeks of healing in a 
canine model is equivalent to 12 weeks in an ovine model and to 16 weeks in humans (Duncan, 
2005). The difference in healing rates can explain why we see more new bone formation in 
extraction sockets in dogs than in humans. It is difficult to draw any conclusions about the type 
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of xenograft material with regards to new bone formation, as the differences in rates of animal 
healing may outweigh the influence of xenograft type.  
Xenograft bone substitute is also known for its slow resorption and residual graft material is 
frequently reported in the socket months after grafting (Artzi et al., 2001; Carmagnola et al., 
2003). For that reason, we included the presence of residual graft material in the secondary 
outcome measures. Five studies reported on this result, with two human and three animal 
studies showing various amounts of remaining graft material in the sockets (Barone et al., 2008; 
Cardaropoli et al., 2012; Kim et al., 2017; Liu et al., 2016; Raveendiran et al., 2019). Once 
more, different graft materials were used in each of these reports, resulting in different amounts 
of remaining grafting material inside the healed extraction socket. Two canine studies that used 
bovine-derived xenograft with collagen demonstrated a high amount of residual graft (Kim et 
al., 2017; Raveendiran et al., 2019) despite the fact that dogs have the fastest bone remodelling 
and healing rate of all species considered in this systematic review. Human studies reported 
similar figures for residual graft within the socket although different xenografts were used. One 
study used corticocancellous porcine-derived bone (Barone et al., 2008) and reported 29.2 ± 
10.1 % of graft material remaining after seven months of healing, while the bovine-derived 
xenograft used in another study demonstrated  18.46 ± 11.18% of residual graft following four 
months of healing (Cardaropoli et al., 2012). The least amount of remaining xenograft was 
reported in the ovine study that used bovine-derived xenograft, with similar results for two- 
and four-month healing periods (Liu et al., 2016). The amount of residual graft materials in 
human extraction sockets did not seem to be influenced by the healing time, with considerably 
more remaining graft observed after seven months of healing compared to four months healing 
(Barone et al., 2008; Cardaropoli et al., 2012).  One would naturally expect less residual graft 
following longer period of healing, however differences in grafting material particle sizes and 
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grafting protocols as well as inter-participant variations could contribute to differences in the 
observed results. 
Greater post-extraction reduction of ridge width and height on the buccal or labial surface, 
when compared to the lingual surface, is also well established (Pietrokovski and Massler, 1967; 
Nevins et al., 2006). Five of the included studies focused on measuring the changes in the 
buccal ridge (Barone et al., 2008; Festa et al., 2013; Iorio-Siciliano et al., 2017; Jung et al., 
2013; Jung et al., 2018). The results of these studies confirmed that CMX for ARP reduced 
buccal ridge resorption when compared to non-grafted NH sockets. This is consistent with 
other reports on buccal ridge changes using various grafting materials when compared to NH 
sites (Al Qabbani et al., 2018; Al-Hamoudi et al., 2015; Barone et al., 2013; Cardaropoli et al., 
2014; Fickl et al, 2008). Successful rehabilitation of an edentulous space involves not only a 
well-functioning tooth replacement but also an aesthetically acceptable prosthesis. 
Consequently, limiting buccal ridge dimensional changes is important especially in anterior 
extraction sites (Merheb et al., 2014). Based on the studies considered in this systematic review, 
the use of CMX for ARP may minimise buccal vertical changes in extraction sockets and 
therefore can help clinicians achieve good aesthetically acceptable treatment outcomes. 
2.4.2 Limitations 
Quantitative analysis of patient-related outcomes was not possible as reporting pain, discomfort 
and swelling was subjective, and no specific scale was used. Some degree of discomfort, 
bruising and swelling is expected following tooth extraction and was reported by three of the 
included human studies (Barone et al., 2008; Cardaropoli et al., 2012; Festa, 2013). It is 
difficult, however, to ascertain whether pain or postoperative morbidity was related to the 
extractions or alternatively to the grafting procedure. 
Several limitations need to be acknowledged for this systematic review. All the included 
studies were judged as having a high risk of bias and all were published in the English-language 
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literature, which may raise the potential for language bias. In addition, none of the studies 




Following tooth extraction, resorption of the alveolar ridge will occur and cannot be prevented 
by any currently available alveolar ridge preservation methods. Whilst it cannot be stopped, it 
can be significantly reduced using CMX when compared to untreated tooth sockets. Although 
extraction sites grafted with CMX showed less new bone formation compared to non-grafted 
sites, CMX grafted sockets also showed less dimensional changes, demonstrating why these 
materials are well accepted and commonly used as an ARP therapeutic option. 
2.4.4 Recommendations for future research 
Future research in this area is required, focussing on adequately-powered randomised clinical 
trials in accordance with the latest CONSORT guidelines. Whilst preclinical research provides 
useful data with respect to primary outcome variables (histological measurement of osseous 
healing) and secondary variables (edentulous ridge resorption), translation to clinical 
therapeutics is limited by inter-species differences in the nature and rate of bone healing. Thus, 
more clinical studies are needed that evaluate both qualitative (histological) as well as 
quantitative (clinical) outcomes, using well-described and reproducible methods. In most 
circumstances, ARP is followed by installation of a dental implant; this surgical intervention 
makes possible the trephination of healed bone from healed sites and therefore enables the 
reporting of new bone formation and residual bone graft presence, alongside  analysis of 
volumetric changes in the post-extraction alveolar ridge.  
In addition, clinical studies should address some of the questions around the need for additional 
augmentation at the time of implant placement, aesthetic outcomes of prosthodontic 
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rehabilitation and cost benefit of ARP by reporting patient-centred outcomes such as post-
surgical complications and participant’s quality of life, and downstream events such as implant 
survival and success. Incorporating these parameters in future research would allow for better 
comparison of different studies in future systematic reviews and help clarify whether ARP 





Chapter 3  
























One of the aims of this study was to analyse healing outcomes and compare  Ovine 
Forestomach Matrix (OFM) to a commonly used barrier membrane Bio-Gide® in a pre-clinical 
and histological equivalency trial; and to test non-inferiority between these two membranes. 
 This chapter describes the materials and methods used for tooth extraction, socket grafting, 
surgical procedures and euthanasia, as well as preparation and analysis of mandible samples 
for histomorphometric and radiomorphometric analyses. 
 
3.1 Experimental animals 
The study was approved by the Otago University Animal Ethics Committee (Application No 
75/2017) in accordance with New Zealand Regulations (New Zealand Animal Welfare Act 
1999). Thirty Romney-cross ewes over 3.5 years of age were used in this study. The animals 
were provided by Hercus-Taieri Invermay breeding station. Due to the slow post-surgical 
recovery of underweight animals, all sheep were required to be above 75 kg. Prior to the 
beginning of the study, all animals underwent thorough screening to exclude footrot and to 
ensure the presence of healthy periodontium. Following screening the animals were tagged 
with individual ear tags, received appropriate immunisations and treatment to control parasites 
and were released to a secure pasture until surgery.  
This study was designed to investigate extraction socket healing at 4-, 8- and 16-weeks after 
grafting for alveolar ridge preservation. The animals were divided into 3 groups of 10 sheep, 
with one group allocated to each time point (Figure 3.1).  
The sample size was based on similar research using BRG in animal models. Previous work 
by Professor Duncan’s research group established that 8 sheep is the minimum required to 
demonstrate statistically significant results following histological analysis where the level of 
statistical significance is set at p< 0.05 (Duncan, 2005; Duncan, 2014; Liu 2013; Liu et al., 
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2016; Philipp et al., 2012; Sheftel et al., 2019). The use of 10 sheep per time point was based 
on previous experience with sheep models, which suggests that one or more animals can 
become ill or die from unrelated reasons, or develop infections which prevent analysis of the 
site(s). 
Each animal underwent the extraction of the three mandibular premolars bilaterally (Figure 
3.2). As there is marked difference in size between the dimensions of first, second and third 
premolar teeth, the extraction sockets were standardised as per our previous protocol, using 
tapered dental implant burs (5.2 mm diameter x 11 mm length). The surgical procedures are 
described in detail below. After radiographic confirmation of successful extractions and site 
preparation, four of the sites (two on each side of the jaw) were filled with deproteinised bovine 
bone substitute (Bio-Oss®, Geistlich, Switzerland). Two of these bone-grafted defects, on each 
side, were then covered with a test membrane (OFM, Aroa, Treatment A), the other two defects 
were covered with the reference membrane (Bio-Gide®, Giestlich, Treatment B). The 
remaining two defects were left ungrafted (Treatment C). “Ungrafted” sites were used as 
negative controls to demonstrate that the created defects were of critical size and that without 
grafting the bone would not completely regenerate during the study. Treatment of all extraction 
sites was randomised prior to surgeries to avoid any positional bias. Each side of the jaw 
received one of each of the treatments A, B and C. A Latin square model was used to ensure 
that each site had equal exposure to each treatment on both sides of the jaw (Table 3.1). 
Intraoral radiographs were taken at the completion of grafting. 
Following initial extractions and grafting surgery, the animals were left to heal for 4-, 8- and 
16-weeks, and euthanised at the designated time point. Tissues were fixed via formalin 
perfusion through the carotid artery, defect sites were dissected and fixed for analysis, left side 
of the jaw was scanned using micro-computerized tomography (μCT) then resin embedded for 





Figure 0-1 Study design 
 
 
Figure 0-2 A sheep mandible with premolar teeth 
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LP1 LP2 LP3 
1 597 4 weeks A B C A B C 
2 437 4 weeks B C A B C A 
3 342 4 weeks C A B C A B 
4 586 4 weeks A B C A B C 
5 590 4 weeks B C A B C A 
6 441 4 weeks C A B C A B 
7 583 4 weeks A B C A B C 
8 593 4 weeks B C A B C A 
9 428 4 weeks C A B C A B 
10 595 4 weeks A B C A B C 
11 440 8 weeks A B C A B C 
12 594 8 weeks B C A B C A 
13 589 8 weeks C A B C A B 
14 434 8 weeks A B C A B C 
15 591 8 weeks B C A B C A 
16 598 8 weeks C A B C A B 
17 426 8 weeks A B C A B C 
18 439 8 weeks B C A B C A 
19 438 8 weeks C A B C A B 
20 450 8 weeks A B C A B C 
21 430 16 weeks A B C A B C 
22 436 16 weeks B C A B C A 
23 599 16 weeks C A B C A B 
24 584 16 weeks A B C A B C 
25 587 16 weeks B C A B C A 
26 585 16 weeks C A B C A B 
27 442 16 weeks A B C A B C 
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28 592 16 weeks B C A B C A 
29 427 16 weeks C A B C A B 
30 425 16 weeks A B C A B C 
RP1 – first right premolar; RP2 – second right premolar; RP3 – third right premolar; LP1 – 
first left premolar; LP2 – second left premolar; LP3 – third left premolar  
 
Key socket grafting Graft Membrane 
A Test membrane Bio-Oss®, Giestlich OFM, Aroa 
B Control membrane Bio-Oss®, Giestlich Bio-Gide®, Giestlich 




Figure 0-3 Extracted ovine mandibular premolars (a)LP1; (b) LP2; (c) LP3;  
 
 
3.2 Surgical and grafting materials 
3.2.1 OFM – resorbable collagen membrane (Aroa biosurgery, New Zealand) 
OFM (Figure 3.4) is an extracellular matrix membrane containing a mix of biological 
molecules, including structural proteins such as collagens type I, III, IV and elastin; adhesive 
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proteins such as fibronectin and laminin; glycosaminoglycans such as heparin sulphate and 
hyaluronic acid and growth factors – fibroblast growth factors 2 and tissue growth factor β.  
 
Figure 0-4 OFM Aroa Biosurgery, New Zealand 
 
OFM (20mm diameter) was placed in a single layer over the extraction site grafted with Bio-
Oss®, with one membrane used per animal. It was provided by the manufacturer and was 
terminally sterilised using a certified ethylene oxide sterilisation process, according to Aroa 
Biosurgery’s internal quality procedure and specifications. The membrane was trimmed to size 
per standard practice and placed over the grafted defect.  
 
3.2.2 Bio-Gide® - resorbable collagen membrane (Giestlich, Switzerland) 
Bio-Gide® is a well-established resorbable porcine collagen membrane (Figure 3.6). This 
membrane is a widely used collagen membrane in Australia for oral tissue regeneration (Darby 
et al., 2008). Bio-Gide® is describe by the manufacturer as a non-artificially cross-linked native 
collagen membrane with a unique bi-layer that comprises both smooth and rough open pore 




Figure 0-5 Bio-Gide® membrane layers, (a) smooth top layer; (b)rough bottom layer. 
 
Bio-Gide® membrane (30 x 40mm) was also placed in a single layer over the extraction defect 
grafted with Bio-Oss®. One commercially available packet was used per animal; the membrane 
was trimmed to size to fit the defect prior to placement. 
 
Figure 0-6 Bio-Gide® Giestlich, Switzerland 
 
3.2.3 Bio-Oss® – bone mineral, xenograft (Giestlich, Switzerland) 
Bio-Oss® (Giestlich, Switzerland) is a particulated deproteinised bovine bone mineral used in 
regenerative dentistry (Figure 3.7). It has been extensively researched and widely used for the 
past 25 years. It is an osteo-conductive material and has no osteogenic or osteoinductive 
properties. The small-size Bio-Oss® granules (0.25-1 mm) were used in this study, with 0.5 g 
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placed in each of the allocated defect sites, one pack per defect. The amount of graft required 
was based on the previous studies carried out at the University of Otago (Lander, 2016; Liu, 
2013).  All Geistlich products were purchased from the manufacturer. 
 
 
Figure 0-7 Bio-Oss® Giestlich, Switzerland 
 
3.3 Surgical protocol 
Hercus-Taieri Resource Unit at Invermay Agricultural Research Centre in Mosgiel provided 
sterile surgical facilities at a designated large animal surgery. 
 
3.3.1 Sterilisation of equipment 
Full-scrub aseptic theatre techniques and sterile instruments were used at all times. All surgical 
equipment was autoclave sterilised prior to use. All surgical disposables and consumables were 
procured sterilised from the manufacturer. All membranes and bone graft used in the study 




3.3.2 Anaesthetic technique 
The animals selected for the experiment were housed separately for 48-72 hours prior to 
surgery. In the 24 hours preceding general anaesthesia, no oral intake of food was allowed, but 
the animals received water twice daily and were pre-medicated with antibiotics (Amphoprim® 
– Trimethoprim sulpha, subcutaneous injection 1 ml/15 kg, Virbac New Zealand Ltd., East 
Tamaki, Auckland). 
General anaesthesia was induced with Diazepam (Pfizer, New Zealand Ltd) 0.2 mg/kg and 
Ketamine (Baxter Healthcare Ltd) 2 mg/kg both administered intravenously. Oral intubation 
and a stomach tube were placed, and general anaesthesia was maintained using Isoflurane gas 
2.5-3.5% to effect. The animals were restrained and placed in lateral recumbency with the 
animal’s head rotated onto either left or right side. The operative side of the head was shaved 
and prepared with Betadine. The animal’s head and body were draped with sterile surgical 
drapes. Full-scrub aseptic theatre technique and sterile instruments were used.  
Dental local anaesthetic was administered via infiltration next to the operative site, using 
Septodont Lignospan® Lignocaine Hydrochloride 2% with Adrenalin 1:80000 (Ivoclar 
Vivadent Ltd, New Zealand). Two cartridges (2.2 ml each) was used per side pre-operatively 
to decrease discomfort and to provide haemostasis during surgery. 
 
3.3.3 Tooth extraction protocol 
Intrasulcular and crestal incisions were made from mid-buccal of the first mandibular molar to 
1cm mesial to the first mandibular premolar. Full thickness buccal and lingual mucoperiosteal 
flaps were raised. The first, second and third mandibular premolars were removed using the 
minimally traumatic approach. Initially the teeth were separated by gently tapping the elevator 
with a surgical mallet in the interproximal contact areas. The teeth were carefully loosened 
using Coupland’s and Cryer’s dental elevators, periotomes and forceps. Molar and premolar 
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forceps were used to deliver the teeth with special care taken not to damage the cortical plates 
and inter-radicular bone as well as prevent root fractures. When root fractures did occur the 
fractured root was carefully removed using a piezotome and root pick elevators. 
Complete tooth removal was verified radiographically with Kodak® size 2 periapical intraoral 
film and a Rinn® holder in a paralleling technique. 
 
3.3.4 Grafting site preparation 
The size of the premolar teeth varies between sites and between animals, with first premolars 
often being smaller or absent, and the third premolars being the largest of the three teeth. For 
that reason, the extraction sockets needed to be standardised. The sockets were standardised 
using an implant bur (Southern Max Ex-Hex system, catalogue number D-6.0 TP-11, Southern 
Implants, Irene, South Africa). Each socket was >11 mm deep x 5.2 mm wide at the most 
coronal portion. The crestal level ridge width was measured mid-defect using a standard 
Williams periodontal probe (Figure 3.8 a, b). The individual sockets were separated by the 
interseptal bone. Following extractions, the presence of separation between the sockets was 
observed visually, without recording the thickness of the interdental septum. The size of the 





Figure 0-8 Grafting site preparation. (a) standardisation of grafting site depth and width, (b) 
measuring the alveolar ridge width with Williams periodontal probe. 
 
3.3.5 Grafting the extraction sites 
To ensure equal exposure of each site to each therapy, a Latin square model was used to allocate 
treatments (Table 3.1). Each animal received a total of six extraction with three premolars 
removed from each side. Both sides of the jaw were grafted with test and control materials, 
with each side receiving one of each treatment. One socket per side was grafted with Bio-Oss® 
(Figure 3.9 a and b) and covered with OFM (Treatment A), one socket was grafted with Bio-
Oss® and covered with Bio-Gide® collagen membrane (Treatment B) and one socket was left 
untreated receiving no graft and no membrane (Treatment C) (Figure 3.9c). Sites that received 
bone grafting material were filled with approximately 0.5 g of Bio-Oss® to the level of crestal 
bone prior to membrane placement. 
The ease of handling for the two membranes was described and recorded in a spreadsheet at 
the time of surgery, and subsequently summarised. 
Upon completion of surgery each animal had a total of four sockets filled with Bio-Oss® bone 
mineral, two of which were protected with OFM and the other two covered with Bio-Gide® 
collagen membrane, with the remaining two sockets left to heal naturally. 
Defect closure was achieved by coronally positioning buccal and lingual mucoperiosteal flaps 
which were sutured to achieve primary closure. Resorbable 3.0 Polyglycolic acid sutures 
(Ethicon Vicryl®, catalogue number J497H, Somerville, NJ, USA) were used (Figure 3.9 d). 
Long-acting local anaesthesia was administered at the end of surgical procedure to control pain 
at the surgical site. Marcain® (0.5% Bupivacaine Hydrochloride with adrenalin 1:200000, 
Carestream Health, UK) was the anaesthetic of choice and was delivered by buccal infiltration 
next to the surgical site. 
106 
 
Immediately post-operatively a final intraoral periapical radiograph was taken using the same 




Figure 0-9 Grafting of extraction sites. (a) application of Bio-Oss® into the socket, (b)  first 
and second premolar sites grafted with Bio-Oss®, (c) from right to left – OFM, Bio-Gide® 
collagen membrane, ungrafted socket, (d) primary closure of surgical site 
3.3.6 Post-surgical care 
Following wound closure, the experimental animals were extubated when actively swallowing 
and transported to a housing pen for post-surgical recuperation. A registered veterinarian 
closely monitored the animals to ensure complete recovery. For the first three days following 
surgery, daily postoperative antibiotics and anti-inflammatory medications were administered. 
Animals received Caprofen 4 mg/kg (Rimadyl® injection 50 mg/ml, Zoetis, Mt Eden, New 
Zealand) and Amphoprim (Trimethoprim sulpha, Virbac New Zealand Ltd., East Tamaki, 
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Auckland) 1 ml/15 kg via subcutaneous injections, while intraoral surgical sites were 
disinfected daily with 20 ml of Chlorhexidine gluconate (0.2%) antiseptic solution. In addition, 
food and water intake was closely monitored daily, as well as animal health and behaviour; any 
complications at surgical sites were examined and recorded. Subsequent to post-surgical 
recovery, the animals were transported to the farm paddock and allowed to graze freely until 
the designated euthanasia date. 
 
3.3.7 Euthanasia and sample harvesting 
This study evaluated alveolar ridge healing at 4-, 8-, and 16-weeks with 10 sheep allocated to 
each group. At each nominated time point 10 animals were returned to Invermay Agricultural 
Research Facility, anaesthetised following the same protocol as described above (see 3.2.2) – 
induced with Diazepam and Ketamine, intubated orally, and kept under general anaesthesia 
with Isoflurane and euthanised. 
The animals were euthanised by anaesthetic overdose (Isoflurane), and the carotid arteries were 
exposed bilaterally by blunt dissection, ligated and cannulated, then 1 L per side of sterile saline 
with heparin (0.9% Sodium chloride, Baxter Healthcare Ply Ltd., NSW, Australia + 5000 IU 
heparin) was used to flush the vasculature. This was followed by 1 L per side 4% formaldehyde 
(BioLab Ltd., New Zealand) to perfuse and fix the tissues. Subsequent to fixation, the jugular 
veins were cut bilaterally, and blood drained into a biohazard container. The mandible was 
dissected, with experimental sites separated by en-bloc resection. The left and the right sides 
were stored separately in 10% neutral buffered formalin. The containers were labelled 




3.4 Specimen preparation 
3.4.1 Specimen sectioning 
Only the left side specimens were analysed in this report. The rightside specimens were 
processed separately and have been reported elsewhere. 
The left side specimens were left in 10% neutral buffered formalin solution for 1 week. Prior 
to taking radiographs, the resected left side jaws were transferred to 20% ethanol solution 
(absolute for analysis, Emsure®, ACS, ISO, reag. Ph Eur), which was prepared fresh by 
combining distilled water and 100% ethanol. Each left hemi-mandible was radiographed by 
placing the specimen onto an E-speed extra-oral Kodak film (Carestream Health, NY, USA), 
exposed at a focal length of 38 cm for 0.16 seconds using the Scanora Dental system. The films 
were developed in an automatic processing unit. 
 
 
Figure 0-10 Post-mortem extra-oral radiograph of mandibular left side 
 
The corresponding radiograph and specimen were superimposed using the molar teeth as 
reference markers. The borders between adjacent grafted sites were identified and marked on 
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the extra-oral radiographs, these marking were later transferred onto the mandibular bone to 
guide the sectioning (Figures 3.10 and 3.11). Each mandible was sectioned in a bucco-lingual 
direction following the pre-determined markings using a manual coping saw (Spear and 
Jackson, England). Three samples were produced from each hemi-mandible. The most anterior 
sample corresponded to the first premolar site and was labelled “A” (anterior), the middle block 
corresponded to second premolar and was labelled “M” (middle) and the third premolar block 
was labelled “P” (posterior). Each sectioned sample was placed into a histology cassette and 
was double labelled with a paper label placed inside the cassette as well as a label attached to 
the front of the cassette. All labels indicated animal ID number, followed by the side of the 
mandible (left) and the position of the extraction site within the jaw (anterior, middle, posterior) 
(Figure 3.12 and 3.13). 
 
 






Figure 0-12 Markings transferred to the mandible prior to sectioning the specimen 
 
 
Figure 0-13 Labelled histology cassettes 
 
3.4.2 Micro-computerised tomography (μCT) 
We used two modes of assessment (μCT and histology) to measure the percentage of bone fill 
within the healing extraction sites. All sectioned specimens were scanned using a Skyscan 1172 
micro-computerized tomographic unit (μCT, Skyscan, Belgium). Each section was scanned 
individually at medium resolution using fixed parameters as previously described (Duncan et 
al 2008). In brief, the X-ray source was set to 40kV with a current of 250 μA to allow high 
contrast but to minimise beam hardening. An aluminium filter of 0.5mm was used to further 
reduce beam hardening and absorb radiation. To optimise the image quality, the rotation step 
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was adjusted to 0.4° and frame averaging was set to 3. Sixteen weeks samples were scanned 
first without prior embedding in resin, while 4- and 8-weeks samples were resin embedded 
before the scans. During scanning the parameters were optimised for the specimens in the study 
(Table 3.2). 
Table 0-2 Micro - computerized tomography settings 
Item Settings and parameters 
Camera Hamamatsu 10 Mp  
Camera XY ratio 0.9960 
Number of files 490 
Included in lifting 0.0128 μm/mm 
Source voltage 40 kV 
Source current 250 μA 
Number of rows 1048 
Number of columns 2000 
Image pixel size 17.45 μm 
Object to source 261.849 mm 
Camera to source 343.679 mm 
Filter 0.5 mm aluminium 
Optical axis 450 line 
Image format TIFF 
Depth 16 bits 
Exposure 1180 ms 
Rotation step 0.400 degrees 
Frame averaging 3 
Random movement  4 
Scan duration 00:48:45 
 
 
The scanned images were processed using Skyscan’s NRecon software (ScancoMedical, 
Bruttisellen, Switzerland) to produce reconstructed cross-sectional slices (Figure 3.14). An 
image analysis program, Image J (NIH, Bethesda, MD, USA) was used to examine the changes 
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in hard tissue in a volume of interest (VOI) corresponding to the middle of the extraction 
socket, oriented using the following landmarks: long axis of the centre of the socket, apex of 
the socket, buccal and lingual bone crest at the extraction socket sites.  
 
Figure 0-14 μCT image of 437LP (4-weeks healing) specimen with the marked region of 
interest (yellow), 4mm wide and 6mm high 
 
3.4.3 Hard tissue histology sample embedding 
All specimens were embedded without demineralisation in methacrylate resin. The protocol 
initially described by Donath and Breuner (1982) and later modified by Duncan (2005) was 
used for resin embedding (see Appendix II). 
Briefly, the specimens housed in individual plastic cassettes were gradually dehydrated in 
ascending concentrations of ethanol (20, 40, 70, 95 and 100%). Following dehydration, all 
samples were transferred to a fume hood and placed into xylene solution (Ajax Finechem Pty 
Ltd, New Zealand) on a rotating platform. The samples remained in xylene for 4 days with two 
changes of solution during that time. Specimens were rinsed with methyl methacrylate (MMA) 
(Methyl Methacrylate 99% stabilised, PN:127140010, Acras Organics) wash and then placed 
in MMA I and MMA II (see Appendix II) for two days each on a rotating platform. MMA I is 
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pure methacrylate; MMA II and III containing increasing concentrations of polymerisation 
initiator (Benzoyl peroxide) and plasticiser (Dibutyl phthalate). 
Each specimen was removed from its individual cassettes and transferred into its own glass jar 
with pre-set MMA III base. A paper label was placed in each jar with a specimen corresponding 
to its identification number. The jars were filled with MMA III, tightly sealed with the screw 
top lid, and placed in a water bath (at room temperature) for 4 weeks to allow setting.  
The glass jars were broken to retrieve the resin-embedded specimens, which were then trimmed 
and polished prior to final sectioning (Figure 3.15. 
 
 
Figure 0-15 Resin embedded specimens 
 
3.4.4 Sectioning of resin-embedded samples 
A Struers Accutom precision table-top cut-off machine (Ballerup, Denmark) with a diamond 
cut-off wheel (MOD 13: 127 x 0.4 x 12.7 mm) was used to section the resin-embedded 
specimens. Each resin block was mounted onto the machine along the long axis of the tooth in 
a bucco-lingual direction. Sequential 500 μm sections were cut, polished, and mounted onto an 
opaque acrylic slide using cyanoacrylate glue. 
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The sections were ground and polished using a Tegra-Pol rotating grinding machine (Tegra-
Pol, Struers, Ballerup, Denmark) and waterproof Silicon Carbide Paper (grit sizes #500 to 
#2400). The final thickness of the slides was between 80 and 120 μm as determined using a 
digital micrometer (Digital Indicator, Mitutoyo, Japan). The acrylic slides were labelled with 
specimen identifying codes using a permanent marker and a straight handpiece with a round 
bur. The code included the sheep number, the side from which the sample was taken, the 
position of the site within the jaw and the number of the section from the block counting from 
the end. Following superficial decalcification and etching with 20% ethanol and 1% formic 
acid in an ultrasonic bath, the sections were stained with one-part MacNeal’s tetrachrome and 
two parts toluidine blue solution, as previously described by Schneik et al., (1984), Hunziker 
and Driesang (2003) and Kolonidis et al., (2003),  for 5 minutes, then rinsed with distilled water 
and left to air dry (Figure 3.16). For the detailed description of this process see Appendix II. 
 
 




3.5 Histomorphometric analysis 
3.5.1 Imaging of histological sections 
From each specimen, two adjacent slides representing the middle of the extraction socket were 
visually selected and included in the histomorphometric analysis. If one of the selected slides 
was not of a sufficient quality, then the next slide in the sequence was selected.  
For histomorphometric analysis, high resolution images were acquired and digitised using a 
confocal light microscope (Nikon Eclipse Ti2 series, Japan) with an imaging system 
(Micropublished 5.0 RTV, Qimaging) at 10x magnification. To produce an image of the entire 
healing socket a series of images were taken using the montaging software Velocity 5.2.0 
(Improvision, MA, USA) and combined together using Autopano Pro 3.5.3 (Kolor, USA) 
software. Digital images were re-sized using Adobe Photoshop 19.0 (Adobe Inc 2018) to 300 
dpi to allow image analysis. 
 
3.5.2 Morphometric measurements 
Analysis was carried out on specimen from all three healing timepoints – four, eight and sixteen 
weeks. A computer-based image analysis system Image J (version 1.52p, National Institute of 
Health, USA) was used to measure the percentage of newly formed bone, connective tissue 
and bone graft within the region of interest using a full colour threshold plugin. 
The region of interest (ROI) representing the portion of the site most likely to be utilised for 
implant placement was selected manually for each specimen using the following protocol. An 
area measuring 4x6 mm was defined and its coronal portion was aligned with the level of 
alveolar crest, taking care to avoid the cortical bone. The size of the ROI was determined by 
the anatomy of the sheep’s mandible with the presence of large bone marrow space and in line 





Figure 0-17 Histomorphometric analysis. Representative slide with ROI (yellow) 4 mm wide 
and 6 mm high 
 
To measure the percentages of newly formed bone, connective tissue and residual graft within 
the ROI, colour thresholding was manually adjusted depending on the staining intensity of the 
tissue being measured. Each specimen was represented by two bucco-lingual sections from the 
centre of the socket, the mean values of these sections were used to calculate the overall mean 
for each treatment group. An example of manual selection of thresholding for connective tissue 





Figure 0-18 Representative image of thresholding for connective tissue (red) 
 
3.5.3 Examiner reliability test 
Inter- and intra-examiner reliability were tested. Fifteen images were randomly selected using 
a random number generator for repeated measurements. These images were re-measured three 
weeks after the initial analysis was performed, both by the primary investigator and by another 
member of the team who was not aware of the initial measurements. The results are shown in 
Appendix III, section 5. The Pearson correlation significance for the measurements range from 
0.871 to 0.998, with two datasets having high correlation and no statistically significant 




3.6 Statistical analysis 
Descriptive statistics (mean and standard deviation) were calculated for all variables using 
sheep as a statistical unit. At each healing time point one socket contributed two sections to 
analysis. The mean amount of new bone, connective tissue and residual graft in each socket 
was averaged across all specimens to determine the mean and standard deviation of the tissue 
of interest at each healing group. The normality of the data was tested using Shapiro Wilks test, 
QQ plot and K-density plot. Three data sets failed to meet the assumption of normality – new 
bone and connective tissue in the control group at four weeks and new bone in the OFM group 
at sixteen weeks. All other groups were deemed to have normal distribution and for that reason 
parametric statistical tests were used. The differences between groups were analysed using 
paired t-test. The comparison of tissue composition between times for each group was analysed 
using Bonferroni adjustment post-hoc analysis. Differences between groups were considered 
statistically significant when p<0.05. The statistical analysis was performed with STATA 



































4.1 Material handling properties 
The handling properties of OFM and Bio-Gide® membranes were different with regards to the 
manipulation within the extraction socket.  
The preparation of both membranes prior to grafting, such as measuring, trimming, and 
transferring to the surgical site was similar - easy and requiring little time. The adaptation of 
the membranes to the alveolar ridge to ensure the correct position during suturing, as well as 
prevention of membrane displacement was more challenging with the Bio-Gide® membrane. 
The stiffer OFM was readily shaped into a tented conformation by moulding it around a dental 
mirror handle, and could then be placed over the grafted socket without immediate collapse, 
whereas the more hydrophilic Bio-Gide® membrane immediately became limp and adherent to 
soft tissues, which made positioning the membrane and suturing the overlying flap more 
challenging. 
4.1.1 OFM 
OFM is an extracellular matrix membrane containing a mix of collagen, adhesive proteins, 
glycosaminoglycans and growth factors with a dense contoured matrix on one side and an open 
smooth matrix on the other side resulting in a robust barrier material. Without initial re-shaping 
and moulding of the membrane to give it slight curvature it was rigid and would not drape 
naturally over the bony ridge - the membrane attempted to return to its normal “flat-sheet” 
shape, making it harder to position it under the surgical flap. However, pre-shaping of the 
membrane was very straight-forward and was achieved by gently wrapping the material around 
the dental mirror handle to create a curved surface. Following that, the placement of OFM was 
straightforward, it stayed in place over the alveolar ridge, it did not soften upon contact with 




4.1.2 Bio-Gide® membrane 
Bio-Gide® membrane was easier to position over the alveolar ridge, as it draped naturally over 
the bone. However, it was more difficult to keep in the correct place during wound closure. 
With the Bio-Gide® membrane having a unique bilayer structure with native non-crossed 
linked collagen fibres, it was not rigid and consequently did not require shaping prior to 
placement over the alveolar ridge. However, when the membrane came into contact with blood 
it softened and became hard to handle, failing to stay in the confines of the surgical site and 
was easily displaced with any movement of the flaps during suturing. This prolonged the 
procedure with the time spend repositioning the membrane back to the correct position. 
 
4.2 Tooth extraction 
The main complications during the extraction procedure included fractured roots, discovery of 
pre-existing abscesses and minor fractures of the lingual cortical plate.  Although special care 
was taken to prevent root fractures and to avoid damage to the cortical plates and inter-radicular 
bone, five out of thirty animals had fractured roots during the extraction procedure. All of the 
fractured roots were carefully elevated, and their removal was confirmed using intraoral 
radiography.  
One animal (585) had not buccal cortical plate present in the third premolar site due to an 
existing abscess, which was only uncovered following flap elevation during the extraction 
procedure. Another animal (425) had a lingual cortical plate fracture during the extraction of 




4.2.1 Post-operative recovery 
No immediate post-operative complications were encountered in relation to healing of 
extraction sockets. All animals survived the initial surgery and were euthanised at the pre-
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determined time points. During the euthanasia procedure it became apparent that three sheep, 
one from week 8 and two from week 16, developed abscesses and had foreign bodies, most 
likely grass, lodged in some of the extraction sites. For this reason, these animals were excluded 
from the final analysis. 
 
4.3 Site harvesting 
Six sockets were harvested from each animal, three from the right and three from the left side. 
For this study only the sockets from the left side were included, while the right-side specimens 
were used for another study. A total of ninety sites were harvested. 
 
4.4 Micro CT analysis 
4.4.1 Descriptive analysis of matched images of μCT and histology 
All specimens were scanned using μCT; four- and eight-weeks specimens were scanned after 
resin embedding was completed, while 16 weeks sites were scanned prior. The images showed 
reasonably good contrast in which the areas of old cortical, new woven bone and residual bone 
graft were easily identified. The connective tissue spaces appeared as porosities in the scans 
but were well matched between μCT images and the corresponding histology slides (Figure 
4.1).  
 
Figure 0-1Matched μCT and histology image of a 4-weeks grafted site, (a) μCT of the entire 
socket, (b) μCT of the region of interest (ROI), (c)matching histology ROI (MacNeal’s 




Following four weeks of healing, complete soft tissue bridging was evident in all three groups 
(Figure 4.2). 
 
Figure 0-2 μCT demonstrating complete soft tissue healing after 4 weeks (red arrow) 
 
Overall, μCT findings reflect the histological data. Limited new bone formation at four weeks 
was found on the internal surfaces of the socket walls, with all ungrafted sites composed of 
fibrous connective tissue, while the grafted sites were filled with Bio-Oss® particles (Figure 
4.1b). 
At eight weeks, new bone formation was evident, although no hard tissue bridging was present 
in the ungrafted sites (Figure 4.3). 
 
Figure 0-3Matched μCT and histology images; 8-weeks of healing, ungrafted site: (a) μCT of 
the complete socket; (b) μCT of the ROI demonstrating new bone formation (red outline) 
without hard tissue bridging; (c) matching histology ROI showing newly formed bone (red 





















Figure 0-4Matched μCT and histology of grafted and ungrafted sockets after 16-weeks of 
healing: (a) μCT of the ungrafted socket; (b) histology of the ungrafted socket (MacNeal’s 
tetrachrome and toluidine blue stain); (c) μCT of the grafted socket (red arrow highlighting 
the Bio-Oss® graft particles); (d) histology of the grafted socket (red arrow highlighting the 
Bio-Oss® graft particles) (MacNeal’s tetrachrome and toluidine blue stain) 
 
 In the grafted sites the Bio-Oss® particles were well incorporated and often completely 
surrounded by well organised trabecular bone making them harder to identify in μCT scans 
(Figure 4.4c). 
In summary, the acquitted μCT data reflects the histological finding. 
 
4.4.2 μCT quantitative analysis 
The raw data obtained from μCT scans was processed but the quantitative analysis is still being 
completed. 
 
4.5 Descriptive histology 
The three extraction sites, from each of the thirty animals (90 samples), were processed for 
resin embedding. In the eight-week healing group one animal (ID tag 450) had developed an 
abscess on the left side of the jaw and all three sockets had to be excluded from analysis. In the 
sixteen-week group two sheep (ID tags 442 and 587) also had developed abscesses and these 




4.5.1 Four weeks post-surgery healing 
The ungrafted control sites had limited new bone formation, with only small irregular 
projections extending from the lateral walls of the extraction sockets. In contrast, new irregular 
bone was observed on the external surfaces of the alveolar bone. These sites comprised mainly 
of connective tissue. Small woven bone projections could be seen extending from the newly 
formed blood vessels (Figure 4.5a). Extraction sockets treated with Bio-Gide® membrane 
demonstrated a similar pattern of healing (Figure 4.5b). Small irregular woven bone projections 
extended from the old trabecular bone from the inner and outer surfaces of the socket walls. 
There was evidence of Bio-Oss® particles associated with osteoblasts surrounding the 
periphery of the graft and the deposition of a minimal amount of new bone. Like the BioGide® 
specimens, the OFM specimens also contained Bio-Oss® particles which were evenly 
distributed throughout the socket and were surrounded by osteoblasts with a small new layer 
of woven bone, as well as connective tissue. Newly formed irregular woven bone also extended 
from the inner and outer walls of the socket. No bridging across the coronal margin of the 
socket was detected in any of the four-week specimens. (Figure 4.5c) 
 
 
Figure 0-5 Four-week: Resin embedded histology for the bucco-lingual sections of the 
extraction sockets at (MacNeal’s tetrachrome and toluidine blue stain): (a) ungrafted control 
site; (b)Bio-Gide® site; (c) OFM. B, buccal socket wall; L, lingual socket wall; MB, bone 




Complete epithelialisation with keratinised epithelium was evident for all specimens (Figure 
4.6). 
 
Figure 0-6 Four weeks post-surgery healing, ungrafted site demonstrating full epithelium 
coverage of the extraction socket (red arrow); MacNeal’s tetrachrome and toluidine blue stain; 
B, buccal socket wall, L, lingual socket wall. Scale bar = 1mm 
 
4.5.2 Eight weeks post-surgery healing 
By eight weeks the ungrafted control sockets were predominantly filled with connective tissue. 
New bone, although present, had not formed a bridge between the buccal and lingual walls of 
the socket in the coronal potion. The newly formed bone was disorganised and irregular in 
appearance. Only a small part of the socket had undergone remodelling and transitioned from 
woven to lamellar structure (Figure 4.7a). In both grafted specimens a newly formed hard tissue 
bridge composed of woven bone was present. In some areas woven bone was being replaced 
by lamellar bone. In addition, the bone of the socket walls showed signs of remodelling. The 
Bio-Oss® particles were completely surrounded by trabecular bone, which uniformly filled the 
extraction socket. Connective tissue was interspersed between woven and lamellar bone within 
128 
 
the socket. No difference was seen between the Bio-Gide® and OFM treated sites. (Figures 
4.7b and 4.7c). 
 
Figure 0-7 Resin-embedded histology for the bucco-lingual sections of the extraction sockets, 
at 8 weeks (MacNeal’s tetrachrome and Toludine blue stain: (a) ungrafted control site; (b) 
Bio-Gide® site; (c) OFM. B, buccal socket wall; L, lingual socket wall; BM, bone marrow 
space; red arrow, residual bone graft (Bio-Oss®). Scale bar = 1mm 
 
4.5.3 Sixteen weeks post-surgery healing 
Evidence of socket healing continued in the control specimens and was characterised by thick 
trabecular projections extending from the lateral walls of the socket to forming a bridge 
between the buccal and lingual plates. However, the bridging was less defined, compared to 
the grafted sockets, with less trabecular bone and more vascularised connective tissue (Figure 
4.8a). 
At sixteen weeks approximately thirty percent of the analysed grafted sockets had no Bio-Oss® 
graft present, 31.25% in the OFM group and 37.50% in the Bio-Gide® group. This was 
attributed to graft loss rather than resorption. Hard tissue bridging between buccal and lingual 
margins of the extraction socket was observed, consisting of layers of well organised lamellar 
bone with parallel collagen fibres. In specimens where the bone graft was lost (Figure 4.8b), 
there was no difference in bridge formation and new bone socket fill, when compared to the 
specimens where the graft was retained (Figure 4.8c). When Bio-Oss® graft material was 
retained, in both the Bio-Gide® and OFM treated sites, it was either completely surrounded by 




Figure 0-8 Resin-embedded histology for the bucco-lingual sections of the extraction sockets, 
at 16 weeks (MacNeal’s tetrachrome and Toludine blue stain: (a) ungrafted control site; (b) 
Bio-Gide® site; (c) OFM. B, buccal socket wall; L, lingual socket wall; BM, bone marrow 
space; red arrow, residual bone graft (Bio-Oss®). Scale bar = 1mm 
 
4.5.4 Summary of descriptive histology 
All samples in the four-week group had minimal newly formed bone, and no bony bridge 
formation was observed between the buccal and lingual crests. Small projections of newly 
formed bone were found in the lumen of the sockets and around the graft particles in Bio-Gide® 
and OFM groups. Remodelling of the outer surface of the socket walls was found in all three 
groups. Following eight weeks of healing, the control group had more newly formed bone in 
the socket but no bridging between the buccal and lingual alveolar crests. Both grafted groups 
had more new bone surrounding the graft particles and loosely organised bone that formed a 
hard tissue bridge. After 16 weeks of healing, all three groups demonstrated the hard tissue 
bridge formation joining the buccal and lingual crests. In the control group the bridge was more 
loosely formed compared to the Bio-Gide® and OFM groups. Bio-Oss® graft particles were 
surrounded by newly formed bone in the grafted groups and the newly formed lamella bone 
appeared well organised. 
 
4.6 Histomorphometric analysis 
Two bucco-lingual sections, best representing the central area of each extraction socket, were 
selected for histomorphometric analysis, with a total of 162 sections examined. For each 
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section, the percentages of newly formed bone, connective tissue and residual bone graft were 
calculated and used to establish the overall mean for each treatment group.  
 
4.6.1 Four weeks post-surgery healing 
The amount of newly formed bone in the extraction socket after 4 weeks of healing was 
7.54±5.55% for the untreated control group, 7.31±4.42% for the Bio-Gide® group and 
8.36±5.30% for the OFM group. The greatest amount of new bone was found in the OFM 
group; however, it was not statistically significant and overall, all three groups had a similar 
percentage of new bone. Comparison of connective tissue between three treatment groups 
revealed the largest amount of connective tissue in the untreated control group and the smallest 
amount in the OFM group, 83.87±12.45% and 66.21±14.74% respectively. The differences in 
the amount of connective tissue within the socket were statistically significant between the 
control and the treatment groups (control versus OFM p=0.045 and control versus Bio-Gide® 
p=0.022) but were not statistically significant between the two treatment groups (Bio-Gide® 
versus OFM p=0.335). Statistically significant difference (p=0.005) at four weeks, was found 
in the amount of residual bone graft between the treatment groups. With the Bio-Gide® group 
having nearly three times the average amount of residual graft compared to the OFM group, 
13.92±10.64% and 5.45±6.59% respectively. 
 
4.6.2 Eight weeks post-surgery healing 
After eight weeks of healing the control group displayed the smallest amount of newly formed 
bone at 27.49±16.41%, followed by the OFM group with 29.35±12.49% and the Bio-Gide® 
group having the largest amount of the three groups at 32.10±9.67%. However, the differences 
between these groups were not statistically significant (p≥ 0.475).  The control group at 8 weeks 
continued to have the largest amount of connective tissue compared to the two treatment 
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groups, however only the difference between the control and the Bio-Gide® groups was 
statistically significant, with p=0.045. The OFM group contained 53.78±20.25% of connective 
tissue which was less (p=0.111) than in the control group at 66.57±18.39%. The differences 
between two treatment groups were very small and did not reach statistical significance. The 
amount of residual graft material was very similar between two treatment groups, 6.43±9.87% 
for the OFM and 7.61±7.91% for the Bio-Gide® group with p=0.371. 
 
4.6.3 Sixteen weeks post-surgery healing 
Following sixteen weeks of healing, all three groups had a similar amount of newly formed 
bone, occupying just over 40% of the extraction socket. The OFM group showed slightly more 
new bone formation compared to Bio-Gide® and control groups (46.95±14.07% vs 
42.24±16.49% and 41.32±18.96% respectively), but this did not reach statistical significance. 
Connective tissue percentage was also similar across the three treatment groups getting close 
to the 50% mark. For this parameter, the control group recorded the greatest amount at 
55.31±18.61%, followed by Bio-Gide® group with 44.98±15.85% and the smallest amount of 
connective tissue was found in the OFM group with 43.04±13.49%. These differences were 
not statistically significant.  
The amount of residual bone graft present was 5.08±4.08% for OFM sites and 7.14±8.65% for 





















4.6.4 Within the OFM group at 4, 8 and 16 weeks 
Healing in the OFM treatment group over time, showed an increase in newly formed bone, 
with the largest increase between 4- and 8-weeks with mean values at 4-weeks 8.36±5.30%  
and 29.35±12.49% at 8-weeks, which demonstrates a significant increase (Table 4.2). A further 
increase in new bone formation took place between 8- and 16-weeks but it was not as large 
(Figure 4.9). As the new bone formed inside the extraction socket, the amount of connective 
tissue progressively decreased from 66.21±14.74% at four weeks, to 53.78±20.25% at eight 
weeks and to 43.04±13.49% at sixteen weeks. The amount of residual graft in the OFM group 
remained fairly constant between different healing time points with 5.45±6.59% of graft 
recorded in the 4-weeks group, 6.43±9.87% in the 8-weeks healing group and 5.08±4.08% in 
the 16-weeks healing group.   
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Figure 0-9 A comparison of tissue composition between groups and between times for each 
group (Mean ± SD). Abbreviations: New Bone, newly formed bone; CT, connective tissue; RG, 
residual bone graft; *p≤0.05; **p≤0.01; ***p≤0.001 
 
 
4.6.5 Within the Bio-Gide® group at 4, 8 and 16 weeks 
A similar trend was observed in the Bio-Gide® group between 4-, 8- and 16-weeks of healing 
(Table 4.2 and Figure 4.9). The longer the socket was left to heal, the more bone formed, with 
mean values increasing from 7.31±4.42% at 4-weeks to 32.10±9.67% at 8-weeks and 
42.24±16.49% following 16-weeks of healing. The most significant increase occurred OFM 
between weeks 4 and 8, which was similar to the OFM group.  
The amount of connective tissue decreased between groups from week four to sixteen, as it 
also did in the OFM group. The Bio-Gide® group connective tissue average value at 4 weeks 
was 71.4±14.5%, at 8 weeks it decreased to 51.8±13.3% and by 16 weeks to 44.9±15.7%. 
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The differences in the amount of residual graft between groups at 4-, 8- and 16-weeks were 
striking. Although there was no differences between weeks 8 and 16 with very similar average 
amount of graft remaining 7.61±7.91% at week 8 and 7.14±8.65% at week 16, the 4-weeks 
group had nearly double the amount of residual graft with 13.92±10.64% present. 
 
4.6.6 Within the control group at 4, 8 and 16 weeks 
The amount of new bone formation had a similar trajectory in the control groups from week 4 
to 16 as it did in the OFM and the Bio-Gide® groups, with an increase in the amount of new 
bone between healing time (Table 4.2 and Figure 4.9). At four weeks on average 7.54±5.55% 
of new bone was found in the extraction socket of control group, at eight weeks that amount 
increased over three times to 27.49±16.41% and increased again at sixteen weeks of healing to 
41.32±19.47%. 
The amount of connective tissue decreased in the same manner as was observed in the other 
groups. However, the control group at four weeks had the largest mean value for connective 
tissue at 83.87±12.45% compared to the grafted groups. This value decreased to 66.57±18.39% 
at eight weeks and decreased again in the sixteen-week group to 55.31±18.61%. 
The control sockets did not receive any grafting material and for that reason the amount of 
residual graft for all three time points was recorded as zero. 
 
4.6.7 Summary of histomorphometric analysis 
All three groups had significant increases in newly formed bone at 4- to 8- and to 16-weeks, 
while no difference was found in the amount of bone between the groups at any time points.  
Residual graft material was missing from several grafted sites. In the OFM group at 4-weeks 
seven grafted sockets (35%) did not have any traces of grafting material in them, at 8-weeks 
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nine sockets were without a graft (50%) and at 16-weeks no graft could be found in five sockets 
(31.25%). Bio-Gide® also did not retain bone grafting material as well as we expected. Four 
extraction sites (20%) had no graft material after 4-weeks of healing, eight sites (44%) had 
none in 8-weeks healing group and six sites (37.5%) had none after 16-weeks of healing. 
When the sockets with lost graft were included in the analyses, histomorphometric analysis 
revealed a statistically significant difference (p=0.005) between the amount of residual graft 
between OFM and Bio-Gide® groups at 4-weeks with the latter retaining more graft material, 
5.45±6.59% and 13.92±10.64% respectively. 
The amount of connective tissue between Bio-Gide® and control groups, as well as OFM and 
control groups were also different with statistical significance at 4- and 8-weeks of healing 
with the control group having more connective tissue. However, no differences were detected 
for that parameter after 16-weeks. Table 4.1 shows summaries for each type of treatment after 






Table 0-1 Comparison of tissue composition (%) between groups (Paired sample test), mean ± SD. Abbreviations: NB, newly formed bone; CT, connective tissue; RG, residual bone graft; Cont, 
Control; EN, OFM; BG, Bio-Gide®. 
 Control Intervention  p-values 
  Bio-Gide OFM  OFM vs BG BG vs Cont OFM vs Cont 
 NB                (%)          Mean ±SD Mean ±SD        Mean ±SD     
Week 4 7.54 ± 5.55 7.31 ± 4.42 8.36 ± 5.30  0.590 0.918 0.792 
8 27.49 ± 16.41 32.10 ± 9.67 29.35 ± 12.49  0.625 0.475 0.799 
16 41.32 ± 18.96 42.24 ± 16.49 46.95 ± 14.07  0.464 0.918 0.562 
        
CT                 (%)        
Week 4 83.87 ± 12.45 71.43 ± 13.00 66.21 ± 14.74  0.335 0.045 0.022 
8 66.57 ± 18.39 51.82 ± 12.06 53.78 ± 20.25  0.811 0.045 0.111 
16 55.31 ± 18.61 44.98 ± 15.85 43.04 ± 13.49  0.751 0.304 0.233 
        
RG                 (%)        
Week 4 -- 13.92 ± 10.64 5.45 ± 6.59  0.005 0.002 0.027 
8 -- 7.61 ± 7.91 6.43 ± 9.87  0.371 0.020 0.086 
16 -- 7.14 ± 8.65 5.08 ± 4.08  0.495 0.052 0.009 









Table 0-2 Comparison of tissue composition (%) between times for each group. Abbreviations: NB, newly formed bone; CT, connective tissue; RG, residual bone graft. 
 
      p-value 
 Timepoint (weeks)     Bonferroni adjusted post-hoc analysis 
 4 
 
8 16  f-statistics p-value  4 vs 8 4 vs 16 8 vs 16 
NB             (%) Mean ±SD Mean ±SD Mean ±SD        
           
Control 7.54 ± 5.55 27.49 ± 16.41 41.32 ± 19.47  12.64 ≤ 0.001     0.018 ≤ 0.001 0.177 
Bio-Gide 7.31 ± 4.42 32.10 ± 9.67 42.24 ± 16.49  25.18 ≤ 0.001  ≤ 0.001 ≤ 0.001 0.199 
OFM 8.36 ± 5.30 29.35 ± 12.49 46.95 ± 14.07  27.87 ≤ 0.001  ≤ 0.001 ≤ 0.001  ≤ 0.009 
           
CT            (%)           
Control 83.87 ± 12.45 66.57 ± 18.39 55.31 ± 18.61  6.90     0.004   0.095 ≤ 0.004 0.519 
BioGide 71.43 ± 13.00 51.82 ± 12.06 44.98 ± 15.85  9.38        0.001   0.014 ≤ 0.001 0.934 
OFM 66.21 ± 14.74 53.78 ± 20.25 43.04 ± 13.49  4.45     0.023   0.341    0.020 0.576 
           
RG            (%)           
Control -- -- --  -- --     
BioGide 13.92 ± 10.64 7.61 ± 7.91 7.14 ± 8.65  1.58    0.227     
OFM 5.45 ± 6.59 6.43 ± 9.87 5.08 ± 4.08  0.08    0.924     

































The present study was designed to evaluate the efficacy of the OFM and to compare it to a 
commonly used resorbable membrane (Bio-Gide®) in an established ovine tooth extraction 
model. The objectives of this investigation were to determine through histomorphometric and 
radiomorphometric analyses the percentage of newly formed bone, connective tissue, and 
residual bone graft within extraction sockets. 
The results demonstrated equivalent outcomes between OFM and Bio-Gide® in terms of 
osteogenesis, graft retention and connective tissue presence within the extraction sockets of the 
test animals. 
Histologically, at four weeks of healing the extraction sites showed very little difference when 
the three groups were compared. A small, irregular projection of newly formed woven bone 
was found in all extraction sockets examined. The Bio-Oss® graft material was found in both 
treatment groups and was associated with thin non-mineralised osteoid. At eight weeks, a 
difference between the control and the treatment groups was more apparent. The control group 
did not show formation of a bony bridge between the buccal and lingual alveolar crests, but 
instead had thicker projections of woven bone extending from the inner surfaces of the socket 
walls. Conversely, the treatment groups demonstrated thick sheets of woven bone creating a 
loosely formed bridge across the coronal aspect of the socket. In both treatment groups, the 
graft particles were typically surrounded by newly formed bone. Although the eight-week sites 
in all three groups demonstrated more bone formation compared to the four weeks samples, a 
large portion of each socket was still fibrous connective tissue. At sixteen weeks, all three 
groups were completely epithelialised and a hard tissue bridge had formed between buccal and 
lingual alveolar plates in the coronal part of the socket. In all groups woven bone was replaced 
by lamellar bone, although in the control group the bone was separated by larger areas of 
fibrous connective tissue. 
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The descriptive analysis of μCT scans revealed close similarities between the radiographic 
scans and the histology slides with regard to new bone formation and residual bone graft. 
Histomorphometric analysis did not show statistically significant differences in the amount of 
newly formed bone between any of the three groups at any healing period. At four and eight 
weeks, statistically significant differences were found between the Bio-Gide® and the control 
groups in the amount of the fibrous connective tissue in the extraction site. The differences in 
the amount of fibrous connective tissue between the control and the OFM groups also reached 
statistical significance at four weeks, with greater amount of connective tissue found in the 
control group. The amount of residual bone graft in the treatment groups differed at four weeks, 
while no statistically significant differences were detected at eight or sixteen weeks. 
 
5.2 Study design 
Since its introduction in the late 60’s ARP therapy developed into an umbrella term for various 
techniques and materials designed to limit the loss of alveolar bone following tooth extraction 
(Araujo et al., 2009; Gumaer et al., 1985; Kubilius et al., 2012; Lam and Poon 1968; Stanley 
et al., 1976). The use of resorbable collagen membranes has overtaken the use of non-
resorbable membranes as the preferred material with over 20 different types of resorbable 
membranes currently available on the market (Darby et al., 2008; Sbricoli et al., 2020).  Despite 
a large number of available membranes, none of them met all the characteristics of a perfect 
barrier, which is one of the reasons new collagen barriers continue to be created and tested. 
The current study is the first to investigate OFM in a tooth extraction animal model. For 
experimental comparison, a well-researched and commonly used collagen membrane Bio-
Gide® was used (Darby et al., 2008). Both membranes were tested in an ovine tooth model as 




5.2.1 The animal model 
In this study, thirty animals were obtained from a large pool of commercially farmed sheep. 
The aim was to reduce inbred heterogeneity, as inbreeding can increase homozygosity of the 
less desirable traits and potentially adversely affect bone healing, surgical recovery, reactions 
to medications and grafting materials (Li et al., 2001; Mandal et al., 2005; Manigrasso and 
O’Connor 2008). To account for heterogeneity between animals we used sheep as a statistical 
unit in our statistical analysis. 
Ten animals were randomly assigned to each healing group based on similar experiments using 
BRG in sheep (Duncan, 2005; Duncan, 2014; Haas et al., 1998; Haas et al., 2002; Liu, 2013; 
Liu et al., 2016). Several previous studies have reported that eight animals per group was the 
absolute minimum to allow statistical comparison (Duncan, 2005; Lander, 2016; Liu, 2013). 
Based on the recommendations made by Liu, ten animals were included in this study, allowing 
for illness, death, and other adverse events during the investigation.  
Sheep experimental models are becoming more widespread (Pearce et al., 2007; Vlamnick et 
al., 2008), although ARP research has traditionally been dominated by dog studies (Araujo et 
al., 2008; Araujo et al., 2010; Araujo et al., 2010a; Kim et al., 2017; Raveendiran et al., 2019).  
Despite, the prevalent use of dogs in ARP research, the current study is not the first to use an 
ovine extraction model for the investigation of a novel dental material. Sheep have been used 
for periodontal and implant research for the past three decades (Duncan, 2014), with published 
studies investigating implant treatment (Duncan, 2005; Mayer et al., 2020; Vlamnick et al., 
2008), maxillary sinus augmentation (Haas et al., 1998;Haas et al., 2002; Sheftel et al., 2019; 
Smith et al., 2018), periodontitis (Duncan, 2003), bone healing and periodontal defects 
(Danesh-Meyer et al., 1997; Gaggl et al., 2000; Liu et al., 2016; Sirak et al., 2019).  
144 
 
The three healing time points investigated in this study corresponded to the time of implant 
placement in humans and were first studied by Duncan (2005). Healing in sheep is more rapid 
than in humans with four weeks of healing in sheep corresponding to five weeks of healing in 
humans, eight weeks to eleven and sixteen weeks to twenty-one. In humans, placement of an 
implant is usually carried out three to eight months following an APR procedure with the use 
of BRG material (Barone et al., 2012; Darby, 2008; De Coster et al., 2011). Therefore, the 8- 
and 16-weeks healing groups corresponded to implant placement times in humans. 
The mandibular premolar extraction model for testing novel materials was first described in 
2013 (Liu, 2013). Our study followed a similar protocol and did not include the molar teeth 
due to restricted surgical accessibility (Liu et al., 2016).  
Over the years several tooth extraction techniques have been extensively described and include 
a range of procedures such as commissural incisions, osteotomies, tooth sectioning, raising of 
a full thickness buccal and lingual flap and the use of Piezosurgery® unit (Danesh-Meyer et al., 
1997; Duncan, 2005; Liu, 2013; Vlaminck et al., 2008). In the current study the full-thickness 
commissural incisions, as described by Danesh-Meyer, were not used to minimise post-
operative discomfort (Danesh-Meyer et al., 1997). Instead full thickness buccal and lingual 
flaps were elevated, the teeth were gently loosened using a chisel and a mallet at the interdental 
contacts, and the teeth were carefully removed with elevators and extraction forceps, with 
minimal trauma to the bone. 
 Unlike some of the earlier studies where only second and third premolars were used (Liu, 
2013; Vlaminck et al., 2008), all three premolars were extracted for this investigation. The first 
mandibular premolar is a very small tooth with short roots. Extractions of first mandibular 
premolars resulted in very narrow and shallow sockets therefore, the size of the socket was 
surgically increased using a surgical implant bur, to match the extraction sites of the second 
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and third premolars. If the root fractured, it was removed using a Piezosurgery® unit. This 
technique avoided the use of osteotomies and tooth sectioning. 
This study was designed to compare two resorbable collagen membranes and control sites with 
no membrane in alveolar ridge preservation in an ovine model. The test membrane was a novel 
collagen barrier (OFM) that has never been tested in a large animal model and has not been 
approved for human use. To meet regulatory requirements an animal study was required to 
assess the safety and performance of this new dental material by comparing it to an established 
and widely used equivalent Bio-Gide®. 
 
5.2.2 Differences in membrane handling properties 
The main objective of the current investigation was to compare the two collagen membranes. 
One comparison was the handling of the membranes during surgery. In the current study, both 
membranes were resorbable collagen barriers and were easily trimmed with surgical scissors 
to ensure the correct fit over surgical sites. 
Bio-Gide® membrane has been on the market for nearly two decades and some members of our 
surgical team were familiar with the handling of this membrane based on previous research 
and clinical work. Bio-Gide® did not require shaping prior to placement over the surgical site 
as the membrane consistency allowed it to drape over the residual ridge. On the contrary, OFM 
was a more rigid membrane that required shaping before insertion into the wound. As it is a 
new material and has not been tested intra-orally or in alveolar ridge preservation therapy prior 
to this investigation, difficulties in positioning the membrane over the grafted extraction site 
were experienced in the first few surgeries. The membrane edges did not conform to the shape 
of the ridge even when wetted with blood and sprang up from under the soft tissues of the flap. 
The repeated uplifting of the membrane edges led us to start shaping the membrane over a 
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dental mirror handle, creating a curve in the membrane. This was successful since the 
experimental material exhibited sufficient rigidity to allow it to be adapted over the alveolar 
ridge and remain in place, without further movement or uplifting of the edges. 
The time it took to place each membrane was not recorded. Therefore, our reporting of 
membrane handling properties is subjective.  
No studies were identified in published literature that recorded and reported the time of Bio-
Gide® or other collagen membrane placement for any treatment modalities. One recently 
published study by Llanos et al., recorded the time it took for the placement of a bone 
replacement grafting material, although no detailed description of the protocol was provided 
(Llanos et al., 2019). The other studies comparing resorbable collagen membranes did not 
include membrane handing as a primary investigation objective and instead focused on either 
hard or soft tissue healing (Chung et al., 2014; Jung et al., 2012; Willershausen et al., 2014).  
Handling properties may influence the selection of the particular membrane by the clinician, 
so having this information would be useful and it is something that should be considered in 
future investigations. 
 
5.2.3 Experimental sites loss 
In this study, 30 animals had mandibular premolar teeth extracted and designated sites grafted. 
All animals recovered well following the initial surgery. Following healing, each group of 10 
sheep were brought back for euthanasia and specimen collection. Following healing and prior 
to euthanasia, the examination of healed extraction sockets revealed that three animals, sheep 
numbers 422, 587 and 450 developed dental abscesses due to foreign substances (grass and 
sticks) lodged in the extraction sockets. The presence of a foreign material in the socket resulted 
in incomplete healing of the extraction sites. Two of these animals were from the 16-weeks 
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group and one from the 8-weeks group. All three sockets from each animal demonstrated 
incomplete healing and although the samples were collected and resin embedded, they were 
excluded from the analysis. Exclusion of these samples from the final analysis reduced the 
number of sheep in the 16-weeks group to 8 animals which was at the limit of number of 
animals required to reach statistical power. The eight weeks group lost one animal and had nine 
sheep. The remaining animals contributed 81 experimental sites, providing 162 histological 
slides for the analysis. The two adjacent slides best representing the middle of the extraction 
socket were chosen, if one of the slides was of a questionable quality the next slide in the 
sequence was selected. In 17 experimental sites, the non-adjacent slides were selected due to 
poor slide quality, in the remaining 64 sites the adjacent sequential slides were obtained. 
Similar issues have been reported in a number of other animal studies, with reports of 
incomplete healing and insufficient quality of histological slides (Lander, 2016; Liu, 2013; 
Sheftel et al., 2019). 
 
5.2.4 Histomorphometric analysis limitations 
To calculate the area for each tissue type present in the digitised histology slides, a semi-
automated segmentation method was used in this study. The differences in pixel intensity were 
used to distinguish between areas of newly formed bone, connective tissue and the residual 
bone graft. For every slide colour thresholding was manually adjusted using the manual tool in 
Image J software. To ensure accurate representation of the selected structure, the segmented 
colour-thresholded images were compared to the original histology slides. The highlighted 
segmented tissues were measured and expressed as area percentage within the region of 
interest. 
The semi-automated segmentation method using computer software is a common approach in 
histologic image analysis and has superseded the previously used light-point counting method.  
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There are several published studies which describe measuring tissue volumes using the semi-
automated segmentation technique (Heberer et al., 2008; Lander, 2016; Liu, 2013; Liu et al., 
2016; Sheftel et al., 2019). This technique, although commonly used, is not without limitations. 
The data collected by colour-thresholding depends on the quality of resin embedding and the 
preparation of the histological slides. Any artifacts inadvertently included during the resin-
embedding phase, such as impurities or bubbles, can affect the final data and require more 
image processing. The preparation of the histology slides, the stain intensity, and uneven slide 
thickness can all lead to poor image quality during capture and image processing affecting the 
final result. Grinding of the slides from 500 μm to their final thickness of 80-120 μm can also 
introduce more impurities and debris, which remain on the slide despite thorough cleaning. 
With that in mind, careful sample preparation is paramount to allow accurate data collection 
and to reduce impurities and artifact inclusions as well as reduce image processing. In this 
study although all care was taken with hard tissue embedding and histological sample 
preparation, artifacts were present on the slides and more image processing using colour-
thresholding was required.  
 
5.3 Differences in the histomorphometric analysis between the groups 
5.3.1 The negative control group – ungrafted sites, natural healing 
In the current study, after four weeks of healing, a minimal amount of newly formed bone was 
present. Wisps of fine immature woven bone were observed within the extraction socket and 
on the outer wall near the alveolar crest. The fibrous connective tissue occupied most of the 
socket and since control sites did not receive a BRG, no residual graft was present. Following 
8- and 16-weeks of healing, the newly formed immature woven bone first increased in volume 
and then began to remodel forming thick bony trabeculae. At eight weeks, no bridging of the 
socket was noted with disorganised irregular trabecular bone filling the socket lumen. By 16-
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weeks thick trabecula projections extended from the buccal and lingual sides of the socket and 
joined over the crest forming a hard tissue bridge. As the volume of bone increased, the amount 
of connective tissue decreased. The ungrafted sites had the largest volume of connective tissue 
at 16-weeks compared to the grafted groups, although the difference was not statistically 
significant. 
These results are consistent with results reported in other animal and human studies 
investigating hard tissue healing in extraction socket. Following extraction of maxillary or 
mandibular premolars and four months of healing in a clinical human trial, Cardaropoli and 
colleagues found that ungrafted extraction sites had a slightly higher volume of connective 
tissue compared to the grafted sockets (Cardaropoli et al., 2012). Another study reporting 
similar healing events was an extraction study in dogs (Kim et al., 2017). Following 12-weeks 
of healing, the investigators reported more connective tissue in the control group compared to 
the test groups. In the current study, the extraction sites in the ungrafted control group healed 
well, although it took much longer for the new bone to form in these specimens. As discussed 
in the introductory chapter, in the ungrafted critical size defect tooth sockets, osteogenesis 
happens at a much slower rate. The current study agrees with other investigations that described 
slower rate of new bone formation and a higher percentage of connective tissue in the ungrafted 
tooth extraction sites (Araujo et al., 2008; Liu et al., 2016). We consider that, based on the 
incomplete regeneration of the bone in the treatment group C, as judged from 
histomorphometric analysis, the current study provides further evidence that the ovine defect 
model as conducted is a CDS model, consistent with previous description of this model 
(Duncan, 2005).  
 At each healing time point, the percentage of newly formed bone increased as the connective 
tissue decreased in the extraction sites. The amount of newly formed bone was consistently 
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5.3.2 The positive control group – Bio-Gide® 
Bio-Gide® is a commercially available and widely used collagen membrane manufactured by 
Geistlich. With over 18 years of successful clinical use, it was selected as a comparative control 
in the current study. The Bio-Gide® group in this investigation demonstrated a minimal amount 
of newly formed bone at four weeks of healing. The newly formed woven bone consisted of 
small irregular projections extending from the inner walls of the extraction socket. In some 
parts of the socket, the bone graft particles were in contact with the newly formed bone. In the 
eight-week group, the newly formed woven bone formed a hard tissue bridge in the coronal 
part of the socket and by 16-weeks the woven bone bridge remodelled and largely consisted of 
well organised lamella bone. With significant increases of newly formed bone at each healing 
group, the volume of connective tissue decreased between healing points. There are several 
human and animal investigations that used Bio-Gide® collagen membrane for ARP in their 
research, unfortunately none of them investigated tissue volumes at different time points 
(Bashara et al., 2012; Cardaropoli et al., 2012; Iorio-Siciliano et al., 2017; Jung et al., 2018; 
Kim et al., 2017). For that reason, we cannot with absolute certainty conclude that our results 
are in agreement with these studies. 
In human clinical trials histomorphometric analysis is usually performed on the trephined bone 
cores that are harvested prior to implants placement. One such study by Carmagnola et al., 
collected bone cores from Bio-Oss® and Bio-Gide® grafted extraction sockets seven months 
after grafting and found 21.1±20% of RG in trephined cores, which is significantly higher 
compared to the amount found in the current study at all healing time points (Carmagnola et 
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al., 2003). In our study at four weeks of healing, a significantly greater volume (13.92±10.64%) 
of residual graft was detected in the Bio-Gide® group compared to the OFM group. It is similar 
to the volume of 18.46±11.18% reported by Cardaropoli et al., (2012), however, the healing 
time differed significantly.  The latter investigation assessed the amount of residual graft (RG) 
after 16-weeks of healing, which is equivalent to 12-weeks of healing in sheep. In our study, 
we did not have a 12-weeks healing group, however at 8- and 16-weeks of healing the volume 
of RG was 7.61±7.91% and 7.14±8.65% respectively, which is considerably less than reported 
by Cardaropoli et al., (2012). A study that closer matched the healing time frame of our 
investigation was carried out in dogs by Araujo and colleagues (Araujo et al., 2009b). In that 
study, the animals were sacrificed two weeks after the grafting surgery and the authors reported 
18.9±9.8% of Bio-Oss® Collagen particles in the region of interest, although no barrier 
membrane was used in the study. The healing time and the amount of the residual bone graft 
in the study by Araujo et al, was similar to our study, despite the lack of barrier membrane. 
Kim and colleagues (2017) also reported the amount of RG within the extraction socket in a 
dog study. Although this investigation did not include different time healing groups, they 
reported different tissue amounts after 12-weeks of healing. The volume of RG was 
significantly higher in this investigation after 12-weeks compared to our results after 8- and 
16-weeks, 27.04±5.25% vs 7.61±7.91% and 7.14±7.65% respectively. 
Both Cardaropoli et al., and Carmagnola et al., conducted their investigations in human 
participants, which could explain why the quantities of RG are much higher in their studies 
compared to the current trial. The other possible explanation for these differences could be the 
variances in healing patterns of different species and differences in osteoconductive properties 
of bone grafting materials used in the studies. With the current study using Bio-Oss® BRG 
material, while Kim et al., and Cardaropoli et al., used Bio-Oss® with 10% collagen. The 
differences could also potentially be attributed to post-operative care. Cardaropoli et al., and 
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Carmagnola et al., carried out the study in human participants who would treat the surgical site 
with outmost care, thus potentially minimising and avoiding any graft displacement prior to 
complete healing of the socket. The subjects in the dog study by Kim et al., (2017) were fed a 
soft diet to avoid any trauma to the surgical area. In the current study following the mandatory 
recovery period, all animals were returned to the farm paddock and resumed their normal 
grazing behaviour. There is a probability that through normal ruminant feeding, some of the 
grafted sites had graft particles displaced prior to completion of the soft tissue healing, resulting 
in lower RG particles in our study at eight and 16 weeks compared to investigations by 
Cardaropoli et al., and Kim et al. In the current investigation, four extraction sites (20%) in the 
Bio-Gide® group completely lost all the grafting material; at eight weeks – eight sites (44%) 
were found without any remnant of the graft and at 16-weeks, six sites (37.%) also lost all of 
the graft.  
 
5.3.3 The test group – OFM 
One of the main functions of a barrier membrane is epithelial and connective tissue exclusion 
(Bashutski et al., 2011; Dahlin et al., 1988). This concept aims to promote the healing of 
extraction sockets by eliminating fast proliferating epithelium and connective tissue from the 
extraction site and allowing the slower regenerating bone tissue to fill the socket (Dahlin et al., 
1988; Dahlin, 2010; Dimitriou et al., 2012). With the development of resorbable membranes, 
the dental profession started to move away from the use of non-resorbable membranes due to 
the associated complications and second surgery requirements with some researchers going as 
far as to say that resorbable membranes should be preferred over non-resorbable (Darby et al., 
2008). 
A space-making capacity is an important prerequisite for a barrier membrane to facilitate bone 
regeneration. Unfortunately, many resorbable collagen membranes lack that criteria and are 
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unable to support the weight of the soft tissue, thus needing a membrane supporting bone graft 
(Elgali et al., 2017; Omar et al., 2019). The use of the barrier membranes alone or in 
combinations with a bone graft has been extensively investigated and several studies reported 
a synergistic effect on regenerative outcomes with the combined use of membranes and bone 
graft (Donos et al., 2008; Hermann and Buser, 1996; Stavropoulos et al., 2004).  
The current investigation is the first study to evaluate the OFM in a large animal model. The 
histology samples collected after 4-, 8- and 16-weeks of healing showed no significant 
differences between that found in the Bio-Gide® group for all parameters except the volume of 
RG at four weeks. Similarities in the healing patterns between the two grafted groups were also 
observed. The OFM group, at four weeks, demonstrated small volumes of newly formed 
irregular woven bone extending from the socket walls towards the middle of the sites. Some 
graft particles had newly formed bone around them, but no hard tissue bridging was observed. 
By eight weeks of healing, thickening of woven bone trabeculae was evident with coronal 
portion of the socket bridged by hard tissue. Similar to the Bio-Gide® group, as the bone 
volume increased the connective tissue volume decreased. At 16-weeks of healing, woven bone 
remodelling and formation of organised lamella bone surrounding the grafted particles were 
present. The volume of RG in the OFM group remained constant across the time groups. 
Comparable to the Bio-Gide® group, several sockets in the test group lost the grafted particles. 
At four weeks in the OFM group seven sites (35%) had no traces of graft material, at eight 
weeks of healing – nine sites (50%) were without a graft and at 16 weeks of healing five sites 
(31.25%). A similar pattern was noted in the Bio-Gide® group with the largest number of sites 
missing graft material at eight weeks. Interestingly in the OFM group, the largest number of 
sites with missing bone graft was observed in the eight weeks healing group, it was also the 
group that has the highest volume (although not statistically significant) of residual graft. This 
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observation was different to the Bio-Gide® group, in which a significantly higher amount of 
RG was identified in the four-week group.  
Liu et al (2016) was the only other study to evaluate tissue healing following ARP in a 
mandibular extraction site in sheep. A different collagen membrane and different bone graft 
were used. For that reason, we cannot compare the results directly. However, Liu et al (2016) 
reported that in the eight-week healing group a “very low” amount of bone graft was recorded. 
The possible explanation for lower RG amount was profuse bleeding from the extraction sites 
during surgery resulting in graft displacement. In the current investigation, haemostasis was 
observed, and no bleeding was noted following primary wound closure, although we cannot 
rule out with absolute certainty that internal displacement of the RG and membrane did not 
occur due to bleeding. Another possible explanation for graft displacement is the post-surgery 
animal diet. For the first few days following surgery, all recovering animals were fed a diet of 
small pellets or muesli-type feed and given water twice daily. This type of food is not soft and 
potentially could have contributed to graft displacement, which is something that needs to be 
considered for future research.  
 
This investigation showed the OFM resulted in similar outcomes to Bio-Gide® in terms of bone 
formation at all healing times with p>0.590. However, significant increases in new bone 
formation over time were observed in all three groups. Although, at four and 16-weeks healing 
the OFM group demonstrated higher volumes of newly formed bone (8.36±5.30% and 
46.95±14.07% respectively) compared to the other two groups. At eight weeks healing, the 
Bio-Gide® group had a slightly higher volume of newly formed bone (32.10±9.67%) compared 
to the other groups. The volume of connective tissue in the region of interest was significantly 
different between grafted and naturally healed groups at four weeks of healing (p≤0.045), while 
there were no differences between the grafted groups for this parameter at any healing stage. 
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The two grafted groups also demonstrated a difference in the volume of residual bone graft at 
four weeks. Bio-Gide® group had 13.92±10.64% of RG, while OFM group had 5.45±6.59%. 
All other healing times showed no statistically significant differences. Extraction socket 
healing and alveolar ridge preservation has been reported in other animal and human studies, 
however they either did not investigate multiple healing time points or used different 
membranes and grafting materials making any comparison difficult (Cardaropoli et al., 2012; 
Kim et al., 2017; Liu et al., 2016; Raveendiran et al., 2019). The healing pattern and changes 
in tissue volume observed in this investigation are consistent with those described by Liu et al., 
(2016) in a study conducted in an ovine model and by Raveendiran et al., (2019) in a canine 
model. The investigation by Liu and colleagues reported healing of tooth extraction sockets in 
sheep at eight and sixteen weeks. On one hand, the results of that study could be compared to 
the results of the current investigation, as the former used the same animal model and a similar 
protocol. However, the investigation by Liu and colleagues used a different grafting material 
and different collagen membrane, therefore a comparison of tissue present in the healing socket 
should be interpreted with caution. Liu and colleagues reported no statistically significant 
differences in the volume of newly formed bone between any of the study groups at both time 
intervals. However, small differences of 47.9±5.0% and 45.7±10.7% were observed between 
8- and 16-weeks of healing in the ungrafted control group, and in the demineralised bone graft 
group with 38.6±18.1% and 41.1±11.1% respectively. At 16-weeks only one group was 
recorded to have a statistically significant difference in the volume of residual bone graft, while 
no differences were reported for the connective tissue volumes for any of the groups or healing 
times (Liu et al., 2016). 
 The study by Raveendiran and colleagues was conducted in a dog tooth extraction model. The 
duration of the study was twelve weeks. The bone healing rates between canine and ovine 
species were reported to be similar according to Duncan, (2005). Therefore, the results of the 
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Raveendiran et al., investigation could, potentially be compared to 8- and 16-weeks of healing 
in the current study. The authors reported the greatest difference with regards to the amount of 
newly formed bone between grafted and ungrafted sites of 46.49% and 37.51% respectively. 
The standard deviation values were not provided so the distribution of means is hard to 
compare. Also, it is unclear whether this difference is statistically significant. In the current 
investigation the newly formed bone volumes at sixteen weeks of healing were similar to the 
volumes reported by Raveendiran et al., but the differences in the current investigation were 
not statistically significant between the different membrane groups. 
5.3.4 Grafting material 
Demineralised bovine bone mineral graft, was used in the current study which is known for 
slow resorption rates based on the results of multiple human and animal trials (Araujo et al., 
2015; Araujo and Lindhe, 2009b; Artzi et al., 2000; Carmagnola et al, 2003; Liu et al., 2016). 
Some of these trials also report that ungrafted sites exhibit more newly formed bone when 
compared to the grafted sites, which was not the case in the current study. In this study no 
statistically significant differences were observed in the amount of newly formed bone between 
three groups at any of the healing time points, which is in agreement with the study by Liu and 
colleagues (Liu et al., 2016). Liu et al., also found no statistically significant differences in the 
amount of newly formed bone between ungrafted control group and the demineralised bovine 
bone mineral group (45.7±10.7% and 41.1±11.1%) respectively. In contrast Carmagnola et al., 
(2003) in a clinical trial in humans reported 56.1±18.1% of newly formed bone in a control site 
compared to 26.0±23.7% in Bio-Oss® group after four months of healing. The aforementioned 
dog study by Raveendiran and colleagues also reported that the “greatest difference” was seen 
in the amount of newly formed bone between grafted and non-grafted sites, 37.51% and 
46.49% respectively. These differences in reported outcomes could be attributed to differences 
in the follow up times, healing variations and the size of the extraction site. Carmagnola et al., 
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study was conducted using human participants and Raveendiran et al., study was conducted in 
dogs, while the current study and Liu et al., used an ovine mandibular extraction model. 
 
5.4 Clinical significance of the research 
The presence of a tooth within a bony envelope of an alveolar ridge determines bone shape and 
volume. Following extraction and natural healing, bone resorption can compromise future 
prosthodontic tooth replacement (Schropp et al., 2003; Walker et al., 2017). 
To minimise alveolar ridge resorption various alveolar ridge preservation techniques and 
materials have been investigated for the past few decades (Darby et al., 2008; Nart et al., 2017). 
To date, no “gold standard” material or technique have been identified with current materials 
limiting, but not completely eliminating the loss of alveolar bone (Atieh et al., 2015). 
Dental implant treatment is the prosthodontic tooth replacement option which is most affected 
by the loss of volume and changes in shape of the alveolar bone. However, the shape and 
volume of alveolar ridge are not the only parameters that influence the success of implant 
treatment. The quality of alveolar bone within the extraction socket is also an important factor 
that can influence the outcome of implant therapy. The quality of newly formed bone varies 
depending on the type of grafting material and technique used for alveolar ridge preservation, 
with some studies reporting graft interferences with the normal bone healing process (Becker 
et al., 1996; Heberer et al., 2008; Horvath et al., 2013). The current investigation has shown 
that OFM is a semi- rigid resorbable membrane. However, its potential to support the soft tissue 
on its own, without a bone replacement graft should be evaluated in further pre-clinical studies.  
In 2010 Dahlin defined a set of requirements that barrier membranes should meet. These 
included biocompatibility, occlusive properties, space-making capacity, integration with the 
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surrounding tissues and manageability (Dahlin, 2010). The current study demonstrated that 
OFM possesses several of these requirements. 
Our study has demonstrated that OFM had better handling properties as well as less 
displacement during soft tissue flap repositioning compared to Bio-Gide® membrane. OFM 
was equivalent to Bio-Gide® membrane in terms of bone graft retention and osteogenesis. 
Biocompatibility of this novel material was also established as no adverse events were 
observed. Another clinical significance of this material in alveolar ridge preservation is 
potentially a better acceptance by certain cultural and religious groups who currently are unable 
to use GTR materials of bovine or porcine origin. The current investigation may also contribute 
to future research of OFM and future human trials.  
 
5.5 Limitations, confounding factors, and other issues with the study 
The current study has a number of limitations that could have influenced the outcomes. 
 
5.5.1 Study design 
All three left side mandibular premolars were extracted. The protocol originally used by Liu 
et, (2013) and later modified by Lander, (2016) was used. The entire tooth was removed with 
care taken not to damage the inter-radicular bone, which allowed the extraction sites to remain 
self-contained. The first premolar is a very small tooth and the socket had to be enlarged 
surgically to ensure similar size defects for all three extraction sites. Despite the use of the 
implant drills the differences between the first and third premolars in some animals could not 
be eliminated and the dimensions of the extraction sites although similar were not the same. 
The use of implant drills to enlarge the sockets of first premolars potentially could have 
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overheated the bone or introduced particles into the socket that could influence the healing of 
those sites.  
Latin square allocation was used to ensure that every treatment had an equal distribution across 
the three extraction sites, so the potential limitation of the first premolar healing might have 
been compensated for by the study design. 
Other animal studies, instead of extracting the entire tooth, conducted their research by 
sectioning the teeth and extracting only one of the roots, while leaving the other root in situ 
(Araujo et al., 2008; Araujo and Lindhe, 2005; Cardaropoli et al., 2003). We could look at 
replicating that extraction model in sheep, to help avoid having grafted sites immediately 
adjacent to each other and separated only by thin interseptal bone. The sectioning of the tooth 
and extraction of just one root could also provide a reasonably reliable reference point and 
allow easier socket separation particularly in eight- and 16-weeks groups. 
Graft retention also seemed to be an issue in the current study, with 50% of sites in one group 
having no RBG material. Graft loss was also reported by other studies (Liu et al., 2016). There 
are a number of potential reasons for graft loss. One is bleeding following surgery and the 
resultant graft displacement from the socket. The other is the post-operative diet that was used 
in the current study. The animals were fed pellets and muesli-type food, both of which are hard 
foods and could have contributed to membrane loss/displacement and eventual graft loss prior 
to soft tissue healing. 
Difficulties with sample preparation were also encountered. The separation of the extraction 
sites into small individual blocks, was performed based on the radiograph of the jaw segment. 
Although, it seemed like a simple process, the accuracy of that could be questioned, as at times 
it was hard to distinguish the extraction sites and differentiate the borders of the sockets. That 
could have inadvertently contributed to the inclusion of the extra material, such as a portion of 
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an adjacent socket and influenced the results of this study, by introducing bias. This issue could 
be mitigated by the use of implanted markers or sectioning the teeth and extracting one root 
only. 
Initial limited experience of the primary investigator with the sample preparation technique, 
particularly with slide polishing and grinding could have limited the number of good quality 
slides available for data processing, which in turn could have introduced additional bias.  
 
5.5.2 Randomisation, allocation concealment, blinding 
Blinding the operator (surgeon, examiner, statistician) was not possible in the current study. 
The same examiner was involved in every step of this investigation from surgery to statistical 
analysis. Although blinding was not possible during surgery as the differences between the 
treatments were immediately apparent, during data processing the differences between the test 
membrane and the control membrane groups were less apparent and thus could alleviate some 
of the examiner bias. However, analysis of intra- and inter examiner reliability using repeat 
measurements of a randomly selected subgroup showed little evidence of systematic error or 
bias. 
5.5.3 Animal variation 
The experimental animals, 30 sheep, were selected from a large pool of farm animals, to avoid 
inbred heterogeneity. All animals were pre-screened by the veterinary staff to ensure dental 
health. Although, the pre-screening for dental heath was undertaken prior to surgery, the age 
of the animals was not made clear to the surgical team and we can only assume that the animals 
were between 3 and 4 years of age as required by the protocol. The weight requirement for this 
study was not adhered to, as was discovered immediately prior to surgery, with the lightest 
animal weighing in at 55kg and the heaviest at 71.5kg, considerably below the required weight 
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of 75kg. Having all animals in the study under the required weight threshold is a potential 
limitation, as underweight and malnourished animals have a slower rate of healing. 
 In avoiding inbred heterogeneity, the study ensured a diverse study group which could 
potentially account for the differences in healing patterns and explain large standard deviation 
in some groups. The age of the animals could also play and important role in hard tissue 
healing. According to Newman et al., (1995), age related bone structure changes are found in 
sheep. The animals between 3-4 years of age histologically demonstrate a plexiform bone 
structure, that has a vascular plexus within a combination of woven and lamella bone. As the 
animals age, secondary Haversian remodelling becomes more prominent and is observed in 7-
9-year-old sheep (Newman et al., 1995; Pearce et al., 2007). This age-related change in bone 
remodelling could potentially have influenced the outcomes of this study if the older animals 
were inadvertently included. 
 
5.5.4 Excluded specimens 
A total of nine samples (three extraction sites from three different animals) were excluded from 
the analysis due to abscess formation and incomplete healing of the sockets. One animal 
belonged to the eight weeks group and two to the sixteen weeks group, reducing the number of 
animals in both groups to nine and eight, respectively. According to sample size calculation, 
from the previous studies based on the same animal model, each group required eight animals 
to achieve statistical power. Therefore, despite exclusions, all groups had sufficient number of 




5.6 Conclusion and recommendations for future research 
5.6.1 Conclusions 
The current investigation was conducted to evaluate the materials handling properties and 
efficacy of a novel membrane - OFM in alveolar ridge preservation therapy and to compare it 
to a commonly used resorbable collagen membrane (Bio-Gide®). Histological and 
histomorphometric analyses were carried out for all included samples. Radiomorphometric 
data was also collected but is currently being processed and will be published separately.  
In all three groups, the ungrafted control, Bio-Gide® and OFM, bone formation followed a 
similar pattern in the early stage of healing, with very small volume of bone present in the four 
weeks group, with a large volume of fibrous connective tissue and no hard tissue bridging. At 
eight weeks the grafted sites differed from the ungrafted control in the sense that the coronal 
portion of the socket was covered with loose newly formed woven bone, while the ungrafted 
control group demonstrated no bridging. At 16 weeks of healing, all three groups had hard 
tissue bridge covering the socket and a smaller volume of connective tissue interspersing the 
newly formed bone. In the grafted sites, no differences were observed between Bio-Gide® and 
OFM groups in terms of bone formation around the grafted particles, with Bio-Oss® bone graft 
incorporated into newly formed bone. 
The results of histomorphometric analysis revealed significant new bone increase over time in 
all groups but showed no statistically significant differences between the groups at any of the 
time points. The amount of residual graft differed significantly between the Bio-Gide® and 
OFM groups at four weeks only. 
The placement of the membranes, although not timed, was perceived by the primary 
investigator as being easier with OFM due to its ability to stay in place better during flap 
repositioning and suturing. 
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The current investigation was the first study to evaluate hard tissue healing and safety of the 
OFM in an animal tooth extraction model. Within the limitation of this study, the results 
suggested that OFM demonstrated equivalent outcomes to Bio-Gide® membrane in terms of 
graft retention and osteogenesis in alveolar ridge preservation therapy in sheep. 
 
5.6.2 Recommendations for future research 
5.6.2.1 Future developments of the study design 
The ovine extraction model has been modified and improved with every investigation over the 
past few years. The modifications to the study design were undertaken in order to better answer 
the research question. 
The goal of this investigation was to evaluate the safety and efficacy of OFM and to compare 
it to an established marketed product. The parameters for investigation were handling of the 
membranes, graft retention and formation of new bone within the extraction site. 
The handling of the membrane should be an objective evaluation. With that in mind, timing of 
membrane placement is recommended for the future studies. The timing of the placement 
procedure should commence as soon as the membrane packaging is opened. That would allow 
a record of the entire process from trimming of the membrane to size, to positioning of the 
membrane over the edentulous ridge and eventually soft tissue approximation and suture 
placement. This would give a more accurate, objective comparison for the handing of different 
barrier materials. 
To increase graft retention, which was an issue in our study, a softer diet is recommended for 
the first two weeks post-surgery. Obviously, this recommendation needs to be verified by the 
veterinary staff to make sure that the animals would get proper nutrition and would accept that 
form of food. 
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If the recommendation of a soft diet is not acceptable due to a potential harm to the animals, 
another method of preventing graft loss could be implemented. That includes the use of 
titanium bone tack or similar materials to secure the membrane in place. This would prevent 
membrane displacement and graft loss and depending on the shape of the tacks might serve as 
a good reference point for specimen preparation and sectioning post-euthanasia. This 
suggestion, however, has a limitation, in that the normal application of resorbable membrane 
in alveolar ridge preservation does not require the use of bone tacks. Therefore, using this 
method in the animal model would influence the results and might not be representative of the 
actual outcomes achieved in human participants.  
Another means of increasing graft retention is employing a different study design, for example 
using a “protected site model”, such as a cranial defect. Using the cranial defect model could 
answer the question of which membrane contained the grafting material better, however it will 
cease to be a tooth socket model and the results would be difficult to compare to the alveolar 
ridge preservation studies. 
One of the goals of alveolar ridge preservation is to minimise the changes in shape and volume 
of the edentulous ridge. In the current study volumetric and morphologic changes were not 
investigated. Subsequent to this investigation, access to CT scanning has become possible and 
is now being investigated as a means to compare vertical and horizontal alveolar ridge 
resorption in sheep, at baseline and after post-extraction healing. With the available 
technologies such as mobile phone 3D scanner appts, digital impressions through CEREC and 
3-D radiographic imaging with CBCT, the future studies could add another dimension to hard 
tissue healing evaluation and investigate morphological and volumetric changes following 
application of novel grafting materials. 
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Another goal of alveolar ridge preservation is the placement of dental implants without the 
need for further bone augmentation procedures. A valuable extension to this study would be 
investigation of dental implants placed into the grafted sockets and their osseointegration. 
 
5.6.2.2 Investigation in other periodontal therapies 
The use of a barrier membrane is employed in several other periodontal therapies and is not 
exclusively for the use in alveolar ridge preservation technique. Guided tissue and bone 
regeneration, mucogingival deficiencies are just some of the other applications in which barrier 
membranes could be used. OFM was originally created for the use in soft tissue wound healing 
for patients with chronic diabetic ulcers and potentially could work for soft tissue regeneration 
intra-orally. Further animal studies are needed to investigate the safety and efficacy of OFM in 
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1. Medications used on experimental animals 
Medications or Materials 
 
Purpose Route Quantity 
Amphoprim 
(Trimethoprim sulpha) 
Antibiotic Subcutaneous injection 1mL/15kg 
Diazepam General anaesthesia IV infusion 0.2mg/kg 
Ketamine General anaesthesia IV infusion 2mg/kg 
Isoflurane General anaesthesia Inhalation 2.5-3.5% to effect 
Nitrous oxide General anaesthesia Inhalation 1-2% (to effect) 
Betadine (Povidone-
iodine) 





Topical  As required  
Lignospan (Lignocaine 
with Adrenalin 1:80000) 







Local anaesthesia Local infiltration 2-3x 1.8ml 
cartridges around 
surgical site 
Caprofen Anti-inflammatory Subcutaneous injection 4mg/kg 
Sterile saline Irrigation Topical  As required 
Bio-Oss® Bone replacement 
graft 
Placed into the socket 0.5g per defect 
Bio-Gide® Control membrane 
 (graft retention) 
Placed over the 
extraction socket 
(single layer) 
1 membrane per 
animal 
OFM    
Vicryl (3.0 resorbable 
sutures) 




2.  Chemical reagents used 




10% Natural Buffered Formalin (NBF), (BioLab Ltd, New Zealand) 
Ethanol, C2H5OH, (High Grade, Absolute Ethanol, Thermo Fisher Scientific, USA) 
Xylene C6H4(CH3)2, (Ajax Finechem Pty Ltd, New Zealand) 
Methyl methacrylate 99% (MMA), (Sigma Aldrich, USA) 




3.  Equipment 
PiezotomeTM (Satalec, Acteon, Merignac, France) 
Dyna-Surg electric handpiece and irrigation system (LV, USA) 
Gendex dental system (Monza, Italy) 
Air Techniques Peri-Pro III X-Ray film processor/developer (Melville, NY, USA) 
Elema-Schonander extraoral radiography unit (JARNHS, Stockholm, Sweden) 
Carestream T-MAT G/RA extra-oral film (Rochester, NY, USA) 
MediRay cassettes LA14125 (Livingstone, Albany, New Zealand) 
Tegra-Pol, polishing machine (Struers, GmbH, ZNL Schweiz, Germany) 
Silicon Carbide Paper, 500-2400 (Struers, GmbH, ZNL Schweiz, Germany) 
Accutome, cutting machine, Struers (GmbH, ZNL Schweiz, Germany) 
Rotation platform (Multitron®, Infors HT, Switzerland)
191 
 












 1st premolar 




1 597 4  29.1.18 60 26.2.18 OFM Bio-Gide® Control 
2 437 4  30.1.18 61 26.2.18 Bio-Gide® Control OFM 
3 432 4  31.1.18 60 26.2.18 Control OFM Bio-Gide® 
4 586 4  31.1.18 61 26.2.18 OFM Bio-Gide® Control 
5 590 4  31.1.18 62 26.2.18 Bio-Gide® Control OFM 
6 441 4  1.2.18 57 1.3.18 Control OFM Bio-Gide® 
7 583 4  1.2.18 61 1.3.18 OFM Bio-Gide® Control 
8 593 4  1.2.18 62.5 1.3.18 Bio-Gide® Control OFM 
9 428 4  2.2.18 64.5 1.3.18 Control OFM Bio-Gide® 
10 595 4  2.2.18 60.5 1.3.18 OFM Bio-Gide® Control 
11 440 8  5.2.18 71.5 4.3.18 OFM Bio-Gide® Control 
12 594 8  5.2.18 73 4.3.18 Bio-Gide® Control OFM 
13 589 8  5.2.18 62.5 4.3.18 Control OFM Bio-Gide® 
14 434 8  7.2.18 60.5 4.3.18 OFM Bio-Gide® Control 
15 591 8  7.2.18 70.5 4.3.18 Bio-Gide® Control OFM 
16 598 8  8.2.18 63.5 5.4.18 Control OFM Bio-Gide® 
17 426 8  8.2.18 63.5 5.4.18 OFM Bio-Gide® Control 
18 439 8  8.2.18 66 5.4.18 Bio-Gide® Control OFM 
19 438 8  8.2.18 64.5 5.4.18 Control OFM Bio-Gide® 
20 450 8  12.2.18 62.5 5.4.18 OFM Bio-Gide® Control 
21 430 16  12.2.18 58.5 5.6.18 OFM Bio-Gide® Control 
22 436 16  12.2.18 58 5.6.18 Bio-Gide® Control OFM 
23 599 16  13.2.18 62.5 5.6.18 Control OFM Bio-Gide® 
24 584 16  13.2.18 58 5.6.18 OFM Bio-Gide® Control 
25 587 16  13.2.18 57 5.6.18 Bio-Gide® Control OFM 
26 585 16  14.2.18 55.5 6.6.18 Control OFM Bio-Gide® 
27 442 16  14.2.18 61 6.6.18 OFM Bio-Gide® Control 
28 592 16  14.2.18 62 6.6.18 Bio-Gide® Control OFM 
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29 427 16  15.2.18 65 6.6.18 Control OFM Bio-Gide® 





5. The database search strategy and keywords 
Databases                                                                          Keywords 
Published studies 
PubMed (1965 - January 22, 2020)                             (.mp. = search as keyword) Tooth extraction OR             
                                                                                          alveolar socket OR extraction socket OR tooth socket          
                                                                                          OR alveolar ridge OR animal model OR sheep AND  
                                                                                          Bio-Oss.mp. OR Bio-Gide.mp. OR membrane OR  
                                                                                          collagen membrane.mp. OR resorbable membrane  
                                                                                          OR absorbable membrane OR barrier membrane OR            
                                                                                          bone replacement OR bone substitute OR bone graft  
                                                                                          OR xenograft AND Socket healing OR natural socket  
                                                                                          healing OR extraction socket healing AND Socket  
                                                                                          preservation OR alveolar ridge preservation OR bone  
                                                                                          preservation OR ridge preservation OR new bone  
                                                                                          formation OR bone fill 
EMBASE via Ovid (1974 – January 15, 2019)            Tooth extraction OR alveolar socket OR extraction         
                                                                                          socket OR tooth socket          
                                                                                          OR alveolar ridge OR animal model OR sheep AND  
                                                                                          Bio-Oss.mp. OR Bio-Gide.mp. OR membrane OR  
                                                                                          collagen membrane.mp. OR resorbable membrane  
                                                                                          OR absorbable membrane OR barrier membrane OR            
                                                                                          bone replacement OR bone substitute OR bone graft  
                                                                                          OR xenograft AND Socket healing OR natural socket  
                                                                                          healing OR extraction socket healing AND Socket  
                                                                                          preservation OR alveolar ridge preservation OR bone  
                                                                                          preservation OR ridge preservation OR new bone  
                                                                                          formation OR bone fill 
Scopus (2004 – January 15, 2019)                             “Tooth extract*” OR “alveolar socket*” OR 
                                                                                         “extraction socket*” OR “tooth socket*” OR  
                                                                          “alveolar ridge” OR “animal model*” OR “sheep” 
                                                                                          AND “Bio-Oss” OR “Bio-Gide” OR “membrane*”      
                                                                                              OR “collagen membrane*” OR “resorbable  
                                                                                              membrane*” OR “absorbable membrane*” OR  
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                                                                                              “barrier membrane*” OR “bone replacement” OR  
                                                                                              “bone substitute*” OR “bone graft*” OR  
                                                                                              “xenograft” AND “Socket healing” OR “empty  
                                                                                               socket healing” OR “extraction socket healing” 
Web of Science (1990 – January 15, 2019)                    Tooth extract*” OR “alveolar socket*” OR 
                                                                                              “extraction socket*” OR “tooth socket*” OR  
                                                                              “alveolar ridge” OR “animal model*” OR “sheep”   
                                                                                               AND “Bio-Oss” OR “Bio-Gide” OR “membrane*”      
                                                                                               OR “collagen membrane*” OR “resorbable  
                                                                                               membrane*” OR “absorbable membrane*” OR  
                                                                                               “barrier membrane*” OR “bone replacement” OR  
                                                                                               “bone substitute*” OR “bone graft*” OR  
                                                                                               “xenograft” AND “Socket healing” OR “empty  

















1.  Resin embedding – materials 
Methyl methacrylate, (Product catalogue number M55909, Sigma Aldrich, USA) 
Benzoyl peroxide, (Product catalogue number 517909, Sigma Aldrich, USA) 
Dibutylphthalate, (Product catalogue number 524980, Sigma Aldrich, USA) 
Xylene, (ajax Finechem Pty Ltd, New Zealand) 
MMA I and III 
4 parts Methyl methacrylate 
1% Benzoyl peroxide 
1part Dibutylphthalate 
 MMA II 




2.  Resin embedding protocol 
Transfer specimens to alcohol in cassettes with labels. 
20% ethanol for 4 days, changes solution after 2 days. 
40% ethanol for 2 days. 
75% ethanol for 2 days. 
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95% ethanol for 4 days, change solution after 2 days. 
100% ethanol for 4 days, changes solution after 2 days, keep container tightly covered to 
prevent evaporation. 
Transfer specimens in xylol for 4 days, change solution after 2 days. Keep xylol container on 
a rotating platform in fume hood. 
Wash specimens in MMA monomer. 
Prepare MMA bases in advance. Put 6-12mm MMA III in each jar. Place jars in a plastic light-
proof container partly filled with water. Leave without disturbing for at least 2 days. 
Transfer specimens to MMA I for 2 days in fume hood on rotating platform. Keep covered. 
Transfer specimens to MMA II for 2 days in fume hood on rotating platform. Keep covered. 
Transfer to individual jars with tightly- sealing lids, having pre-set bases of 6-12mm thick 
MMA III. Place a paper ID tag with each specimen. Specimens must be oriented flat on the 
bottom of a jar and not touching the sides. Place jars in a water bath within a light-tight 
container, at room temperature in fume hood and leave undisturbed for 2 weeks. If MMA is 
not set after 2 weeks, place unset specimens in a warm place at approximately 40°C. 
 
3.  Staining protocol (MacNeal’s Tetrachrome and Toluidine Blue) 
Solution A (supplied by Histology Unit, University of Otago, New Zealand) 
0.5g Methylene blue 
0.8g Azur II 





Mix all ingredients together and stir with magnetic stirrer. Leave for 12 hours at 50°C, then for 
3 days at 37°C. 
Solution B (supplied by Histology Unit, University of Otago, New Zealand) 
Toluidine blue in 10ml distilled water + 1.0g borax 




Place slides in 20% ethanol in a glass jar and place the jar in ultrasonic bath for 5 minutes. 
Place slides in 0.1% formic acid in a glass jar for 5 minutes in ultrasonic bath. 
Rinse with distilled water for 5 minutes. 
After 5 minutes remove distilled water from the slide and cover the section on the slide with 
combination of solutions A and B for 5 minutes. 







Appendix III Clinical and histological data 




























1 597 6 8 9 5 8 9 
2 437 7 7 9 10 12 15 
3 432 8 9 12 10 8 9 
4 586 8 10 10 12 12 10 
5 590 7 8 9 9 9 15 
6 441 8 7 10 15 15 15 
7 583 6 7 9 10 12 12 
8 593 8 7 9 9 12 12 
9 428 7 7 9 12 11 11 
10 595 7 7 9 15 15 9 
11 440 7 9 10 11 12 12 
12 594 7 7 10 11 12 12 
13 589 7 9 11 10 15 9 
14 434 6 7 7 8 15 15 
15 591 7 9 8 15 15 12 
16 598 7 8 10 15 12 12 
17 426 7 8 10 10 10 12 
18 439 7 9 10 10 12 15 
19 438 6 6 9 10 10 12 
20 450 7 7 9 15 10 15 
21 430 6 7 8 15 12 12 
22 436 6 7 8 10 12 15 
23 599 7 7 8 9 15 12 
24 584 6 7 8 15 10 10 
25 587 6 7 9 10 15 10 
26 585 7 7 12 12 15 20 
27 442 6 7 8 15 11 13 
28 592 7 7 9 15 10 9 
29 427 7 7 8 12 12 15 







2. Histomorphometric analysis - percentage of new bone, connective tissue and residual graft in all treatment groups after 4-weeks of 
healing (Bone – newly formed bone; CT – connective tissue; Graft = residual graft). 
A (OFM) 
    
B  
(BioGide) 
   
C  
(Control)    




C T 4 
 
Graft 4 
   
% % % 
 
% % %  % % % 
1 428LM2 4.870 80.241 1.3583 428LP1 2.495 66.395 27.108 428LA3 6.012 42.762 0 
2 428LM3 8.820 50.225 0 428LP2 9.287 55.241 12.291 428LA4 3.9 66.366 0 
3 432LM5 12.920 69.566 8.833 432LP2 14.512 73.995 9.854 432LA4 6.404 85.504 0 
4 432LM6 21.891 73.175 0 432LP4 2.345 86.762 7.316 432LA5 5.175 88.133 0 
5 437LP3 11.35 80.125 0 437LA1 14.412 50.212 17.35 437LM2 16.533 77.729 0 
6 437PL5 3.437 87.729 0 437LA2 21.279 73.295 0 437LM4 12.741 73.170 0 
7 441LM5 2.383 92.775 1.4 441LP10 1.2 98.591 0 441LA3 14.883 83.970 0 
8 441LM6 2.05 90.633 1.975 441LP11 0.262 99.575 0 441LA4 23.770 75.55 0 
9 583LA1 9.533 58.187 7.387 583LM2 10.179 59.733 0.7 583LP4 11.566 84.337 0 
10 583LA2 9.104 61.841 4.279 583LM3 6.054 76.783 10.95 583LP5 2.391 97.037 0 
11 586LA4 8.266 62.320 13.308 586LM3 5.041 58.658 24.312 586LP3 5.129 93.595 0 
12 586LA5 5.637 74.558 8.341 586LM4 7.845 64.704 25.283 586LP4 4.958 93.941 0 
13 590LP2 0.629 48.620 0 590LA3 4.995 75.629 12.658 590LM2 7.016 83.85 0 
14 590LP4 1.941 40.837 8.55 590LA4 6.266 63.362 29.95 590LM3 13.191 80.812 0 
15 593LP2 5.966 75.158 14.595 593LA7 7.395 51.975 37.087 593LM2 1.05 97.362 0 
16 593LP3 10.645 59.333 28.779 593LA8 11.008 60.954 26.012 593LM3 4.387 93.166 0 
17 595LA3 5.437 60.908 0 595LM3 5.725 71.433 0 595LP1 1.1 98.862 0 
18 595LA4 9.412 68.462 0 595LM4 2.425 94.708 1.691 595LP2 5.491 94.508 0 
19 597LA4 17.408 35.829 3.425 597LP6 4.745 74.937 17.583 597LP1 2.429 93.720 0 




3. Histomorphometric analysis - percentage of new bone, connective tissue and residual graft in all treatment groups after 8-weeks of 
healing (Bone – newly formed bone; CT – connective tissue; Graft - residual graft). 
A (OFM)         B 
 (BioGide) 
      C 
 (Control) 
      
No Label Bone 8  C T 8 Graft 8 Label Bone 8  C T 8 Graft 8 Label Bone 8  C T 8 Graft 8 
    % % %   % % %   % % % 
1 440LA4 29.412 28.720 0 440LM5 45.645 52.662 0 440LP1 24.720 67.395 0 
2 440LA6 23.808 26.579 0 440LM6 21.35 63.112 9.225 440LP2 34.687 44.2 0 
3 594LP3 7.687 91.833 0.287 594LA2 56.45 29.591 0.520 594LM2 31.141 67.091 0 
4 594LP6 4.920 94.908 0 594LA6 39.7 38.916 10.104 594LM6 28 71.987 0 
5 589LM3 33.395 63.358 0 589LP2 36.187 60.462 0 589LA2 29.995 68.220 0 
6 589LM4 39.9 42.495 0 589LP3 37.891 41.058 0 589LA3 42.983 56.066 0 
7 434LA3 19.958 74.85 0 434LM1 31.291 66.862 0 434LP3 0.316 99.162 0 
8 434LA4 22.066 75.295 0 434LM2 15.412 75.237 0 434LP4 4.704 95.216 0 
9 591LP3 47.233 51.458 0 591LA2 14.783 61.929 10.008 591LM2 23.604 73.962 0 
10 591LP4 7.804 72.254 19.35 591LA3 13.354 62.695 10.187 591LM3 36.375 59.645 0 
11 598LM3 35.925 35.341 27.729 598LP3 14.825 52.691 31.933 598LA3 65.095 22.325 0 
12 598LM4 17.491 61.15 19.333 598LP4 42.304 51.029 5.154 598LA4 58.85 40.825 0 
13 426LA3 40.058 47.8 0 426LM2 37.516 49.637 0 426LP2 13.845 85.15 0 
14 426LA4 44.758 45.304 1.075 426LM5 29.812 67.754 0 426LP3 15.941 77.025 0 
15 439LP2 33.108 37.870 19.479 439LA1 33.55 35.004 24.008 439LM4 20.637 74.245 0 
16 439LP3 21.983 43.833 25.35 439LM1 29.341 42.387 18.537 439LM5 18.1 80.070 0 
17 438LM3 48.979 35.895 2.5208 438LP3 40.191 31.333 17.425 438LA5 25.183 55.833 0 
18 438LM4 49.870 39.254 0.695 438LP4 38.195 50.566 0 438LA6 20.662 59.862 0 
19 
    
  
   
  
   




4.  Histomorphometric analysis - percentage of new bone, connective tissue and residual graft in all treatment groups after 16-weeks of 
healing (Bone – newly formed bone; CT – connective tissue; Graft - residual graft). 
A (OFM)         B  
(BioGide) 
      C  
(Control) 
      
No Label Bone 16 CT 16 Graft 16 Label Bone 16 C T 16 Graft 16 Label Bone 16 C T 16 Graft 16 
    % % %   % % %   % % % 
1 430LA4 61.841 34.112 3.525 430LM1 49.795 43.220 5.225 430LP4 28.941 68.470 0 
2 430LA5 55.812 27.362 5.541 430LM3 40.537 38.8 20.587 430LP5 38.912 59.858 0 
3 436LP3 58.458 38.837 0 436LA1 67.725 31.116 0 436LM1 70.662 28.891 0 
4 436LP4 59.920 35.708 0 436LA2 68.825 28.116 0 436LM3 55.141 43.937 0 
5 599LM3 58.283 30.7 5.429 599LP6 39.804 55.887 3.854 599LA3 14.779 84.520 0 
6 599LM4 57.162 35.908 5.075 599LP7 50.404 39.379 10.025 599LA4 17.470 82.4 0 
7 584LA1 63.408 21.116 9.991 584LM4 34.9 45.125 18.537 584LP3 42.266 57.570 0 
8 584LA2 62.325 35.433 1.979 584LM5 20.525 44.029 3.479 584LP4 34.804 62.758 0 
9 585LM2 24.062 66.195 8.629 585LP3 33.379 66.575 0 585LA5 23.245 68.987 0 
10 585LM5 37.662 61.975 0 585LP5 5.425 67.225 0.7416 585LA6 40.45 51.829 0 
11 592LP9 31.445 62.85 4.3 592LA3 43.233 25.441 29.787 592LM3 29.454 54.658 0 
12 592LP10 34.733 53.070 12.033 592LA4 51.4 24.383 18.983 592LM4 49.370 50.291 0 
13 427LM5 38.908 50.679 7.383 427LP6 28.329 68.479 0 427LA3 76.141 22.033 0 
14 427LM6 23.329 55.425 17.458 427LP7 26.579 68.433 3.125 427LA4 75.15 22.858 0 
15 425LA2 37.95 42.437 0 425LM3 60.687 34.608 0 425LP3 24.941 73.808 0 
16 425LA4 45.991 36.887 0 425LM4 54.379 38.958 0 425LP5 39.412 52.220 0 
17 
    
  
   
  
   
18 
    
  
   
  
   
19 
    
  
   
  
   





5. Re-measurement of new bone, connective tissue and residual graft in the ROI to establish reproducibility 
  New bone   Connective 
tissue 
  Residual 
graft 
 
















Original Original Repeat 
measurement 
Original Original Repeat 
measurement 
Original 
436LA1 67.7 64.6 66.8 31.1 32.1 29.8 0 0 0 
437PL5 3.4 4.6 11.7 87.7 83.6 78.3 0 2.3 1.9 
438LP4 38.2 38 38.5 50.6 51.9 41.9 0 4.6 8.4 
440LA6 23.8 22.8 26.4 26.6 26.2 21.3 0 0 0 
583LM3 6.1 5.7 7.1 76.8 78.4 79.3 11 11.1 10.4 
583LP4 11.6 11.8 22.5 84.3 83 74.5 0 0 0 
585LP3 33.4 32.9 38.5 66.6 66.8 60 0 0 0 
586LA4 8.3 8.2 12.2 62.3 61.4 62.8 13.3 13.3 18.3 
586LP3 5.1 6.9 12.4 93.6 91.5 86.5 0 0 0 
591LM3 36.4 39.4 37.4 59.6 59.6 59.2 0 0 0 
592LM3 29.5 31.8 49.4 54.7 53.9 44.4 0 0 0 
592LP10 34.7 35.5 31.9 53.1 51.2 35.3 12 11.7 8.3 
594LP6 4.9 4.6 1.5 94.9 91.7 98.1 0 0 0 
598LA3 65.1 62.6 76.7 22.3 24.2 20.1 0 0 0 





6 Pierson correlation of intra- and enter-examiner reliability (1° - primary; Bone – newly formed bone; CT – connective tissue; Graft – 
residual graft). 
Pearson 































    Bone Bone Bone CT CT CT Graft Graft Graft 
1° investigator 
(Original) Bone   .957**               
Research 
member 
(Original) Bone     .961**             
1° investigator 
(Repeat 
measure) Bone .997**                 
1° investigator 
Original CT         .973**         
Research 
member 
(Original) CT           .977**       
1° investigator  
(Repeat 
measure) CT       .998**           
1° investigator 
Original Graft               .871**   
Research 
member 
(Original) Graft                 .942** 
1°investigator 
(Repeat 
measure) Graft             .966**     
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** Correlation is significant at the 0.01 level (2-tailed) 
